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Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

The Cost of Arthroscopy
To the editors. —The letters of Profitt and
Giachino and of Sullivan in the Septem
ber 1986 issue of the Journal (page 301)
both deserve comment.
Simple arithmetic indicates that Profitt
and Giachino are doing about 10
arthroscopic examinations per week — a
considerable number. Have they given
any thought to “ containing” the cost of
investigating knee symptoms by reducing
the number of arthroscopies?
I agree with Dr. Sullivan about the exis
tence of enthesopathy — more commonly
known as “ tendon-bone junction syn
drome” — but it can be diagnosed
without arthroscopy. Indeed, the bonetendon interface at the lower pole of the
patella cannot be seen from inside the
joint as it is covered with synovium and
the retropatellar fat pad.
I think far too many arthroscopic
examinations are being done and that this

leads to unwarranted surgical procedures,
particularly now that instruments for
arthroscopic surgery are widely available.
W .R. H a r r is ,

m d , frcsc

Ste. E.N. 1-234,
Toronto General Hospital,
200 Elizabeth St.,
Toronto, Ont.
M5G 2C4

The Need to Use the Huber-point
Needle in the Port-A-Cath
Implantable Device
To the editors.—The Port-A-Cath (Phar
macia [Canada] Inc., Dorval, PQ) is a
totally implantable drug delivery system,
with a stainless steel port connected to a
silicone catheter, which is implanted into
a vein. The reservoir is entered through

The Canadian Journal of Surgery
Tel.: (6 1 3 ) 7 3 1 -9 3 3 1
The Canadian Journal o f Surgery is published by the Canadian Medical Association
and sponsored by the Royal College of Physicians and Surgeons o f Canada. The es
tablishment o f editorial policy is the responsibility of the Royal College. The objec
tives o f the Journal, endorsed by the Council of the College, are: (1) to contribute
to the effective continuing education o f Canadian surgical specialists, using innova
tive techniques when feasible and (2) to provide Canadian surgeons with an effec
tive vehicle for the dissemination o f their observations in the area o f clinical research.

a self-sealing silicone rubber septum
which, according to the m anufacturer’s
manual, will accept 2000 punctures, using
an atraumatic 22-gauge Huber-point nee
dle, without leakage. The manufacturer’s
recommendation is not to use regular nee
dles, such as a 22-gauge Yale hypodermic
needle, for fear of damaging the septum.
Since March 1984 we have implanted
over 75 Port-A-Cath devices at the Royal
Victoria Hospital in Montreal, using
mainly the Huber-point needle to gain
access to the venous system. Occasionally,
we ran short of Huber-point needles,
making access through the Port-A-Cath
impossible.
In view of the lack of information in
the medical literature on the use of dis
posable Yale hypodermic needles through
the Port-A-Cath septum, we decided to
test and compare leakage from the sep
tum using both types of needle.
continued on page 99
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A Report on Clinical Trials
of NU GAUZE* Sponges including in vitro
and in vivo com parisons
w ith conventional cotton gauze sponges

In this study by Dr. Dale C. Birdsell, Chief of Plastic
Surgery at Calgary’s Foothills Hospital, and his associate
Dr. John S.D. Davidson, also of Foothills Hospital,
conventional cotton gauze sponges were compared with
NU GAUZE* rayon sponges.
In the field of medicine, the most newsworthy items are
usually new surgical procedures or medications. Little
attention is given to advances made in the everyday ‘tools
of the trade', so to speak, such as instruments, sutures,
dressings and sponges. As Dr Birdsell says in his study,
“One could take the view that the cotton gauze sponges
presently used (in use for more than 50 years) are
perfectly adequate and no changes are required. This
would be wrong. Firstly, they may be adequate, but they
are not perfect.” Dr. Birdsell then gives a very appropriate
comparison of our attitudes towards our ‘tools of the trade’,
“If surgeons 20 years ago had not taken a progressive
attitude concerning new suture materials, we would
probably still be using silk and cotton sutures. Is it possible
that the presently used cotton gauze sponge will someday
be considered in the same category with silk and cotton
sutures?”
Considering the work that the sponge is called upon
to do, everything from prepping to dressing wounds, it
should do these tasks with maximum efficiency and
minimal possible deleterious side effects. A lot has been
written about effects of lint in wounds and about maceration
under wet dressings. Dr. Birdsell investigated linting and
absorption, both in vitro and in clinical trials, comparing
NU GAUZE* sponges and cotton gauze sponges.
The results of these clinical investigations showed that
NU GAUZE* sponges fared considerably better than
cotton gauze sponges.
ABSORPTION CAPACITY (in mL of citrated blood)
OF NU GAUZE* SPONGES COMPARED TO 8
AND 12 PLY COTTON GAUZE SPONGES
Trial #

NU G AUZE*

C o tto n
g a u ze

D iffe re n ce

C otto n
ga uze

D iffe re n c e

12 ply

s p ly
1

17

11

6

14

3

2

16

11

5

14

2

3

17 .5

11

6 .5

14

3 .5

4

18

11

7

13

5

5

17

11

6 .5

13.5

4

17 .2

11

6 .2 (5 6 .4 % )

13.7

A v e ra g e

3 .5 (2 5 .5 % )

“The total absorption capacity of the NU GAUZE* sponge
exceeded that of the 8 ply and 12 ply cotton gauze
sponges by approximately 56% and 26% respectively.
Furthermore, subsaturation amounts of blood were always
more completely absorbed by the NU GAUZE* sponges
in both the laboratory and clinical settings. In the latter
case, donor sites were left drier and hence more
amenable to easy and efficient dressing of the wound. As
well, removal of the NU GAUZE* sponge from the wound
was consistently associated with less disruption of the
exposed and friable dermal capillary bed. Less disruption
and thus less bleeding contributed to the efficiency of
dealing with the donor site wound.
In vitro studies show quite conclusively that NU GAUZE*
sponges contain less free lint than conventional cotton
gauze sponges. Free lint in surgical wounds poses a real
threat from the standpoint of inciting foreign reactions.
Such reactions could enhance scar formation that may
jeopardize the final outcome in plastic surgical procedures
ranging in scope from cosmetic surgery to tendon and
peripheral nerve surgery. Further, any retention of lint
(a foreign body) could increase the likelihood of bacterial
contamination progressing to infection.”
Concerning the handling properties of NU GAUZE*
sponges, both investigators found the enhanced resiliency
of the NU GAUZE* sponges to be a positive feature when
packing closed spaces or applying dry pressure dressings.
As Drs. Birdsell and Davidson summarized, “From these
investigations, the NU GAUZE* sponges display features
that make them comparable to, and in many aspects
superior to conventional cotton gauze sponges. We found
NU GAUZE* to have better absorption, while being less
linting, less wound disruptive and more resilient than
ordinary cotton gauze sponges. This makes NU GAUZE*
a more rational choice for an all-purpose, absorbent
sponge for dressing and wound care.”
NU GAUZE* Sponges are available from Johnson
& Johnson Inc.
For a copy of the complete clinical report, contact the
Patient Care Division, Johnson & Johnson Inc., Montreal,
Quebec H1V2E4.

‘ Trademark of JOHNSON & JOHNSON

SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Determining and Rationalizing
the Supply of Physicians
The Royal College of Physicians and Sur
geons of Canada and the Canadian Med
ical Association are working together to
determine how many specialists are
needed now and in the future. Their first
step is to find out how many physicians
are currently practising in the 39 special
ties, relying mainly on data collected by
CMA’s “ physician manpower question
naire” sent out in 1982, and they are
validating the information.
Coordinating the operation is James A.
Low, FRCSC, who chairs the manpower
committee of the Royal College; he is sup
ported by staff in the CMA Department
of Economics who expect the job to be
complete about December 1987. Also,
each medical and surgical specialty has a
working group to share the task of con
tacting hospitals across the country. Once
the information has been updated, the
groups will be drafting statements about
the current numbers in the specialty and
the “ ideal” number as a proportion of
the population.
For example, the Canadian Association
of General Surgeons’ manpower and eco
nomics committee undertook the task for
general surgery. The committee, chaired
by Frank Turner, FACS, FRCSC, in
Kelowna, BC, had completed the legwork
at the end of January.
Said Turner, “ We split the task up by
province; in Prince Edward Island, the
job was not so bad — of the 11 surgeons
on the list, 6 were in practice. In Ontario
where we found 560 surgeons, the task
was done in two ways because Ontario
already had a list. We compared the
names on the two lists and then called col
leagues to verify information not appear
ing on both lists.
“ The figures indicate that of 2683
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

surgeons listed on CMA’s data bank as
full-time general surgeons only 1517
(56.5%) are in fact practising general
surgery full time. Quite a number have
retired, several have died, and others have
moved into other branches of medicine
or into administration. This figure seems
to apply right across the country, which
means that government forecasts have
been based on incorrect data, and it
explains why we as an association have
always been hearing about 2000 general
surgeons but could only get about 1200
members.
“ In some parts of the country, physi
cians, although not certificated, are prac
tising general surgery, but most are senior
doctors in remote communities who have
done it for years and are quite competent.
“ To get a handle on the needs for the
future, we have been approaching com
munities and finding out whether they
have enough or too many general sur
geons” , but the group is still wrestling
with the problem of determining an
appropriate ratio for general surgeons to
population.
Turner commented: “We may find that
in a large community one general surgeon
can serve 17 000 people whereas a com
munity of 10 000 also needs at least one
surgeon.”
Said N. Tait McPhedran, FACS,
FRCSC, of Calgary, who has been work
ing with Turner, “ We’ve known for at
least 10 years that general surgeons are
one of the groups getting older. It was one
of the first specialties to fill after the War,
and general surgeons are retiring as
predicted very quickly. We are going to
see a major shortage within the next 5 to
10 years.
“ Training takes a minimum 4 years so
there’s no turn on, turn off mechanism.
We have attempted to interest university
people and government in providing more
slots for training, but so far our requests
have fallen on deaf ears.”

The federal/provincial advisory com
mittee on health manpower forecast a
shortage of 994 in the surgical specialties
and 389 in laboratory specialties by the
year 2000. The same report, founded
mainly on information from Southam
Medical Data Base and released early in
1985, asserted that a surplus of general
practitioners and medical specialists
existed in 1980 and that it would grow to
4870 and 2495, respectively, by the year
2000. However, CMA and the Royal Col
lege believe that the forecast was inac
curate for several reasons, not the least
of which was an underestimate o f death
and retirement of physicians in the next
four decades. Also the government com
mittee, which did not include any physi
cians, projected a decline in emigration
rates.
Figures about the ages of physicians
suggest that annually 600 physicians will
retire or die during the years 1986 to 1990
and the numbers will rise to 1550 each
year during the period 2010 to 2020.
According to the Royal College and
CMA, this finding and the current
emigration rates indicate an overall short
fall of 1754 physicians in the year 2000
even if the government’s physician-topopulation ratios are correct.
Two specialty groups — laboratory
medicine and neurology — undertook
validation as a pilot project last summer.
Both called for growth not cutbacks in
residencies. For example, the committee
for laboratory medicine recommended
increases such that the ratio, which is cur
rently one specialist to 19 764 people,
would be one to between 15 659 and 17
307. The committee based its recommen
dation on numbers of vacant positions
currently funded in hospitals across the
country and estimates by laboratory
directors about positions needed to pro
vide standard services.
Both McPhedran and Turner agreed
that few specialty groups are likely to ask
for a cut in residency positions, but, said
McPhedran, “ There are some that are
obviously overfilled — if you look at it
objectively — pediatrics, family practice
and medical specialties.”
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The groundwork for validation of data
about medical specialists and family phy
sicians has been laid. Emergency physi
cians have already completed the task.
Said Jan Ahuja, FRCPC, “ We were for
tunate in that we as a group (the Cana
dian Association of Emergency Physi
cians) had undertaken in the summertime
a study on our own. We used the same
five people in the geographic areas and
they had subcommittees phoning every
hospital in Canada.
“ For the Ottawa area, I participated in
the original survey and I spent about 10
hours on the phone; I’m quite sure that
literally hundreds of man hours went into
this. We contacted department heads and
sent them a questionnaire.”
Like general surgeons, the emergency
physicians found the data were not relia
ble: “ We found many people who were
listed as emergency physicians but did not
have certification from the Royal College
or from the College of Family Physicians
of Canada.” The implication is that more
such specialists are needed so the focus
is to find out not only who has formal
qualifications to practise a specialty but
who is actually practising, that is, spend
ing about 70% of his or her time work
ing in the specialty.
In the next issue of the Journal the
question of mandatory retirement will be
discussed.

78

Work Under Way
on New Heart Facilities for VGH
A project estimated at $2.7 million will
give the Vancouver General Hospital six
new operating rooms and 62 new beds —
18 for cardiac intensive care and 44 for
patients who have had heart operations.
Costs of the project will be shared on
a 60 to 40 basis by the provincial govern
ment and the G reater Vancouver
Regional Hospital District. Completion
is expected in autumn 1987.

Defence Association Wants
More Surgeons Ready for Service
The Canadian Forces Medical Services
need more surgeons who are familiar with
the military and who can respond in an
emergency, said representatives at the
annual conference of defence associa
tions, held in Ottawa in January.
A.V. Grasset, MCFP, president of the
Defence Medical Association, outlined
concerns to CJS: “ We discussed the lack
of medical specialists, specifically trauma
surgeons, orthopedic specialists and
anesthetists, for the armed forces to
respond in case of a crisis.
“ There are barely enough in the Cana

dian forces for peacetime conditions. If
there were an overseas crisis or one in
Canada, such as a 747 going down in the
Arctic, the Canadian forces with its
potential transport, mobility and exper
tise could be called upon to help and
should be able to supply sufficient medi
cal care. If there were sudden hostilities
in Europe, the NATO forces would
require 24 surgical teams immediately.
About seven could be provided by allies
on the spot but the Canadian Forces Med
ical Services would have to provide 17
teams of surgeons, anesthetists and sur
gical assistants.
“ At the moment, the total number of
trained surgical specialists on strength is
13; the total number of anesthetists on
strength is 6. One possibility is to invite
names on a list to supplement the
reserves; the group could be given some
basic training at times convenient to
them. In other words we could ask for
volunteers to be ready for emergencies;
they would be given some incentive and
orientation and would be available in
emergencies. We are asking the govern
ment for such a program, which would
be in addition to the medical reserves. The
reserves provide regular part-tim e
experience in the military and also badly
need health professionals of all sorts.”
A my Chouinard
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Tibialis Anterior Muscle Hernia: a Rationale for Treatment
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Tibialis anterior muscle hernia is an
orthopedic problem that should be dealt
with carefully since the potential compli
cations of treatment are serious. The
literature is reviewed to provide a better
understanding of the natural history, inci
dence, classification and treatment of
muscle hernias.
Guidelines are proposed for a rational
treatment plan for tibialis anterior muscle
hernias. Asymptomatic hernias need no
treatment. Longitudinal fasciotomies are
recommended as the treatment of choice
in symptomatic tibialis anterior muscle
hernias that are refractory to conserva
tive treatment.
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La hernie du muscle jambier anterieur est
un probleme orthopedique qui doit etre
aborde avec precaution car les complica
tions du traitement peuvent etre serieuses. On a fait I'Stude des publications
sur le sujet afin d'en ressortir une meilleure connaissance de I'histoire naturelle
de la hernie musculaire, de son inci
dence. sa classification et son trai
tement.
On sugg&re une marche a suivre visant
a offrir un plan de traitement logique des
hernies du muscle jambier anterieur. Les
hernies asymptomatiques ne necessitent
aucun traitement. Une fasciotomie longitudinale est recommandee comme traite
ment de premier choix dans les cas de
hernies musculaires qui rgsistent a un
traitement conservateur.

Herniation of the tibialis anterior muscle
is generally asymptomatic and a relatively
minor orthopedic problem, but if not
treated with the utmost care it can have
serious consequences. There is a group of
patients who will seek medical attention
because they experience symptoms or are
concerned with the cosmetic appearance
of the leg. Therefore, a thorough under
standing of the natural history of muscle
hernia and an appreciation of potential
complications arising from proposed
treatment are necessary for a rational
approach to management.
History

Muscle hernias are not rare but have
received little attention in the medical
literature, even though the earliest pub
lished report was by Richet in 1855.*-2 A
number of other reports followed3 and
in 1929 Ihde1 published the first compre
hensive review of the literature. In addi
tion he provided a system of classifica
tion for muscle hernia and reported 12
cases in the leg and 1 in the thigh, all
occurring in military personnel. Through

to the late 1940s most of the reports were
provided by military physicians, describ
ing their personal experiences with diag
nosis and management of muscle hernias
in military recruits.4-9 Since then there
has been a relative paucity of published
information on the subject. Authors have
outlined modes of treatment that vary
from simple closure of fascial
defects5,7'10 to patch repair with fascial
grafts,5,11'12 most reporting good func
tional and cosmetic results. Recently, seri
ous complications have been reported
after treatment of muscle hernias.13,14
Wolfort and colleagues14 described two
cases of anterior tibial compartment syn
drome (Fig. 1) after hernia repair.
The purpose of this paper is to propose
guidelines for the management of mus
cle hernias, that, if followed, should
reduce the risk of this complication.
Incidence

Opinions vary as to the true incidence
of muscle hernia. Ihde1reported the con
dition as rare, because there were few
reports of muscle hernia at that time.
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FIG. 1—Compartment syndrome, serious complication of repair of tibialis anterior mus
cle hernia.
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Other authors have now concluded that
the condition is more com m on.715
McMaster in 19437 reviewed 1800 hospi
tal admissions to an orthopedic hospital
for marines and found 21 men with 38
muscle hernias. Only two reports in the
literature of muscle hernia occurred in
women, but since most of these reports
are of military personnel this may not
reflect the true incidence of muscle her
nias in the general population. Obermaier
and Wilson15 reported their experience
with muscle hernia and postulated that its
incidence in the general population is
underestimated since most cases are
asymptomatic and the patients do not
seek medical attention. They also noted
that in a large number of patients the ini
tial diagnosis was incorrect and patients
were not considered for surgery. There
does not seem to be any specific tendency
towards race or geographic location.
Most patients are young men between 18
and 40 years of age.
Etiology and Classification
The preponderance of healthy, active,
young men with this disorder suggests
that heavy muscular activity may predi
spose to muscle hernia. The tibialis
anterior muscle is the one most often
affected, but hernias have been reported
in other muscles in both upper and lower
extremities.14 The simplest and most use
ful classification was proposed by Ihde,1
who divided muscle hernias into two
groups: constitutional and traumatic.
Constitutional hernias result from a con
genital defect in the muscle fascia that
enlarges, permitting a muscle hernia. This
theory has been supported by various
authors.7,15 Although Ihde only noted
single hernial defects, later reports6 sug
gested that constitutional hernias could be

either single or multiple and were often
bilateral. Obermayer and Wilson15 noted
that most hernias occurred approximately
15 cm above the lateral malleolus, the
area in which the small saphenous vein
connects with the deep venous system.
McMaster7 postulated that herniation
occurred at the site where the superficial
peroneal nerve exits the anterior compart
ment fascia. Herniation at this site could
lead to nerve entrapment and be a cause
of symptoms. Traumatic defects (Fig. 2)
can be either direct or indirect. Direct her
nias result from injury to the muscle fas
cia, as with a sharp penetrating wound.
Indirect hernias are the result of a blow
to the contracted muscle causing rupture
of the fascia and subsequent muscle her
niation.7
Clinical Presentation
Most patients present with a wellcircumscribed mass at the junction of the
middle and distal thirds of the tibia that
may be asymptomatic but causes the
patient concern because of the cosmetic
deformity or the possibility of a tumour.
Symptoms include aching after prolonged
exertion that subsides with rest. On phys
ical examination the fascial margins are
easily palpable.1'7’9’15 The hernias are
usually soft and easily reducible and can
be accentuated by various maneuvers
including the “ fencer’s lunge” position
(the patient weight bearing and the hip,
knee and ankle all flexed) described by
Pichon.3 The differential diagnosis
should include thrombophlebitis,16 vari
cosities,1,7 hem atom a,1 lipom a,7,13’15
fibroma, angioma1315 and soft-tissue
sarcoma.
Treatment
Conservative therapy such as the use of
support hose1’10,13 may be beneficial if
symptoms are mild. Various surgical
procedures have been advocated, ranging
from simple fascial suturing5,6,17 to
repair of the fascial defects with fascia
lata grafts.9,11,12 More recently, Boriani13
advocated a periosteal patch graft for fas
cial defects that are adjacent to the
anterior tibial border and LeRiche pro
posed a longitudinal fasciotomy for
symptomatic hernias.13
Discussion and Conclusions

FIG. 2—Post-traumatic tibialis anterior
muscle hernia in young woman.
80

Closure of a fascial defect in the
anterior muscle compartment of the leg
by simple suturing or patch grafting will
inevitably lead to elevated pressures
within that compartment by converting
an open system to a closed system with
a fixed volume capacity. Postoperative
edema and hematoma formation will
accentuate this increase in pressure and
may lead to a compartment syndrome.

Simple repair of a fascial defect by
direct apposition of fascial edges is espe
cially dangerous because not only does it
close the compartment but it also reduces
the volume of that osteofascial compart
m ent. T here are rep o rts in the
literature9,18 of compartment syndrome
following simple muscle hernia repair. We
consider it an unacceptable complication.
Other procedures that have met with
some success include fascia lata
grafts9,11,12 and periosteal patch grafts
from the tibia.13 We have no experience
with these techniques and, theoretically,
the risk of compartment syndrome is
higher. We propose the following guide
lines for the management of tibialis
anterior muscle hernia.
• Asymptomatic muscle hernias need
no treatment. Cosmesis is usually not an
indication for surgery as operative com
plications are serious.
• For mild cases with symptoms, use
of support hose may be of benefit.
• Surgery may be considered for
patients with moderate to severe sym
ptoms and unsuccessful conservative
management. Simple fascial repair should
never be attempted.
If fascial patch grafting is the proce
dure chosen, great care should be taken
not to close the compartment tightly, and
careful postoperative monitoring is neces
sary. We suggest longitudinal fasciotomy
to decompress the entire anterior com
partment and avoid the potential compli
cation of compartment syndrome.
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Long-Term Review
of the McGoey-Evans High-Friction Uncemented
Total Hip Arthroplasty
To assess the long-term clinical results
of uncemented total hip arthroplasty
with the McGoey-Evans bipolar highfriction hip prosthesis, the authors
reviewed the findings in 86 such hip
replacements. The minimum patient
follow-up was 5V2 years (mean 9 years).
Overall, satisfactory results were
obtained in 46 .5% of cases. There were
no deep infections. In contrast to the
experience with the cemented hip
replacements, the authors found that the
results were better in men than women
and that most of the revisions were done
within 5 years of the original operation.
Tissue hypersensitivity resulted in
implant loosening in only two cases and
no harmful systemic effects arose from
the use of this uncemented cobaltchromium prosthesis.
Although this particular hip prosthesis
is not recommended because of its
inferior design, the findings of the study
could be useful in the current practice of
uncemented hip arthroplasty.
Dans le but d'evaluer les resultats a long
terme de I'arthroplastie complete de la
hanche n'utilisant aucun ciment et faisant appel a la prothese bipolaire a fric
tion elevge McGoey-Evans, les auteurs
ont passe en revue les observations de
86 arthroplasties de ce type. Les
patients ont fait I'objet d'examens de
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surveillance pendant un minimum de 5 1/2
ans (moyenne de 9 annees). Dans
I'ensemble, des resultats satisfaisants
ont et£ obtenus dans 46 .5% des cas.
On n'a constat^ aucune infection profonde. Contrairement a ce que Ton sait
des proth6ses cimentees de la hanche,
les auteurs ont observe que les r6sultats
ont 6te meilleurs chez les hommes que
chez les femmes et que les revisions ont
et£ effectuees dans les 5 annees qui suivirent la premiere operation. L'hypersensibilite tissuiaire fut la cause d'un relachement de la prothese dans deux cas
seulement. Aucune reaction systemique
adverse n'a et6 reliee a I'utilisation de la
prothese au cobalt-chrome.
Bien que cette prothese particuliere de
la hanche ne puisse etre recommandee
du fait de sa moins bonne conception,
les observations recueillies dans cette
etude peuvent servir dans la pratique
actuelle des arthroplasties de la hanche
sans ciment.

A significant early contribution to hip
arthroplasty was that of Smith-Petersen
who, in 1923, introduced the cup
arthroplasty to cover the reshaped
femoral head.1 Subsequently Moore2 and
Thomson3 described proximal femoral
hemiarthroplasty. A few years later,
Urist4 and McBride5 introduced the
acetabular cup replacement arthroplasty.
The combination of an acetabular cup
with a proximal femoral replacement
started the modern era of total hip
arthroplasty. The early prostheses, with
all-metal components, were implanted
into bone either with or without the use
of acrylic cement. In 1964 McGoey and
Evans in Toronto started using a cement
less all-metal total hip replacement
prosthesis. Based on the concept of low
friction, hip arthroplasties6’7 sharply
improved results and with time rendered
early total hip systems obsolete. However,
long-term studies have shown a number
of late complications related to these

prostheses, the most common o f which
is component loosening, a particularly
worrisome complication in younger active
patients.8-12 These long-term problems
have led to the promotion, especially in
Europe, of newer types of uncemented
hip arthroplasties.13-16 Long-term follow
up results of these new uncemented
arthroplasties with respect to durability
and biocom patibility are n o t yet
available.17
The renewed interest in the uncemented
total hip replacement prompted us to
review the long-term results obtained with
the M cG oey-E vans h ig h -fric tio n
uncemented hip prosthesis, in the hope
that some of the lessons learned from its
use would apply to the current practice
o f cementless hip replacement surgery.
Patients and Methods
To make the results o f this study
meaningful we included only cases in
which the patient was followed-up for at
least 5!/2 years; that is, patients who had
undergone a McGoey-Evans uncemented
total hip replacem ent a rth ro p lasty
between 1964 and 1976. In 121 patients
(48 men, 73 women), 135 prostheses were
implanted (14 bilateral replacements).
The mean age of patients at the time of
surgery was 60 years (range from 17 to
84 years). Indications for operation were
osteoarthritis (81 hips), congenital hip dis
location (17), post-traumatic hip arthro
sis (13), rheum atoid arthritis (10),
osteonecrosis (7), hip degeneration related
to slipped femoral capital epiphysis (4),
ankylosing spondylitis (1), hip arthrosis
secondary to Morquio’s syndrome (1) and
pathologic fracture of the femoral neck
due to a bone cyst (1 hip). In 20 o f the
hips other reconstructive procedures had
been performed previously; they included
Moore’s hem iarthroplasty (2 hips),
acetabuloplasty with a McBride’s cup (1),
resectional hip arthroplasty (1) and hip
fusion (1). The surgeons who developed
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the hip replacement under review per
formed all the operations.
The Prosthesis
The prosthesis was a combination of
McBride’s acetabular cup and Moore’s
femoral endoprosthesis (Fig. 1). Both
components were constructed from vitallium (a cobalt-chromium alloy). The com
ponents were correctly paired to allow
total contact during weight-bearing (Fig.

the cup. On the femoral side, the Moore’s
prosthesis was inserted in the regular
fashion. Care was taken to insert the
prosthesis with the widest proximal stem
for optimal bone-implant contact. The
two trochanteric fragments were then
reapproximated and held together by
either a single wire loop (in most cases)
or two long screws.
All operations were carried out in a
standard operating room without clean
air or laminar flow system.

1).

Perioperative Care
Operative Technique
The hip joint was approached through
a long lateral skin incision followed by an
inverted Y trochanteric osteotomy (Olym
pic approach to the hip joint) (Fig. 2). Ini
tially, stabilization of the acetabular cup
was obtained by pressing the three dor
sal fins of the cup into the decorticated
acetabulum. Later the early stability of
the socket was enhanced by cancellous
screws inserted through pierced projec
tions placed superolaterally in the rim of

immediately after occurred in nine
patients. One patient died of myocardial
infarction. Four patients sustained pul
monary embolism and another five
suffered deep venous thrombosis.
Results
We were able to locate 68 of the origi
nal 121 patients. Sixteen others had died
and the remaining 37 were lost to follow
up. In 57 of the 68 patients, the
McGoey-Evans hip prostheses were still
in place (7 patients had bilateral replace-

None o f the patients received
anticoagulants or antibiotics prophylactically. They were kept in bed for an aver
age of 30 days then gradually mobilized
using crutches and canes.
Complications of the Operation (Table I)
Systemic problems intraoperatively or
Table 1-Local Complications
Complication
Intraoperative
Fractured acetabulum
Split fracture of proximal femur
Postoperative
Superficial infection
Hematoma (sterile)
Wound dehiscence
Dislocated prosthesis
Subluxation of prosthesis
Dislodgement of femoral
component secondary to
femoral split fracture

No.
1
1
6
1
1
1
2
1

*
A
FIG. 3—Results of McGoey-Evans total hip
arthroplasty in men and women. White bars
= satisfactory, hatched bars = unsatisfactory,
black bars = revisions.

1

H

FIG. 1—McGoey-Evans uncemented total
hip prosthesis. Original McBride cup has been
modified by adding two pierced superolateral
projections for screw fixation.

1 A

t

FIG. 2—Olympic approach to hip joint.
G reater trochanter is divided (left) with one
vertical and two oblique cuts at 120° to each
other. Two fragments are retracted (right)
laterally and superiorly to facilitate exposure.

82

i

FIG. 4—Results of McGoey-Evans total hip arthroplasty in three age groups. It is evident
that men (top) obtained better results overall than women (bottom). White bars = satisfac
tory, hatched bars = unsatisfactory, black bars = revisions.
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ment); the remaining 11 had undergone
revision. (In the charts of patients who
died or who did not return for follow-up
we found that 11 had undergone revisions
of this prosthesis. Thus, the total
documented revised cases were 22.)
The long-term results are based on 79
(62%) patients with 86 prostheses.
Included are all the recalled patients and
all those with documented revisions. The
average follow-up was 9 years (range
from 5l/2 to 16 years). The results were
assessed objectively, subjectively and.

whenever possible, radiologically. For the
objective assessment, the Harris hip evalu
ation system was used.18 The results were
classified as satisfactory if the hip score
was 80 to 100 points and unsatisfactory
if less than 80 points; revisions were con
sidered failures. The patient’s own satis
faction with the performance of the artifi
cial joint was used for the subjective
evaluation. Assessed radiologically were
the formation of heterotopic bone,
loosening of the component, subsidence
of the femoral prosthesis and union of the

greater trochanter. The method of Jowsey
and colleagues19 was used to classify het
erotopic bone formation. A component
was considered loose whenever 2 mm or
more of radiologic lucency was seen
between it and the adjacent sclerotic
bone. Subsidence was considered a
change in distance between the inferior
margin of the neck of the femoral com
ponent and the proximal part of the lesser
trochanter.
Objective Results
Overall, a satisfactory result with this
prosthesis was obtained in 46.5% of
cases. Further analysis of the results
showed substantially different success
rates between the two sexes. In men, the
rate was 64.3% (18 of 28) compared with
38% (22 of 58) in women (Fig. 3). The
favourable results in men were apparent
in every age group (Fig. 4). Furthermore,
although there were five women over the
age of 60 years with very low hip scores
(less than 40), no man of any age had a
hip score of less than 50. In six o f seven
patients with bilateral hip replacement,
both hips had similar scores. No deep
infections were recorded in this group of
patients.
Subjective Results

FIG. 5—Bilateral McGoey-Evans total hip arthroplasty for osteoarthritis. In this case proce
dure on left side was performed 6 months after that on right. Follow-up at 10 'A and 11 years
respectively showed that both prostheses were performing satisfactorily (hip score 94 bilaterally).

Most patients stated that it took 1 to
2 years before they regained maximum
strength at the operated site. Many com
plained of persistent stiffness, but 85%
of the 57 patients questioned expressed
satisfaction with the overall performance
of the artificial hip.
Radiologic Results
The x-ray films of 44 hips were availa
ble for review.
Heterotopic bone form ation .—This
was seen predominantly in men with
osteoarthritis and considered extensive in
11 hips (Fig. 5). In all but one of these
cases, it was associated with a radiologi
cally loose implant.
Radiologic loosening. —Components
of 11 hip arthroplasties were considered
loose radiologically (Fig. 6); 3 involved
the acetabular cup, 3 the femoral com
ponent and 5 both of these. A poor func
tional result correlated with radiologic
loosening in only five cases; two involved
both components, two the acetabular cup
and one the femoral stem only.

FIG. 6—This McGoey-Evans prosthesis had been inserted 9 years previously. At follow
up, results were rated as poor (hip score 54). There are signs of loosening o f femoral com po
nent and marked heterotopic ossification.

Subsidence.—Consecutive x-ray films
of 23 hips were available. In seven, some
settling of the femoral component was
measured (in most cases between 1 and
2 cm). No clinical correlation between this
subsidence and the clinical outcome was
found.
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Trochanteric union.—All but one
osteotom ized g reater tro ch an ters
reunited. Clinically, the patient with
nonunion exhibited a notable pelvic lurch
during walking and had an overall
unsatisfactory objective result.
Revisions
The revision rate for the McGoeyEvans total hip arthroplasty in this study
was 26% (22 of 86). Closer analysis
showed that the incidence of revision in
men was less than that of women (21%
versus 27.5%), middle-aged women had
the highest revision rate (Fig. 4) and most
revisions (17 of the 22) were performed
within 5 years of the original replacement.
Seventeen patients who underwent revi
sion surgery stated that they were never
relieved of their symptoms after the origi
nal hip replacement. The remaining five
(two men, three women) enjoyed a painfree period ranging from 3 to 9 years
before symptoms began. None of the revi
sions were done as a result of acute injury.
In 18 revisions, the reasons were
recorded clearly — a loose acetabular cup
(8), a loose femoral component (5) and
loosening of both components (5). Infec
tion was never recorded as a cause of revi
sion. Severe metal reaction was seen in the
tissues of two patients with revision. In
both cases (revision performed after 3 Vi
years and 7 years) the surgeon attributed

prosthetic loosening to this local tissue
reaction.
Discussion

The McGoey-Evans uncemented total
hip arthroplasty is outdated and does not
have a place in the current practice of hip
surgery. However, retrospective review of
the results obtained with this prosthesis
(the first long-term follow-up of an
uncemented hip arthroplasty in North
America) has yielded certain interesting
findings that may be useful in prosthetic
hip replacement of the cementless variety
today.
The fact that we found no deep infec
tions in the patients reviewed is of par
ticular importance when one considers
that antibiotics were not given prophylactically and no ultra-clean operating rooms
were used. We believe that the absence of
bone cement may have been a major fac
tor, and experimental evidence supports
this. As shown in the laboratory, the
methylmethacrylate bone cement inter
feres with the ability of the local tissues
to destroy bacteria by depressing the
chemotactic factors of the complement
sequence20 and by reducing the ability of
the leukocytes to phagocytose.21 Also, it
has been noted th a t cemented
arthroplasties in experimental animals
tend to fail from sepsis much more fre
quently than uncemented ones.22

That younger patients and male sex
benefitted the most from this prosthesis
is contrary to the experience with the
cemented hip prostheses8’11’12’17 but is in
accord with the results obtained so far
with the newer generation of uncemented
hip replacements.13’23’24 We believe this
finding suggests that the strength of the
biologic fixation is closely related to the
quality of the host bone. The difference
in the good results between men and
women noted in our study has not previ
ously been reported. The increased ten
dency for osteoporosis in women might
have been the underlying cause.25
The revision pattern of this prosthesis
differs from that of the cemented ones.
Here the majority of the patients who
required revision never became symptomfree, but most patients with cemented
prostheses usually enjoy a few years of
painless hip m otion.10,17’26 The explana
tion for this should be sought in the
difference in implant fixation. With the
cemented hip replacement maximal fixa
tion is obtained at the time of surgery,17
whereas in the noncemented one the bio
logic fixation, by fibrous membrane or,
in the newer uncemented prosthesis, by
bone ingrowth, takes place gradu
ally.23’27 This is the reason why the
symptoms after a noncemented hip
arthroplasty disappear gradually. The
persisting symptoms that often lead to
revision surgery should be attributed to

A Great Achievement

The patient successfully recovered and released
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the failure, for whatever reason, of this
natural bond to mature.
The loosening in 2 o f the 22 revised
arthroplasties was attributed to local tis
sue hypersensitivity. A similar low inci
dence o f loosening related to local tissue
reaction has been reported before.27'28
Local tissue hypersensitivity to the metal
lic implant, therefore, appears to be a
minor factor in prosthetic loosening.
Finally, despite the prolonged presence of
these implants in living tissues no evidence
o f systemic toxic side effects to cobalt or
chromium or development o f a malignant
lesion near the implant was noted.

Conclusions
Although the advances in the total joint
replacement technology have made the
McGoey-Evans prosthesis obsolete, long
term review o f the results o f its use
showed that an uncemented prosthesis
carries a low risk o f infection, patients
with good quality bone (younger, male)
get better results, revision of the
arthroplasty is more frequent early and
less frequent later after the initial replace
ment and local metal hypersensitivity is
an uncommon cause o f prosthetic
loosening.
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Is Preoperative Colonoscopy in Carcinoma
a Realistic and Valuable Proposition?
Colonoscopy was performed preoperatively in 100 consecutive patients as a
prospective study to establish the feasi
bility of the procedure and its value,
which was considered "adequate"when
the colon remaining after surgical resec
tion had also been examined preoperatively. Colonoscopy was adequate in 35
of 46 patients (7 6 % ) with malignant
tumour located in the cecum and
ascending and transverse colon, but in
only 15 of 54 patients (2 8 % ) who had a
tumour in the left colon or rectum. Syn
chronous malignant tumours were
present in 2 patients, and 54 additional
adenomas were discovered in 29
patients. These adenomas could be
removed endoscopically in 13 patients
and were included in the standard resec
tion in 12. Extension of the planned
operation was necessary in only four
patients with synchronous adenomas.
Routine preoperative colonoscopy to
assess the presence of synchronous
colonic tumours is more likely to be ade
quate in proximal or right-sided largebowel tumours than in left-sided tumours
because of the annular configuration of
the latter. Because of the high rate
(4 6 % ) of synchronous adenomas in ade
quate examinations, inadequate preoper
ative colonoscopy should be com
plemented by a repeat examination 3 to
6 months postoperatively in every
patient with a malignant tumour of the
large bowel.
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Afin d'etablir les possibilites et la valeur
reelle d'une coloscopie preoperatoire
dans le cancer du gros intestin, les
auteurs ont fait une 6tude prospective
chez 100 patients consecutifs porteurs
d’un cancer du colon et du rectum oil
une coloscopie preoperatoire a ete tentee. Ms avaient considere que cette
coloscopie etait adequate si la portion
non r6sequ6e du colon a la suite de leur
operation avait ete examinee endoscopiquement. Ainsi la coloscopie a ete jugee
comme etant adequate chez 35 des 46
malades (7 6 % ) oil la tumeur maligne
etait localisee dans la partie proximale du
colon (caecum, colon ascendant et trans
verse). Par ailleurs, elle ne fut adequate
que chez 15 des 54 patients (2 8 % ) oil la
lesion maligne etait situee dans le colon
gauche et le rectum. La presence de
deux lesions malignes synchrones additionnelles fut etablie et 54 adenomes
synchrones ont egalement ete demontres
chez 29 patients. Ces adenomes £taient
enlevables endoscopiquement chez 13,
furent inclus dans le specimen standard
de resection chez 12 et necessitgrent
une extension de cette resection stan
dard chez seulement 4 patients avec des
adenomes additionnels. Les auteurs estiment que la coloscopie preoperatoire de
routine pour le cancer du colon afin de
determiner la presence de tumeurs
synchrones a plus de chance de reussir
et d'etre adequate pour les cancers du
colon proximal a cause de la nature stenosante des tumeurs situ£es dans le
colon gauche. Aussl a cause du haut
taux (4 6 % ) d'adenomes synchrones lorsque I'examen du colon fut adequat les
auteurs recommandent qu'une colosco
pie postop£ratoire dans un delai de 3 a 6
mois soit faite pour tous les cas de can
cers operas chez qui une coloscopie
preoperatoire n'a pu etre tentee ou
reussie.

Total colectomy and even proctocolec
tomy have been advocated for multiple
malignant lesions and for concomitant
benign and malignant neoplasms in
separate segments of the colon.3
Although these extensive resections may
be indicated for synchronous carcinomas,
they are now rarely performed for syn
chronous benign adenomas, since total
colonoscopy allows both excision of the
adenomas and follow-up o f the
patient.4*6 The surgeon performing a
colonic resection for carcinoma is anx
ious to ensure that all tumour has been
removed. The reliability of barium exami
nations to reveal additional lesions in the
colon is often discussed.7,8 Careful pal
pation of the colon at laparotomy may
reveal gross tumour,9 but the soft or
small, benign, villous adenomas are likely
to be missed. For these reasons, several
authors10-14 have recently proposed total
colonoscopy to achieve proper screening
of the bowel for synchronous tumours.
These reports generally mention a 5%
prevalence of synchronous carcinomas
and 25% to 50% of benign adenomas.
Unfortunately, the majority of these
studies do not report consecutive
cases,10-12,14 some include postoperative
examinations11,13 and others exclude
incomplete colonoscopy.11-14 Because a
realistic picture of the expectations of
routine preoperative colonoscopy is not
adequately presented, we carried out a
prospective study to assess the value and
feasibility of this procedure.
Beginning in January 1984 colonoscopy
was attempted preoperatively in 100 con
secutive patients with colorectal car
cinoma.
Patients

There were 56 men and 44 women
ranging in age from 35 to 90 years (mean
64 years). The proportion of index
Resection of a segment of large bowel tumours according to nonmodified
remains the most appropriate treatment Dukes’ staging was class A — 17, B —
for colorectal carcinoma.1 Standard pat 45 and C — 21; 17 had distant metastases.
terns of resection, depending on the site Barium enema established the presence of
of the tumour, are well established.2 carcinoma in 75 patients. In seven,
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colonoscopy was performed to assess a
questionable finding of barium enema. In
11, the barium enema findings were nor
mal and colonoscopy was performed in
an effort to elucidate symptoms; finally,
in 7, barium enema was not done, as
colonoscopy was the primary procedure
that led to the diagnosis of carcinoma.
Ninety-five patients underwent some type
of curative or palliative resection. One
woman had a transanal excision of a
small rectal lesion and four tumours were
judged unresectable; we did an internal
bypass of the tumour in three and the
other had laparotomy only.
For analysis, patients were divided into
two groups according to the site of the
carcinoma: group 1,46 patients in whom
the primary tumour was located in the
right colon (cecum and ascending and
transverse colon) and group 2, 54 patients
who had primary tumour in the left colon
(from the splenic flexure to the rectum).
One patient had two primaries, one on
each side of the colon, and was placed in
group 1.
Preoperative colonoscopy was consi
dered “ adequate” if the unresected por
tion of the colon had been examined (i.e.,
in group 1 to the level of the ileocolonic
anastomosis and in group 2 to the cecum).
Results

Preoperative colonoscopy was adequate
in 50 patients (35 [76%] group 1 patients
and 15 [28%] group 2). Reasons for
inadequate examinations in both groups
are listed in Table I. The technical failures
were due either to fixation of the sigmoid
colon by previous pelvic surgery or to
excessive redundancy. In three instances,
preoperative colonoscopy was inadequate
because the resection was palliative, leav
ing intact a portion of bowel proximal to
the lesion that had not been visualized by
endoscopy; all tumours were transverse
colon primaries. In two patients with low
rectal lesions, the pain was severe, and
physical and endoscopic examinations
had to be done under anesthesia, which
limited the extent of the endoscopy. In 30
group 2 patients the tumour narrowed the
lumen to the extent that the endoscope

could not be passed. No complications
occurred from the procedure.
Synchronous carcinomas were present
in two patients, but since both were seen
on barium enemas their finding cannot be
credited to the colonoscopic inspection.
Fifty-four benign adenomas were dis
covered at colonoscopy in 29 patients:
in 23 of the 50 who had adequate colono
scopy and in 6 of the 50 who had inade
quate colonoscopy. Thirty-two (59%) of
these adenomas were less than 1 cm in
dimension and of the other 22, 4 were
greater than 2 cm. Their distribution
throughout the colon is shown in Table
II; the majority (80%) were located in the
left colon.
Extension of the standard resection for
one primary carcinoma was performed in
the two patients with two primaries but
cannot be credited to preoperative
colonoscopy for the reason already men
tioned. The adenomas were included in
the standard resection for the malignant
tumour in 12 patients. In 17, they were
beyond the limits of the standard resec
tion but were removed or judged to be
removable at a later time by endoscopy
in 13 patients. Therefore extension of the
standard cancer resection was indicated
in only four patients to include the benign
adenoma(s), because of their size or ses
sile configuration in three patients, and
because of their number (seven) in the
fourth.
Discussion

The concept o f preoperative
colonoscopy in colorectal carcinoma has
evolved from the studies of synchro
nous3'915 and metachronous16,17 tumours
in the bowel. Several authors3,6 have
stated that a metachronous lesion disco
vered within 1 or 2 years of surgery is
really a missed synchronous tumour. On
the basis of 4884 cancer operations per
formed between 1928 and 1970, investi
gators at St. M ark’s Hospital have estab
lished the incidence of synchronous
carcinoma at 3% .18 This rate was further
analysed by Heald and Bussey,9 who
noted that in only 16% was the diagno
sis of two cancers known to the surgeon
preoperatively. Moreover, in 54%, the

T a b le I - - R e a s o n s f o r In a d e q u a t e C o lo n o s c o p y

R eason

G ro u p 1

G ro u p 2

(n -

(n -

46)

T e c h n ic a l d if f ic u lty

6

D iv e r t ic u la r d is e a s e

2

-

3

—

P a l lia t iv e r e s e c tio n

second cancer was found only in the
resected specimen. Colonoscopy has since
re-established the incidence of syn
chronous carcinoma at 5% .13 The fre
quency of benign adenomas in patients
suffering from colorectal carcinoma has
been determined by pathological studies
of operative specimens to be 28% .19
Colonoscopy theoretically allows inspec
tion of the entire large bowel and it is not
surprising that the number of syn
chronous adenom as should be
greater,12,14 especially if we accept Cohen
and Waye’s estimate20 that 10% of
polyps are likely to be missed at the ini
tial colonoscopic examination. The pur
pose of our study was not to establish a
similar or distinct rate for synchronous
tumours but to put into a proper perspec
tive both the limitations and benefits of
systematic preoperative colonoscopy.
We thought it preferable to analyse a
consecutive series of cases and, although
limited to 100 patients, our study did not
exclude a single case of colorectal cancer
and in this way, differs from those previ
ously published.
Reilly and associates,10 in a study of
157 cases, 65 of which were examined
postoperatively, reported a 7.6% inci
dence of synchronous carcinoma. Their
polyp yield (62%) seems elevated but was
based on a 5-year follow-up. Maxfield,11
who studied 114 cases but excluded
incomplete examinations, reporting on
90, gave an incidence of 4.4% and 40%
for synchronous carcinomas and ade
nomas respectively. The extension of
resection is mentioned only for the
patients with carcinoma. Pagana and
colleagues12 studied 185 patients and
reported on 157 after excluding the
incomplete examinations. Their rates
were 7.2% and 28.7% for synchronous
carcinomas and adenomas. They also
mentioned extension of the resection in
11% of patients overall and in 26.3% of
those with synchronous polyps, both
figures being substantially higher than in
our own experience. Langevin and
Nivatvongs13 reported a 4.8% incidence
of multiple carcinoma and 27.7% of syn
chronous adenomas in 166 consecutive
patients, a study that also excluded the
incomplete examinations and was based
on pre- and postoperative colonoscopic
examinations. They also stated that 67%
of the adenomas were found in anatomi
cal segments of the colon distinct from
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the carcinoma, but they made no mention
of the impact of these findings on the
extent of resection. The most recent study
by Thorson and colleagues14 with 176
non-consecutive preoperative examina
tions (excluding incomplete studies)
reported rates for synchronous carcinoma
and adenomas of 3.4% and 55.1%.
In our study we did not exclude any of
100 patients and we also report on the socalled incomplete colonoscopy specifically
to assess the feasibility of routine
endoscopic examination of every patient
with colorectal carcinoma.
Our definition of adequate rather than
complete colonoscopy seems more
appropriate for the purpose of preoper
ative colonoscopy, since adequate
colonoscopy asserts that no substantial
benign or malignant tumour is left behind
at operation. The word “ clearance” of
the colon has been used by some6,21 to
define this aim which can be divided in
three components: (a) to determine the
presence of more than one malignant
lesion, (b) to discover benign adenomas
that must be removed by extending the
standard planned procedure and (c) to
remove all endoscopically excisable ade
nomas.
In that respect, we found a 29% inci
dence of associated adenomas. This figure
is in accordance with some of the previ
ously mentioned figures, but rises to 46%
if we include only the adequate examina
tions. In 12 patients, the adenomas were
to be part of planned surgical resection,
but in only 4 of the remaining 17, was
extension o f the resection judged
necessary.
Extension of a standard resection for
a single malignant tumour as a subtotal
or total abdominal colectomy has long
been advocated for multiple carcinomas
and for a single carcinoma associated with
adenomas in a different segment.3'15 This
recommendation still holds for multiple
carcinomas especially when they are in
separate segments9 but is debatable for
synchronous adenomas.22 Colonoscopy
allows removal of the majority of those
adenomas and provides appropriate
follow-up to remove newly formed ones.
Extension of any standard resection to
include adenomas in other segments
should be reserved for those that would
not be excisable endoscopically because
of their size, configuration, possible
malignancy or the risk of complications
from the polypectomy.
The percentage of inadequate examina
tions in our study seems elevated.
Others11,12 have mentioned a high failure
rate due to the obstructive nature of left
sided colonic tumours. Most reports do
not dwell extensively on incomplete
colonoscopic examinations: they either
exclude them 13'14 or simply mention
them when they are done postoperatively.

Conclusions
Physicians attempting routine preopertive colonoscopy in patients with colorec
tal carcinoma should expect an overall
adequacy rate of 50%: 76% in tumours
of the proximal half of the bowel and
20% in tumours of the distal half.
Synchronous adenomas will be present
in up to 46% of patients in which the
colonoscopy is adequate.
Extension of the standard cancer oper
ation to include adenomas will be needed
in 4% , which represents 14% of the
patients with additional adenomas.
Because of the high rate of adenomas
found when preoperative colonoscopy
was adequate, we recommend interval
postoperative colonoscopy in patients in
whom preoperative colonoscopy could
not adequately be performed.
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The e xa m in a tio n s o f th e Royal College
are held in Septem ber o f each year. Can
d id a tes w ish in g to s it fo r th e e xa m in a 
tio n s sh ould note th e fo llo w in g :
1. Every candidate fo r adm ission to th e
e xa m in a tio n s m u st s u b m it an a p p li
c a tio n fo r assessm ent o f tra in in g .
2. C andidates in tra in in g in Canada
sh o u ld apply fo r pre lim in a ry assess
m e n t o f tra in in g a t least one ye a r
before the date on w h ich th e y e x p e c t
to s it fo r th e e xa m in a tio n s, th a t is to
say n o t later th a n Septem ber 1 o f th e
preceding year. Candidates w h o have
had training outside o f Canada should
s u b m it th e ir in itia l a p p lica tio n fo r
a ssessm ent at le a st 18 m o n th s
b e fore th e y e xp e ct to s it fo r th e e xa 
m in a tio n s, th a t is by M arch 1 o f th e
pre ce d in g year. O n ly c a n d id a te s
w h o s e assessm ent o f cre d e n tia ls is
co m p le te w ill be acce p te d to s it fo r
th e exam inations.
3. C andidates w h o desire to s it fo r an
e xa m in a tio n , ha vin g co m p lied w ith
th e above requirem ent o f p re lim in a ry
assessm ent o f tra in in g , m u st n o tify
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and reg u la tio n s relating to th e
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Requests should indicate th e spe
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New Guidelines for
Antithrombotic Therapy
In Surgical Cases
The American College of Chest Physi
cians and the National Heart, Lung and
Blood Institute recently issued new
guidelines for antithrombotic therapy.1
There were four Grade A recom 
mendations for the use of warfarin
(Coumadin®) in surgical cases. In each
of these four (and other Grade A and B
recommendations for Coumadin®) a PT
ratio of 1.2-1.5 (rabbit brain) was
emphasized for clinical efficacy and
reduced side-effects risk.

INDICATIONS: Elective hip surgery/
surgery for fractured
hips.
" . . . patients undergoing elective hip surgery
should be pretreated prophylactically with
adjusted-dose heparin or moderate-dose war
farin sodium . .
. patients undergoing surgery for fractured
hips should be treated prophylactically with
moderate-dose warfarin.

o

INDICATION: Prophylaxis of venous
thromboembolism.
"It is strongly recom m ended that the
therapeutic range for prophylaxis . . . in highrisk medical or surgical patients should be
equivalent to an INR o f 2.0-3.0 (corresponding
rabbit brain thromboplastin ratio 1.2-1.5)."

CONDITION: Bioprosthetic heart valves.
"... all patients with bioprosthetic heart valves
in the mitral position be treated for the first
three months after valve insertion with less
intense warfarin . . . "

INR

1

1.5

2

2.5

’’

3

PT Time with comm only-used rabbit
brain throm boplastin {
j
|

V

"W :

cA

T
e believe these recom m endations
ff
will be o f value to practicing physicians.
'S E Dolen, M D , F

cC

p , Jack Hirsh, M D , F R C P C ; Co-Chairmen ACCP N H L B I Conferer

'

A

n Antithrombotic Therapy

♦

COUMADIN

(warfarin sodium)

for Antithrombotic Therapy
OF

V A L U E

IN

Y O U R

P R A C T I C E

CONDITION: Prophylaxis of venous
thromboembolism.
^
'It is recommended that anticoagulant therapy
should be continued for three months using *
oral anticoagulants to prolong prothrombin 4
time . . . "
1. Chest 1986;89(2);1S-106S
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Portal Vein Injury

With the increasing number of traumatic
injuries being seen in emergency depart
ments, physicians must be aware of the
less common and less obvious types of
serious injury. Portal vein injury is seri
ous (death rate 50%) and may be diag
nosed only at laparotomy. Fortunately
this injury is rare. Its management can
be difficult, but an awareness of the
possible methods of treatment could be
life-saving. The authors report their
experience with this injury and survey
the literature on the subject.

Published reports of portal vein injury are
uncommon, possibly because of the rar
ity o f the injury or because such patients
often die o f exsanguination before surgi
cal exploration can be carried out. We
report three cases, review the literature
and discuss the possible methods of
managing this injury.

Comme les salles d'urgence voient de
plus en plus de blessures individuelles, il
est important de pouvoir reconnattre certaines lesions moins frequentes. Une
atteinte a la veine porte est heureusement assez rare. Elle peut n'etre reconnue qu'a la laparotomie. Son exploration
et sa reconstruction peuvent etre
difficiles, et une bonne connaissance des
resultats possibles du traitement peut
etre vitale, cette lesion entramant une
mortalite de 50% . Les auteurs font part
de leur experience personnels et presentent une revue des autres travaux deja
publies.

A 36-year-old man was admitted to the emer
gency department with a knife wound to the
right upper abdomen. On examination he was
unresponsive and there was no blood pressure.
There was little response to attempted resus
c itatio n so he u nderw ent im m ediate
laparotomy. The knife wound was seen to
penetrate the liver and there was a large hema
toma around the free edge of the gastrohepatic
omentum. This area was rapidly cleared and
a severed posterior superior pancreaticoduo
denal artery ligated. Continued bleeding, on
further exploration, was found to be coming
from the portal vein. Finger compression was
applied to the area while adequate dissection
of the vein was carried out to control the bleed
ing. Anterior and posterior lacerations of the
portal vein, behind the head o f the pancreas,
were repaired by lateral venorrhaphies. Fur
ther exploration of the area, including the right
renal vessels, revealed no abnormalities. The
abdomen was closed and the patient made an
uncomplicated recovery. A total of 8.6 L of
fluid was given intravenously; this included
2 L of saline given immediately on admission
and 3 L of blood.
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Case Reports
Case 1

branch of the portal vein at the porta hepa
tis, a tear in the anterior wall of the inferior
vena cava and a completely severed left hepatic
duct. The Pringle maneuver was used to con
trol bleeding from the portal vein to permit
lateral venorrhaphy of the inferior vena cava
and exposure of the proximal portal vein.
Fogarty balloon catheters were only moderately
successful in controlling back bleeding in the
right and left portal veins. Intermittent finger
pressure was therefore necessary until the left
branch of the vein was repaired, again by
lateral venorrhaphies. The left hepatic duct was
repaired over a stent and the abdomen was
closed. Blood loss was estimated to be 5 L. The
patient was given 7 L of crystalloid fluid and
eight units of blood as replacement. He had
a smooth recovery. A T-tube cholangiogram
before discharge showed that the duct repair
was satisfactory and when seen at 6-month
follow-up he was well.

Case 3
During the course of a subtotal pancreatec
tomy for intractable pain in a 61-year-old man
with chronic pancreatitis, the portal vein was
inadvertently injured at its origin. Both ends
were immediately controlled by vascular
clamps and the subtotal pancreatectomy was
completed. An attempt at end-to-end anasto
mosis was not successful as the gap between
the superior mesenteric vein and the portal vein
itself was too great. The segment of splenic
vein, removed with the specimen, was dissected
off the tail of the pancreas and used as an inter
position graft. Flow through the graft was
satisfactory. A superior mesenteric angiogram
3 months later showed, in the venous phase,
that the interposition vein graft was patent and
of normal calibre. Blood loss during this proce
dure was 2 L.

Case 2
Discussion
Twenty-four hours after the patient in case
1 was admitted, a 13-year-old boy was trans
ferred from a hospital 250 km away with a
knife wound in the right upper abdomen. He
had already received 2 L of crystalloid solu
tion intravenously. On arrival, his blood pres
sure was 70/50 mm Hg and his pulse rate 150
beats/min. Laparotomy again revealed a large
hematoma in the area of the porta hepatis, and
exploration uncovered the following injuries:
a through-and-through stab wound to the left

The portal vein averages 2 cm in
diameter, has a blood pressure o f 10 mm
Hg and a flow rate o f approximately 1
L/min. Injury to this vein therefore will
almost certainly result in hypovolemic
shock. Review o f the literature and our
own experience confirms that this is the
usual clinical picture. Fifty percent o f
these patients will have a temporary
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initial response to resuscitation with intra
venous fluids, while the remainder will
fail to respond before laparotomy and
control of the bleeding.
Again, review of the literature and our
two trauma cases, show that at least one
other organ will be injured (Table I), and
70% of these organs will be other major
vascular structures, giving an overall
death rate of 46% in the reported cases.
Because of the seriousness of this injury
there are very few preoperative diagnos
tic measures on record; the diagnosis is
usually made only at the time of
laparotomy, where rapid control of bleed
ing is the obvious but often difficult solu
tion. It may be necessary to cross-clamp
the aorta below the diaphragm to achieve
local control and permit the patient’s con
dition to be stabilized. Exploration of the
portal vein itself requires adequate
mobilization of the duodenum enhanced
by division of the cystic duct with even
tual cholecystectomy, thus allowing more
mobilization of the structures in the porta
hepatis. If the injury lies behind the neck
o f the pancreas, division of that organ
will be required.
There are various methods of dealing
with portal vein injury (Table II). Lateral
venorrhaphy, if possible, gives an excel
lent result. The portal vein will frequently
have a through-and-through injury mak
ing lateral venorrhaphy more difficult,
but narrowing of the vein is acceptable
under these circumstances.
When lateral venorrhaphy is not feasi
ble, Stone,1 in his latest series, considers
ligation to be the method of choice. In his
Table I—Other Organs and Arteries Injured in
Conjunction With Portal Venous Injuries (in
Descending Order of Frequency)
Stomach
Liver
Inferior vena cava
Duodenum
Pancreas
Small bowel
Colon
Aorta
Spleen
Bile ducts
Kidney
Hepatic artery
Superior mesenteric artery

last 10 cases, treated by ligation, the death
rate was lowered to 20%.
End-to-end anastomosis is rarely pos
sible but obviously would restore con
tinuity.
Free interposition grafting, using either
a vein or a synthetic graft, would appear
to be ideal, where appropriate, but to our
knowledge this procedure has only been
carried out on three occasions. In the ser
ies of Petersen and colleagues,2 and in
our third case, the splenic vein was used.
Other veins available for grafting in the
abdomen are the inferior mesenteric or
the left renal vein, while the internal jugu
lar or the long saphenous vein are avail
able from the periphery. On the one occa
sion when a synthetic graft was used it
thrombosed necessitating exploration the
following day, but the patient died.3
Control of bleeding is certainly the
most difficult problem and although
cross-clamping of the aorta will slow the
flow of blood, retrograde bleeding will
continue to be a problem. Use of Fogarty
balloon catheters may help locally in the
portal vein, but the Pringle maneuver
likely will be the most useful method of
local control until dissection and vascu
lar clamps or catheters can be used at a
distance. It may be necessary to defer
management of the injury to the portal
vein while other major vascular structures
(the inferior vena cava, the aorta, or the
renal vessels) are being repaired.
Although Stone’s results with ligation
were excellent, there is no long-term
follow-up of the effects of portal vein
ligation, his follow-up of 3 years without
problems being the longest reported.
When the portal vein is ligated, overtrans
fusion is necessary because of the pool
ing of blood in the portal system leading
to systemic hypovolemia. Johnstone4
recorded a 50% reduction in the circulat
ing blood volume of experimental animals
after ligation of the portal vein. Starzl and
colleagues5'6 indicated possible endocrine
deprivation of the liver and showed that
insulin is required for the total integrity
of the liver cells. Neidner and Mattes
(quoted by Hubbard7) and Patton and
Johnson8 reported the development of
portal hypertension with its consequences
in patients who had previously undergone
ligation of the portal vein due to injury.
Chisholm and Lenio3 reported thrombo

Table 11-Methods of Possible Management of Portal Vein
Injury: Cases Reported in the Literature
No.
Method
66
Lateral repair
Ligation
30
7
End-to-end anastomosis
2
Portacaval shunt
Free interposition graft
2
Mone
16
Totals
123
92

Survived
44
14
5
1
2
0
66

sis of the portal venous system after liga
tion and suggested a second-look proce
dure, after 24 hours, to exclude this and
to assess the bowel for areas of vein
thrombosis and infarction.
If the patient’s condition permits, an
interposition graft should be considered
when safe closure of a portal vein injury
is impractical. Busuttil and associates9
and Petersen and colleagues2 used this
method with apparently excellent results.
Synthetic grafts are unsatisfactory in
this situation.

A
<

Conclusions
The preoperative, perioperative and
intraoperative management of portal vein
injury is a formidable undertaking, car
rying a death rate of 50%. For the sur
geon who is not well versed in vascular
surgery, ligation appears to be the method
of choice, but lateral venorrhaphy, when
possible, will give a much more satisfac
tory result. If Starzl and colleagues5,6 are
correct in suggesting that there is a fac
tor that is necessary for the integrity of
liver cells, and since the long-term effects
of ligation are unknown, vascular recon
struction using a vein graft should be con
sidered whenever possible.
As reported in the literature, portacaval
shunting under these circumstances car
ries an extremely high incidence of
encephalopathy and should not be con
sidered as an immediate method of
management. Patient survival is para
mount, secondary problems such as por
tal hypertension can be dealt with later.
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Direct Effects of Autotransfused Blood on Myocardial Muscle
Mechanics in Man
Homologous blood transfusions carry
risks — febrile reactions, isoimmunization
incompatibility reactions and transmis
sion of infectious diseases such as AIDS
and hepatitis. Although autotransfusion
techniques will reduce the need for
banked homologous blood, autologous
shed blood does contain various cellular
fragments that may act directly as
myocardial depressants. Accordingly, the
myocardial muscle mechanical properties
of isolated human right atrial trabeculae
contracting in vitro were measured in a
bath containing either blood collected in
the Sorensen A TS Autotransfusion
Receptal unit or arterial autologous
blood. Muscles were tested randomly in
each solution by measuring their isomet
ric resting and developed forces and the
mean rate of developed force at different
stimulation rates (force-frequency rela
tion). In addition, biochemical, hemato
logic and immunologic assays were per
formed on each blood specimen.
Significant increases (p < 0.05) in
potassium and plasma-free hemoglobin
indicated that cell disruption had
occurred in blood collected in the
autotransfusion apparatus; however,
there was no statistically significant
difference in mechanical performance
between muscles contracting in either
solution. From these results, the authors
conclude that autotransfused blood does
not directly affect human heart-muscle
mechanics.
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La transfusion de sang homologue
entraine certains risques — reactions
febriles, iso-immunisation, reactions
d'incompatibilite et transmission de mala
dies infectieuses telles que le SIDA et
I'hepatite. Meme si les techniques
d'autotransfusion peuvent reduire les
besoins en reserves de sang homologue.
le sang autologue renferme divers frag
ments cellulaires susceptibles d'agir
directement comme depresseurs du m yocarde. En consequence, on a etudie les
proprietes mecaniques du myocarde en
mesurant in vitro les contractions des
colonnes charnues de coeur humain iso
lees dans un bain renfermant soit du
sang recueilli a I'aide d'un recipient
d'autotransfusion Sorensen ATS, soit du
sang arteriel autologue. Les muscles ont
ete testes au hasard dans chacune des
solutions par la mesure des forces isometriques de repos et d'effort, et le taux
moyen de la force developpee a divers
frequences de stimulation (rapport
force-frequence). De plus, des epreuves
biochimiques, hematologiques et immunologiques ont ete effectuees sur chaque
echantillon de sang. Des augmentations
significatives (p < 0.05) du potassium et
de I'hemoglobine libre de plasma indiquaient qu'il y avait eu bris cellulaire
dans I'equipement d'autotransfusion.
Neanmoins, on n'a enregistre aucune dif
ference significative de fonctionnement
mecanique entre les muscles qui se contractaient dans I'une ou I'autre des solu
tions. A partir de ces resultats, les
auteurs concluent que le sang autotrans
fuse n'affecte pas directement la mecani
que du muscle cardiaque humain.

In our institution, up to one-third of all
banked blood is used for cardiovascular,
thoracic and trauma surgery. There is
increasing concern over the risks of using
banked blood and the rising costs of
processing. To reduce the amount of
blood used, autotransfusion has become
popular, especially in cardiac surgery
where notable conservation has been

achieved.1 However, autotransfusion
carries potential risks.2 Autotransfused
blood contains products of cellular autol
ysis that may affect hemodynamics, either
directly or indirectly. The administration
of autotransfused blood is sometimes
accompanied by a marked decrease in
blood pressure. This may result from the
release of vasoactive products acting
alone, peripherally, or combined with
electrolyte changes, or acting directly as
myocardial depressants. The direct effect
of autotransfused blood has not been
assessed. The purpose of this study was
to evaluate the direct myocardial
inotropic responses to autotransfused
blood using one of the clinically availa
ble units.
Material and Methods

The atrial muscles and blood Used for
this study were taken from eight patients
(five men, three women) who underwent
coronary artery bypass grafting. Patients
ranged in age from 44 to 70 years (mean
± SEM, 51.3 ± 3.3 years).
The Sorensen Mediastinal ATS Recep
tal System (Sorensen Research Corp., Salt
Lake City, Utah) was evaluated at the
University of Ottawa Heart Institute on
patients who underwent open-heart sur
gery. Right atrial appendages were taken
from consenting patients at the time of
cardiopulmonary bypass. As cannulation
was proceeding, the Receptal unit was
connected to the cardiotomy suction
apparatus by way of plastic tubing (the
system was used in accordance with the
manufacturer’s specifications). Patients
were heparinized (300 mg/kg) before
cardiopulmonary bypass was instituted
and blood was suctioned from the
pericardial cavity and mediastinum
directly into the Receptal unit. This
arrangement was designed to assess the
effects of the Receptal unit on blood,
independent of the damaging effects of
the cardiopulmonary bypass circuit. The
appendage and two blood samples (100
ml of suctioned blood and 50 ml of the
patient’s heparinized arterial blood) were
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sent to the laboratory. The blood samples
were analysed for their electrolyte com
position (Technicon SMAC; Technicon
Instruments Corp., Tarrytown, NY),
hemoglobin content (Coulter counter,
Model S-Plus IV; Coulter Electronics
Inc., Hialeah, Fla.) and serum comple
ment levels — C3 and C4 with the Beck
man ICS Analyze II (Beckman Instru
ments Inc., Toronto, Ont.) and CH50 by
hemolytic assay.
Myocardial performance was assessed
using individual trabeculae isolated from
the patient’s right atrial appendage. The
muscles were placed between two
stainless-steel clips of a muscle stand. The
upper clip was attached to a force trans
ducer (Statham-Gould UC-2; Statham
Instruments, Oxnard, Calif.) whose out
put was amplified and recorded on a
writer-recorder (Grass, model 7 poly
graph; Grass Instrum ents, Quincy,
Mass.). Muscles were immersed in a mus
cle bath containing a buffered Tyrode’s
solution aerated with 95% oxygen and
5% carbon dioxide and maintained at
34°C by a water-jacketed thermoregulat
ing system. Field stimulation (Grass
stimulator, model S88) was used to induce
isometric contractions using square-wave
pulses 5 to 10 milliseconds in duration at
voltages 20% greater than that required
to elicit a maximal response. Muscles were
first lightly preloaded and stimulated at
0.1 Hz for 30 minutes then at 1 Hz for
15 minutes. Muscles were stretched until
maximum force developed (Lmax, peak
of Frank-Starling relation) and then
maintained at this length for the duration
of the experiment. Conditions and proce
dures have already been reported.3
Muscle mechanical performance was
measured from isometric contractions in
terms of isometric resting force (RF) and
developed force (DF) and mean rate of
developed force (MRDF). Once muscles
had equilibrated for 10 minutes, the bath
was drained and replaced with either the
arterial blood or the Receptal blood in
random fashion. After a 10-minute
equilibration period, a frequency-force
relation was determined by stimulating
the muscle at different frequencies ran
domly; 0.5, 1.0, 1.5, 2.0 and 2.5 Hz. The
muscle was allowed to contract for 2
minutes before measurement of RF, DF
and MRDF at each frequency. When
the frequency-force measurements were
completed, the bath was again drained
and replaced with the remaining blood
solution (either arterial or Receptal unit).
Statistical analysis of the muscle
mechanical and blood test results was per
formed using a paired /-test. Probability
values less than 0.05 were considered sig
nificant. At the time of cannulation, some
saline was introduced into the pericardial
cavity. Results of the complement test
were corrected for dilution by multiply
ing the Receptal unit results by a correc
94

tion factor (arterial hemoglobin/ Receptal
hemoglobin).

blood were not statistically significant
(Fig. 3).

Results

Discussion

The eight trabeculae used in this study
had an average muscle length of 6.44 ±
1.05 mm at Lmax, a weight of 6.54 ±
1.01 mg, and a calculated cross-sectional
area of 0.93 ± 0.09 mm2. Control mus
cle mechanical measurements in Tyrode’s
solution at a stimulation rate of 1.0 Hz
were 0.19 ± 0.05 g RF, 1.30 ± 0.08 g
DF and 13.05 ± 0.71 g/s MRDF.
A comparison of the RF, DF and
MRDF between Receptal and arterial
blood at each frequency revealed no
statistically significant differences (Fig.

Autotransfusion reduces homologous
blood transfusion requirements1,2,4 and
was popularized in the 1960s in Viet
nam.5 With respect to cardiac surgery,
41.7% of the patients in our institution
bled more than 500 ml in the first 4 hours
after surgery (unpublished data), a large
percentage who may require blood trans
fusions. Schaff and colleagues1 demon
strated a 50% reduction in the use of
banked blood when patients who bled
more than 400 ml in the first 4 hours
postoperatively were autotransfused
(52.3% of patients). Cosgrove and
coworkers6 at the Cleveland Clinic
reported that more than 60% of patients
who underwent cardiac surgery did not
require banked blood transfusions as a
result of autotransfusion. These results
are impressive.
The risks of homologous blood trans
fusion are well known. They include
febrile reactions, isoim m unization,
incompatibility reactions and transmis
sion of infectious diseases such as hepa-

1) .

There were significant differences in
concentrations of electrolytes between
samples from the Receptal unit and
arterial blood. The most striking differ
ence was seen in potassium concentration
(5.3 versus 3.9 mmol/L [mean values] in
Receptal and arterial blood, respectively)
(Fig. 2).
The total hemoglobin level was signifi
cantly lower in the Receptal blood than
arterial blood (92 g/L versus 110 g/L).
Plasma free hemoglobin concentration
was higher in the Receptal blood (3.2 g/L
versus 0.12 g/L) (p < 0.05). C3, C4 and
CH50 were corrected for dilution. The
differences between Receptal and arterial

FIG. 2—Electrolyte data (mean ± SEM) for
serum sodium, chloride, potassium and cal
cium. White bars = arterial blood, dotted bars
= Receptal blood.

Total Hb
(g/L)

Plasma Hb
(g/L)

C3
(g/L)

C4
(g/L)

C H 50
(x1 C r 3U/L)

* p <0.05

FIG. 1—Myocardial mechanical results
(mean ± SEM) of human atrial trabeculae
contracting on arterial (white bars) blood
and to blood collected by Receptal unit
(dotted bars).

FIG. 3—Hemoglobin and complement levels
(mean ± SEM) from arterial (white bars) and
Receptal (dotted bars) blood. (Note: Receptal
complement values have been corrected for
dilution.)
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titis and AIDS. There may also be
problems with coagulation disorders and
citrate toxicity. Autotransfusion has its
own risks. They include sepsis, microem
bolism, hemolysis, thrombocytopenia,
coagulopathies and renal failure.5
Although it is now clear that there are
increasing risks and costs associated with
banked blood transfusions, there are
numerous questions to be resolved con
cerning the considered alternative.
Autotransfused blood has increased
plasma-free hemoglobin levels1'7 as a
result of hemolysis. With cellular disrup
tion there is a release of intracellular con
stituents including electrolytes, enzymes
and hemoglobin. Electrolyte changes
affect myocardial perform ance8 and
there is the possibility that other released
factors may have myocardial depressant
actions. This study tried to assess the pos
sible direct effects that autotransfused
blood might have on myocardial perfor
mance.
The Receptal unit was used in such a
way that its effect on blood could be
assessed directly without the derange
ments created by passing blood through
the cardiopulmonary bypass system. The
protocol for this study used samples of
fresh arterial blood and the right atrial
appendage from the same patient. To test
the effects of mediastinal shed blood col
lected postoperatively, the patient’s own
appendage would not be of use since
information (unpublished data) indicates
that the mechanical performance of this
unique preparation would deteriorate
with time and thus limit its capacity to
evaluate the inotropic properties. We
recognize that blood collected from the
mediastinum postoperatively contains
more cellular debris than the blood tested
in the present study, but our primary con
cern was to evaluate the Receptal unit
itself. Although the results indicate that
the unit will not produce or induce a nega
tive inotropic response, further experi
ments with a different protocol may be
warranted to evaluate the combined
effects of the Receptal unit and mediasti
nal shed blood. At the time of cannulation, saline introduced into the pericardial
cavity diluted the blood collected in the
Receptal unit, leading to a small but
important rise in sodium and chloride and
a decrease in calcium. Also there was a
marked increase in potassium, which was
underestimated because of the dilutional
effect of the saline and presumably was
a result of hemolysis. While the total
hemoglobin value was reduced in the
Receptal blood (due to dilution), plasma
free hemoglobin was markedly increased.
Changes in complement levels did not
reach statistical significance which is sur
prising since contact with foreign surfaces
is supposed to be a major activating fac
tor as seen with cardiopulm onary
bypass.9'10 This finding might suggest

that the physical trauma of cardiopulmo
nary bypass (bubble oxygenation and
roller pumping) is the culprit in comple
ment activation.
A useful way to study the impact of the
above changes in blood composition on
cardiac function is using isolated
myocardial muscle contracting in vitro.
It has been demonstrated that the relation
between frequency of activation of
human atrial muscle and the force of con
traction describes a fundamental property
of this tissue11-12 and has been termed the
Bodwitch phenomenon. Using this tech
nique, we could find no difference in the
contractile performance of human atrial
trabeculae either in Receptal or arterial
blood, despite differences in their com
position. This leads us to suggest that any
changes in hemodynamics due to
autotransfusion are more likely to be
indirectly or peripherally mediated. It
should be noted that these trabeculae were
adequately oxygenated so that the results
from these studies may only be valid for
normoxic hearts in the postoperative sit
uation.
We thank Mrs. Diane Ayres for her techni
cal assistance in performing these studies and
Miss Maura Watson for her assistance with the
graphs in this manuscript.
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SESAP V Question
3. An 11-year-old boy arrives in the emergency department after trau
matic amputation of the right middle fingertip. An open wound through the
pulp measures 1 cm in diameter. No bone is exposed. Appropriate treatment
for this injury is
(A)

split-thickness skin graft to the wound

(B)

removal of the distal third of the distal phalanx with primary
closure

(C)

full-thickness skin graft from the postauricular area

(D)

occlusive dressings

(E)

cross-finger flap from the dorsal skin of the ring finger

For the incomplete statement above, select the one completion that is best of
the five given.
For the critique of Item 3 see page 131.
(Reproduced by permission from SE SA P V Syllabus; Surgical Education and
Self-Assessment Program No. 5. For enrolment in the Surgical Education and
Self-Assessment Program No. 5, please apply to the American College of Sur
geons, 55 East Erie St., Chicago, IL 60611.)
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Surgical Treatment of Bronchogenic Carcinoma:
the Importance of Staging in Evaluating Late Survival
From 1971 to 1980, 1292 patients with
lung cancer were admitted to the Hdpital
du Sacre-Coeur de Montreal. This diag
nosis represented 0 .5 % of admissions
in 1971 and 1 .7 % in 1980 (2 4 0 %
increase). Only 4 % of patients were
nonsmokers. Patients ranged in age from
30 to 93 years with a male to female
ratio of 5.5 to 1.
Of 414 cervical mediastinoscopies car
ried out for right and left pulmonary
tumours, 120 (2 9 % ) showed mediastinal
lymph-node metastasis (positive biopsy).
For 35 left-sided lesions, both cervical
and left parasternal mediastinoscopies
produced 13 (3 7 % ) positive biopsies.
For 45 left upper lobe and left hilum
tumours, left parasternal mediastinos
copy alone yielded 18 (4 0 % ) positive
biopsies. Only 297 (2 3 % ) of the 1292
patients were considered to have opera
ble lesions and they underwent thoraco
tomy — 164 (5 5 % ) lobectomies, 104
(3 5 % ) pneumonectomies, 2 (1 % ) segmentectomies and 27 (9 % ) exploratory
thoracotomies.
The most common postoperative com
plication was respiratory failure — in 27
cases (9 % ); there were 12 (4 % ) bron
chopleural fistulas. The operative death
rate was 5 % — 1 .8 % for lobectomy,
7 .4 % for exploratory thoracotomy and
9 .6 % for pneumonectomy. Causes of
death were respiratory failure (6 0 % of
the deaths), hemorrhage (1 3 % ), cardiac
events (1 3 % ) and bronchopleural fistula
(1 3 % ). The overall 5-year survival was
9 .2 % . For the 297 patients operated on,
the survival at 5 and 10 years was 5 5 %

De 1971 a 1980, 1292 patients avec
cancers du poumon furent admis a
I'Hopital du Sacre-Coeur de Montreal.
Cette pathologie representait 0 .5 % des
admissions en 1971 et 1 .7 % en 1980,
pour une augmentation de 2 4 0 % . La
moyenne d'age des patients etait de 61
ans, variant de 30 a 93 ans et seulement
4 % des patients etaient non fumeurs. Le
rapport homme-femme 6tait 5.5:1. Dans
revaluation preoperatoire, des 414
mediastinoscopies cervicales pratiquees
pour des tumeurs pulmonaires droite et
gauche, 120 (2 9 % ) ont demontre des
metastases ganglionnaires mediastinales
(biopsies positives). Pour 35 tumeurs du
poumon gauche, des mediastinoscopies
cervicales et parasternales ont resulte en
13 (37% ) biopsies positives, tandis que
pour 45 lesions du lobe sup6rieur gauche
et du hile gauche, seule une mediastinoscopie parasternale gauche fut pratiquee,
donnant lieu a 18 (4 0 % ) biopsies positi
ves. De tous les patients, seulement 297
(2 3 % ) furent consideres comme opera
t e s : 164 (5 5 % ) ont subi une lobectomie, 104 (3 5 % ) une pneumonectomie, 2
(1 % ) une segmentectomie et 27 (9 % )
une thoracotomie exploratrice.
La complication postoperatoire la plus
frequente fut I'insuffisance respiratoire
dans 27 cas (9 % ); 12 (4 % ) fistules
broncho-pleurales furent relevees. La
mortality postoperatoire fut de 5 % :
1 .8 % pour les lobectomies, 7 .4 % pour
les thoracotomies exploratrices et 9 .6 %
pour les pneumonectomies. Les causes
de dec&s furent I'insufficance respiratoire
(6 0 % ), l'h6morragie (1 3 % ), une fistule

broncho-pleurale (1 3 % ) et d'origine
cardiaque (1 3 % ). La survie globale a 5
ans, des 1292 patients, fut de 9 .2 % .
Pour les 297 cas chirurgicaux, la survie a
5 ans et a 10 ans fut de 5 5 % et 3 6 %
pour les stades I, de 3 0 % et 2 0 % pour
les stades II et de 10% et 8 % pour les
stades III, respectivement. La relance
moyenne fut de 41.5 mois allant de 3.5
a 14 ans. L'incidence de cancer du pou
mon continue d'augmenter dans notre
centre hospitalier. Nous concluons que la
stadification selon la methode TNM est
essentielle, que la survie 6 long terme
est reliee au stade de la maladie au
moment du traitement et que la pneu
monectomie est associee a un taux
relativement eleve de mortality.

The occurrence of lung cancer is still
increasing annually at an incredible rate,
especially for women. It is a worldwide
problem, particularly in industrial coun
tries. For annual death rate, Canada
ranks 17th in the world for men and 11th
for women.1
The published results of treatment have
varied greatly over the years, but with
more uniform staging of the disease, it is
becoming easier to evaluate and to com
pare results.
The purpose of this study was to evalu
ate our results of surgery for lung carci
noma, using the staging method of the
American Joint Committee for Cancer
Staging and End Results Reporting.2
Method

We reviewed the medical records of
1292 patients with bronchial carcinoma
admitted to the Hopital du Sacre-Coeur
de Montreal, from Jan. 1, 1971 to Dec.
31, 1980. Our study was limited to
patients with histologically or cytologically confirmed carcinoma of the lung
according to the World Health Organi
sation classification.3'4 Data on the sex
of patients, age at time of diagnosis and
history of cigarette smoking were tabu
lated.
Patients were staged according to the
methods of the American Joint CommitVOLUME 30, NO. 2, M A R C H 1987 / THE CANADIAN JOURNAL OF SURGERY
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and 3 6 % for stage I disease, 3 0 % and
2 0 % for stage II disease and 10% and
8 % for stage III disease, respectively.
The mean postoperative follow-up was
41.5 months (range from 3.5 to 14
years). The incidence of cancer of the
lung is still increasing. Pre-treatment sta
ging according to the TN M system is
essential. Long-term survival is related to
the stage of the disease at the time of
surgical treatment. Pneumonectomy is
associated with a relatively high death
rate.

tee for Cancer Staging and End Results
Reporting.2 Patients who were possible
candidates for surgery underwent further
staging procedures. Early in the series,
concurrent scalene-node biopsy and cer
vical mediastinoscopy were done rou
tinely, but the former procedure was
discontinued5 because of the low yield of
positive biopsies. Beginning late in 1974,
left parasternal mediastinoscopy was
added as a staging procedure for left
sided tumours. Later, left parasternal
mediastinoscopy alone was carried out for
left upper lobe tumours as pre-treatment
staging of mediastinal lymph nodes.
Some results and the surgical technique
of this procedure were reported previ
ously.6
Mediastinal node metastasis (positive
biopsy) at mediastinoscopy and a
preoperative diagnosis of small-cell
tumour were considered contraindications
to surgery. All patients who underwent
thoracotomy had routine intraoperative
staging with sampling of nodes from the
bronchopulmonary area, hilum and medi
astinum. Positive mediastinal node biopsy
at the time of thoracotomy was not neces
sarily a contraindication to resection. All
postoperative hospital deaths were
included in the surgical death rate.
Data were entered on a CYBER-70
(Control Data, Arden Hills, Minn.) for
validation and statistical analysis. The
SPSS (Statistical Software for Social
Sciences) was used to perform actuarial
analysis which was based on the method

Procedure/positive biopsy
Cervical mediastinoscopy, no.
Positive biopsy, no. (%)
Cervical and left parasternal
mediastinoscopy, no.
Positive biopsy, no. (%)
Left parasternal
mediastinoscopy, no.
Positive biopsy, no. (%)

Results
Positive biopsy, no. %
Thoracotomy, no.
Mediastinal metastasis
at thoracotomy, no. (%)
Sensitivity, %
Specificity, %
Predictive value of a
positive test, %
Predictive value of a
negative test, %
Efficiency, %

described by Berkson and Gage.7 The
differences between the actuarial distri
butions were compared by the x2 test,
using Lee and Desu’s algorithm.8
The accuracy of mediastinal node stag
ing by cervical mediastinoscopy, left
parasternal mediastinoscopy and by both
techniques, was evaluated using the
method of Galen:9 sensitivity = TP/(TP
+
FN);
specificity
=
TN/
(TN + FP); efficiency = (TP +
TN )/(TP + TN + FP + FN); pre
dictive value of a positive test = T P/(TP
+ FP); predictive value of a negative test
= TN/(TN + FN), where TP is true
positive, FN is false negative, TN is true
negative and FP is false positive.
Findings
Patient Data
Of the 1292 patients, 199 were women,
giving a male to female ratio of 5.5:1. Of
19 415 patients admitted to our hospital
in 1971, 87 (0.5%) bore this diagnosis,
compared with 280 (1.7%) of 16 098 in
1980, for an increased incidence of 240%.
In 1971, 7% (4 of 59) of newly diagnosed
cases of lung cancer were in women com
pared with 20% (33 of 168) in 1980. The
average age of the group was 61 years
(ranging from 30 to 93 years). Data on
smoking habits were available for 1122
(87%) patients. Only 4% (45) had never
smoked and 76% had smoked 20 or more
cigarettes a day.

Pathological Features
The histologic diagnoses for 1175
patients were as follows: 510 (43%)
squamous-cell carcinomas, 241 (21%)
sm all-cell carcinom as, 214 (18% )
adenocarcinomas, 127 (11%) large-cell
carcinomas, 18 (1.5%) adenosquamous
carcinomas and 65 (5.5%) miscellaneous
undifferentiated cell type. For 117 (9.1%)
o f the 1292 patients, the diagnosis was
made on positive cytologic findings alone
without definition of the exact cell type.
Staging
Of the study group, surgery was con
traindicated in 995 (77%) patients,
because of extension of the disease, inade
quate pulmonary, cardiac or renal func
tion, or because they refused surgical
treatment. Cervical mediastinoscopy was
done for right- and left-sided tum ours in
414 patients. For 35 with left-sided
tumour, both cervical and left paraster
nal mediastinoscopy were carried out.
Forty-five patients underw ent left
parasternal mediastinoscopy alone, for
left upper lobe and left hilar lesions.
Mediastinal lymph-node metastasis was
identified through these staging proce
dures in 151 patients. Results of pre
treatment staging are shown in Tables I
and II. Table II includes the number of
patients found to have unexpected medi
astinal node metastasis at operation
(false-negative staging procedure) and the

Table 1- Staging Procedures, Tumour Location and Results of Nodal Biopsy
Tumour site
Right
Right
Left
Left
upper
Middle
lower
Right
upper
lower
lobe
lobe
lobe
hilum
lobe
lobe
18
64
153
85
4
70
54 (35)
20 (24)
6 (33)
2 150)
14(20)
18(28)
-

-

—

_

—

-

-

—

-

-

-

-

-

-

23
11 (48)

11
2(18)

42
16(38)

-

Table II— Overall Results and Value of Pre treatment Staging
Staging procedure
Cervical mediastinoscopy
Cervical and parasternal
(n = 414)
mediastinoscopy (n - 35)
120 (29)
13(37)
225
19

—

Left
hilum
12
3(25)
1
0

—

_

3
2(66)

-

-

Parasternal
mediastinoscopy (n - 45)
18(40)
27

45 (20)
73
100

2(11)
87
100

3(11)
86
100

100

100

100

80
87

89
94

89
93
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Not
localized
8
3(38)
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accuracy of these procedures as deter
mined by statistical analysis.
Results o f Surgery
Of the 1292 patients, only 297 (23%)
were found suitable for surgical treat
ment. Further staging was performed at
the time of thoracotomy. There were 184
(62%) squamous-cell carcinomas, 60
(20% ) adenocarcinom as, 30 (10%)
large-cell carcinomas, 12 (4%) small-cell
carcinomas, 9 (3%) adenosquamous car
cinomas and 2 (0.7%) undifferentiated
carcinomas.
The type of operation performed and
the hospital death rate are set out in Table
III. The cause of death was secondary to
respiratory failure in 9 (60%) instances,
to cardiac events in 2 (13.3%), to bron
chopulmonary fistula in 2 (13.3%) and to
hemorrhage in 2 (13.3%).
Complications related to operations
were not uncommon. Respiratory failure
(prolonged intubation or reintubation)
was encountered in 27 (9.1%) cases,
atelectasis in 25 (8.4%) and pneumonia
in 8 (2.7%). There were 12 bron
chopleural fistulas (4%). Morbidity from
cardiac causes was related to arrhythmia
in 16 (5.4%) instances and to cardiac
failure in 15 (5.1%). Hemorrhage, neces
sitating multiple transfusions postoperatively or repeat thoracotomy, occurred in
five (1.7%) and of the four repeat thora
cotomies for hemorrhage, three followed
a pneumonectomy. There was one post
operative cerebrovascular accident and
one upper gastrointestinal hemorrhage.
Miscellaneous complications such as
superficial wound infection, urinary tract
infection and gastric dilatation occurred
in 21 (7%) patients.
Survival
Overall survival for the 1292 patients
was 9.2% ± 0.5% (± standard error) at
5 years and 5.8% ± 0.8% at 10 years.
For the 995 patients who had no surgical
treatm ent, 91% ± 0.5% died in the 12
months after diagnosis. At 3 years, only
2% ± 0.5% were alive and at 5 years, 1%
± 0.5% . Overall survival for the 297
patients who were operated on was 36%
+ 3% at 5 years and 24% ± 3% at 10
years. Mean follow-up was 41.5 months
(ranging from 3.5 to 14 years). Overall
survival after operation was significantly

(p < 0.0001) greater for patients with
stage I disease than for those with stages
II and III disease (Fig. 1). Figure 2 indi
cates that overall survival after operation
for patients with no lymph-node involve
ment (NO) or minimal involvement (Nl)
is significantly (p < 0.0001) greater than
that for patients with mediastinal node
involvement (N2).
Five- and 10-year survival after surgery,
according ro cell type, was 39% ± 3.8%
and 25% ± 3.9% for 184 squamous-cell
carcinomas, 35% ± 6.5% and 22% ±
6.8% for 60 adenocarcinomas, 28% ±
8% and 17% ± 8% for 30 undifferen
tiated large-cell and 18% ± 12% and 0%
for 12 undifferentiated small-cell carci
nomas. Comparison of the probability of
survival by cell type was not statistically
significant. Best results were obtained in
patients having T1N0 disease: 5- and
10-year survival for 33 squamous-cell car
cinomas was 73% ± 8% and 50%, ±
10% and for 15 adenocarcinomas 59% +
13% and 50% ± 14% respectively.
Discussion

The trend in our hospital to increasing
incidence of lung cancer, particularly in
women, is consistent with Canadian and
North American tendencies.1,10-12 All
physicians involved agree on the impor
tance of an accurate assessment of
patients with lung cancer in order to select
the proper treatment. Consideration must
be given to cardiopulmonary status, histo
logic findings and stage of the disease
according to the TNM system.2 Particu
lar attention must be given to the nodal
status which is directly related to long
term results (Fig. 2).
We believe that preoperative mediasti
nal node evaluation by mediastinoscopy
is necessary for all bronchial tumours, the
only exceptions being peripheral lesions
smaller than 2 cm.5 Cervical medi
astinoscopy in this series yielded 29%
positive node biopsies which is compara
ble to the results of others.13,14 Many
thoracic surgeons believe that left upper
lobe tumours cannot be adequately staged
by cervical mediastinoscopy alone.5,14-17
Lymphatic vessels of the superior regions
of the left upper lobe drain into the liga
ment node of Botallo and then to the peri
aortic nodes. The ligament node may also
communicate with the left paratracheal

area. The lower area of the left upper lobe
has lymphatic connections with the liga
ment node and the tracheobronchial
nodes.18,19
Table II indicates the accuracy of the
staging procedures. We believe that no
attempt should be made to compare the
accuracy of cervical mediastinoscopy and
left parasternal mediastinoscopy, as thesd
procedures are complementary, each
assessing different nodal areas. In our ser
ies, the accuracy of cervical medi
astinoscopy for right and left lung
tumours was not as high as that demon
strated by others,13,20 but all mediastinal
node metastases found at thoracotomy
were listed as false negative, and no
attempt was made to exclude node
metastases that might be judged inacces
sible by mediastinoscopy. On the other
hand, our results indicate that left
parasternal mediastinoscopy alone is
quite accurate to assess left upper lobe
and left hilar tumours (sensitivity =
86%). It does not appear that both proce
dures, cervical and left parasternal medi
astinoscopy, add substantially to the
accuracy of preoperative assessment of
mediastinal lymph nodes for left upper
lobe tumours. More recently, the trend
toward extensive lymph-node mapping21
has led us to perform more routinely both
cervical and parasternal mediastinoscopy
for left-sided lesions.

N u m b e r o f c as e s

H o s p it a l

(% o f t o t a l]

d e a th s , n o . (% )

L o b e c to m y

1 6 4 (5 5 )

3 (1 .8 )

P n e u m o n e c to m y

1 0 4 (3 5 )

1 0 (9 .6 )

S e g m e n te c to m y
E x p lo r a t o r y th o r a c o to m y
T o t a ls

98

2 (1 ]
2 7 (9 )
2 9 7 (1 0 0 )

2 (7 .4 )
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f-

- b

1

*

FIG. 1—Actuarial survival curves of 297
surgical patients according to stage of disease.
Percentages are cumulative probabilities ±
standard error.

A

A

Y*

0

1 5 (5 .1 )

A

A

T a b le I I I — S u r g ic a l P r o c e d u r e an d D e a t h R a te

O p e r a t io n

A

FIG. 2—Relationship of nodal status to
survival in 297 surgical patients with bron
chogenic carcinoma.
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For some authors mediastinal node
metastasis is not a contraindication to sur
gery, especially if curative resection can
be accomplished.21-23 These surgeons
usually do not carry out mediastinoscopy
preoperatively. On the other hand, when
mediastinal node involvement is demon
strated at mediastinoscopy, others have
shown that the results of surgical resec
tion are very poor, particularly if the
procedure is palliative.24,25 For these
reasons, we like to avoid surgery
and recommend palliative treatment if
mediastinal node metastasis is demon
strated at mediastinoscopy. Figure 2 illus
trates the poor surgical results we have
obtained with patients having N2 disease.
Among patients who underwent thora
cotomy, a resectability rate of 91%, a
hospital death rate of 5% and a 4.4%
incidence of bronchopleural fistula are all
good results, comparable to data found
in the literature.26-31
The death rate following pneumonec
tomy remains high but comparable to that
of other reports and is directly related in
most instances to resected functional pul
monary parenchyma leading to respira
tory failure. Of the 10 deaths after pneu
monectomy, 8 were secondary to respi
ratory failure either as the main cause of
death or as an important contributing
factor.
The overall 5-year survival of 9.2% for
patients with bronchial carcinoma has not
changed much in the past decades.
Results after resection have improved
because of better patient selection for sur
gery. If surgical resection is performed
early, better survival is to be expected.
Overall survival of 36% and 24% at 5 and
10 years for the 292 patients who under
went surgery is comparable to the rates
in many series.26-31 Figures 1 and 2
clearly show that if the tumour itself is
invasive or there is nodal involvement,
survival decreases rapidly. We had poor
results in patients with stage III disease,
especially when mediastinal nodes were
involved. Our longest survival rates were,
o f course, obtained in early-stage
squamous-cell carcinoma: a small tumour
(3 cm or less in dimension) without node
involvement (T1N0).
Conclusions
The incidence of bronchogenic carci
noma is still increasing in Canada and is
reflected in our hospital admissions. The
increase is even more striking in women.
The use of the TNM staging system as
recommended by the American Joint
Committee for Cancer Staging and End
Results Reporting is most important, not
only for evaluation but also to compare
results.
Mediastinoscopy as pre-treatment stag
ing is an excellent means of assessing
superior mediastinal nodes. Left parasterVOLUME 30, NO. 2, M A R C H 1987

nal mediastinoscopy with or without cer
vical mediastinoscopy is essential for ade
quate evaluation of left upper lobe
tumours.
The final solution to lung cancer is
prevention, but results of treatment are
excellent if the cancer is detected and sur
gical treatment instituted early. At an
earlier stage of the disease, a lobectomy
can usually be carried out, but in more
advanced disease, a pneumonectomy with
its associated higher morbidity and mor
tality is often necessary.
We thank Line Trudeau for data collection,
Josee Cyr and Pierrette Gauthier for secretar
ial support, Helene Roussel for graphic work
and the “ Centre de Calcul de 1’Universite de
Montreal” for analysis of data.
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CORRESPONDENCE
continued from page 75

Two new Port-A-Cath devices were
used. One was tested with repeated punc
tures at 90° through the septum using a
22-gauge Yale hypodermic needle and the
other using a 22-gauge Huber-point nee
dle. After each 10 punctures with the
same type of needle, the seal was checked
by injecting air from a 10-ml syringe
through the catheter, with the reservoir
placed under water. After 100 punctures
the seal was checked again by injecting
air through the needle in the septum, with
the reservoir under water and the catheter
clamped.
An air leak was found at 1150 punc
tures with the regular 22-gauge Yale
hypodermic needle and at 1165 punctures
with the Huber-point needle. The centre
of the septum in both devices was
macerated.
We, therefore, could make the follow
ing conclusions.
• The self-sealing septum showed signs
of leakage at 850 punctures less than that
stated by the manufacturer, regardless of
the type of needle used.
• The 22-gauge Yale hypodermic nee
dle seems to be as safe as the Huber-point
needle.
• A safe number of punctures would
be 1000 regardless of the needle used.
• Because the Huber-point needle costs
$1.74 versus $0.26 for the Yale hypoder
mic needle (a difference of $1.48), the lat
ter is more cost effective.

Antoine Loutfi,
Yves Leclerc,

md

md

Department of Surgery
and Department of Oncology,
Royal Victoria Hospital,
McGill University,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1
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Serious Infectious Complications of Open-Heart Surgery
Serious infectious complications of openheart surgery in 521 adults who under
went 534 open-heart procedures are
reviewed. Bacteremia complicated seven
(1 .3 % ) of the procedures, carditis six
(1 .1 % ) and deep sternal wound infec
tions nine (1 .7 % ). The overall rate of
these infections was 4 .1 % with an
associated death rate of 1 1 .7 % (2 of
17). With respect to the risk of this com
plication, no differences were noted in
the age of the patients, duration of sur
gery or perioperative prophylaxis with
cephalothin or cloxacillin. The chance of
carditis developing was significantly
related (p < 0.001) to a valve replace
ment procedure and the risk of a deep
sternal wound infection (p < 0.01) to a
procedure classed as "other".
Staphylococci remained the most com
monly isolated pathogens with an almost
equal frequency of Staphylococcus
epidermidis and Staphylococcus aureus.
Gram-negative aerobes and Strep
tococcus faecalis were found to be other
important pathogens in this clinical
setting.
On a etudie les complications infectieuses serieuses qui sont apparues chez
521 adultes ayant subi 534 operations a
coeur ouvert. Une bacteriemie est venue
compliquer sept (1 .3 % ) de ces interven
tions, une cardite six (1 .1 % ), et une
infection de plaie sternale profonde, neuf
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(1 .7 % ). Pour I'ensemble, le taux d e f e c 
tion a ete de 4 .1 % , avec une mortalite
associee de 1 1 .7 % (2 cas sur 17). En ce
qui a trait au risque de complication
infectieuse, aucune difference n'a ete
observee pour I'age des malades, la
duree de la chirurgie ou I'usage prophylactique peroperatoire de cephalothine ou
de cloxacilline. Le risque de voir se developper une cardite a ete significativement
relie a une valvoplastie (p < 0.001), et le
risque d'infection de plaie sternale pro
fonde, a une operation classifiee comme
"autre" (p < 0 .0 1 ). Les staphylocoques
demeurent les pathog&nes les plus frequemment isoles. Staphylococcus epider
midis et Staphylococcus aureus etant a
peu pr6s retrouves avec une egale fre
quence. Dans cet environnement Clini
que, les aerobies gram-negatifs et Strep
tococcus faecalis ont ete les autres
pathogenes importants.

Serious infectious complications of openh eart surgery include bacterem ia,
endocarditis, purulent pericarditis and
deep sternal wound infections. The fre
quency of endocarditis has ranged from
1% to 10%,1-5 with associated death
rates as high as 86% ,2,3,6-8 The rate of
sternal wound infections and mediastinitis is reported to range from 0.6% to
8.1% ,9-15 with associated death rates of
2.3% to 71% .n '13'14 Factors associated
with an increased incidence of sternal
wound infections and mediastinitis
include the type o f closure,10,11
tracheostomy,9-11 prolonged mechanical
ventilation,10,11 reoperation for bleed
ing,9-12 closed-heart massage,9,10 low
cardiac o utput postoperatively,9,12
prolonged perfusion time,12 surgery last
ing longer than 6 hours16 and age over 65
years.16 Despite the lack of adequate
placebo-controlled trials,17 antibiotic
prophylaxis is recommended for patients
who undergo cardiac valve replace

ment.17,18 A few studies19,20 have shown
the value of antibiotic prophylaxis in
decreasing the incidence of sternal wound
infections after cardiac surgery, and at
present it is recommended for all openheart surgical procedures.18
Staphylococcus sp. are the most com
mon pathogens in p o sto p erativ e
endocarditis6,7 and sternal w ound
infections9,12,14,21 with Staphylococcus
epidermidis being recognized most fre
quently in these clinical settings.1,9,12,22
Changing antibiotic sensitivity o f the
staphylococci, including resistance to con
ventional
agents,
have
been
reported.22-27 Gram-negative aerobes are
also important pathogens.6,9,10,21,28 These
issues have raised questions regarding the
adequacy and appropriateness of the
present regimens used for antibiotic
prophylaxis.
The purpose of this retrospective
review was to determine the frequency of
serious infectious complications o f openheart surgery, death rates associated with
these complications and factors that may
relate to the development of such com
plications. The organisms involved in
these infections and their antibiotic sen
sitivity patterns were also examined.
Patients and Methods
We reviewed the medical records of 521
adults (mean age 56 years, range from 23
to 78 years) who underwent 534 openheart surgical procedures at the Univer
sity of Alberta Hospital between Jan. 1,
1981 and Nov. 30, 1982. The procedures
were considered in four groups — coro
nary artery bypass, valve replacement,
combined coronary bypass and valve
replacement, and “ other” . The last
category included pericardiotomies, ven
tricular aneurysm repairs, removal of
atrial myxomas and repair of congenital
cardiac defects. Data relating to infectious
complications of these procedures were
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noted. An infection was defined as seri
ous if it involved bacteremia, carditis or
deep sternal wound infection. The term
carditis was used to include both
endocarditis and purulent pericarditis.
Endocarditis was diagnosed if positive
blood cultures were accompanied by clin
ical features compatible with endocardi
tis or if bacterial cultures of valvular
material obtained at surgery were posi
tive. Clinical criteria supporting a diag
nosis of endocarditis included a new or
changing murmur, fever, clubbing,
splenomegaly, conjunctival petechiae,
Osier’s nodes, Janeway lesions and
embolic phenomena. Purulent pericardi
tis was confirmed by positive bacterial

cultures of pericardial fluid. Deep sternal
wound infections included sternal
osteomyelitis, mediastinitis and sternal
dehiscence associated with positive bac
terial cultures of bone, mediastinal fluid,
surgical tissue or sternal wound drainage.
Sternal wound cellulitis that responded
favourably to a short course of parenterally administered antibiotics was not con
sidered a serious infectious complication.
Death rates within 2 months of surgery
were examined and correlated with the
presence or absence of infectious compli
cation as defined above.
Factors examined that may have been
related to these serious infections included
age of the patient, type of surgical proce

_______________________________ Table 1—Clinical Data in Seven Cases
Patient
Age,
Duration of
no.
Sex
Procedure
operation, h
Surgeon
yr
1
F
71
CAB X 2
5
B
+ MVR
2
M
65
CAB X 1
12
A
+ AVR
3
M
66
CAB X 4
8
B
+ MVR
4

M

67

5

M

60

6

F

67

7

M

50

CAB = coronary artery

Patient
no.

104

CAB X 2

C

of Bacteremia After Open-Heart Surgery
Organism
isolated
Resistant to
Prophylaxis
Staphylococcus
aureus
Streptococcus
m itis
Serratia
marcescens
Staphylococcus
aureus

Penicillin

Cephalothin

Erythromycin

Cephalothin

Cephalothin,
ampicillin,
tetracycline,
chloramphenicol
Penicillin

Cephalothin

Outcome
Cerebral infarct,
discharged
Discharged
Deep sternal wound
infection,
discharged

Cephalothin

Deep sternal wound
infection,
discharged
CAB X 2
+
5
C
Propionobacter
Cephalothin
Deep sternal wound
infection,
disharged
CAB X 2
5.5
0
Cloxacillin
1 - penicillin,
Staphylococcus
Superficial sternal
erythromycin
epidermidis
wound infection,
(2 strains)
2 - +
discharged
+
MVR
5
A
Staphylococcus
Cloxacillin
Purulent
aureus
pericarditis,
discharged
bypass, MVR = mitral valve replacement, AVR = aortic valve replacement, + = sensitive to all antibiotics tested.

7

M

Age,
yr
50

8

M

37

AVR

9

M

61

MVR

10

M

34

AVR

11

M

54

AVR

12

M

63

AVR

Sex

4.5

dure, duration of surgery and the
prophylactic agent used. During the early
part of 1981, we used cloxacillin routinely
for prophylaxis in patients who under
went open-heart surgery. It was ad
ministered intravenously in 1-g doses 1
hour preoperatively and every 6 hours for
72 hours postoperatively. Cephalothin
subsequently replaced cloxacillin in the
same dosage.
The organisms involved in the serious
infectious complications were examined,
with sensitivity reports based on agar
diffusion studies.
As this was a retrospective study, the
data may be incomplete. Patients who
may subsequently have been admitted to

Procedure
MVR

Table II—Clinical Data in Six Cases of Carditis After Open-Heart Surgery
Duration of
Organism
Culture
operation, h Surgeon
isolated
site
Resistant to
5
A
Staphylococcus
Blood,
Penicillin
aureus (1 mo
pericardial
postop)
fluid
4
Penicillin,
C
Staphylococcus
Blood
epidermidis
erythromycin
(7 wk postop)
A
5
Staphylococcus
Blood
1 — penicillin
epidermidis
2 — penicillin,
(3 strains)
gentamicin,
(3 wk postop)
erythromycin
3 - clindamycin,
clotrimazole
Streptococcus
Valve
Gentamicin,
faecalis
penicillin,
(2.5 mo postop)
erythromycin
B
Blood
Cephalothin,
Streptococcus
6
gentamicin,
faecalis
penicillin,
(3 wk postop)
erythromycin
4
Diphtheroids
Blood
Penicillin,
C
(4 mo postop)
cloxacillin
B
Staphylococcus
Blood,
Not available
3.5
epidermidis
valve
(2 mo postop)
ring

Prophylaxis

Outcome

Cloxacillin

Alive

Cephalothin

Alive

Cephalothin

Died after
valve
replacement

Cephalothin

Cloxacillin

Marfan's
syndrome,
died after
dissection
Alive

Cloxacillin

Alive
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other institutions with complications
would not have been included. The x2
test and paired Student’s /-test were used
for statistical analysis.
Findings

Four-hundred and one cardiac proce
dures were performed on men and 133 on
women. The majority of the procedures
(435 [81%]) were elective and all were
performed by one of four cardiovascular
surgeons.
Of the 534 procedures performed, 383
(72%) were coronary artery bypasses, 97
(18%) were cardiac valve replacements
and 37 (7%) were classed as “ other” .
Overall, the mean duration of surgery

Patient
no.
3

Sex
M

4

M

5

M

12

M

13

M

14

M

15

M

16

M

17

M

was 4.6 hours. When examined by proce
dure, it was 4.5 hours for coronary revas
cularization, 4.7 hours for valve replace
ments alone, 6.3 hours for combined
coronary revascularization and valve
replacement and 4.5 hours for the proce
dures classified as “ other” .
Cloxacillin was administered in 168
(31.5%) of the 534 procedures and
cephalothin in 348 (65.2%). In 18 (3.4%)
of the procedures, there was either no
prophylaxis or some other agent was
used.
Tables I to III outline the clinical details
of the serious infectious complications
documented in this review. Excluding
cases of endocarditis, 7 (1.3%) of the 534
procedures performed were complicated

by bacteremia (Table I) occurring within
4 weeks o f surgery. Carditis (Table II) was
a complication of six (1.1%) procedures
(five cases of endocarditis and one of
purulent pericarditis). Four of the five
cases of endocarditis occurred within 2
months o f surgery. Nine (1.7%) openheart procedures were complicated by
deep sternal wound infections (Table III).
Five patients had more than one serious
complication. Three patients with deep
sternal wound infections and the sole
patient with purulent pericarditis also had
bacteremia. In the fifth patient prosthetic
valve endocarditis developed after valve
insertion and, 1 year later, a deep sternal
wound infection developed after surgery
to repair his paravalvular leak. In total,

Table Ill-Clinical Data in Nine Cases of Deep Sternal Wound Infection After Open-Heart Surgery
Duration of
Organism
Procedure
operation, h
Surgeon
isolated
Resistant to
Prophylaxis
Outcome
CAB X 4
8
B
Cephalothin,
Serratia
Cephalothin Debridement
+ MVR
marcescens
tetracycline,
rectus flap,
ampicillin,
alive
chloramphenicol
1 — penicillin
Staphylococcus
2 — +
aureus
(2 strains)
67
CAB X 2
4.5
C
Staphylococcus
Penicillin
Cephalothin Debridement
aureus
rectus flap,
alive
60
CAB X 2
5
Cephalothin Debridement X 3
Penicillin,
C
Diphtheroids
cloxacillin,
gentamicin
Penicillin
Staphylococcus
epidermidis
Serratia
Cephalothin,
marcescens
tetracycline,
ampicillin,
chloramphenicol
63
Suturing
3.5
B
Cloxacillin
Debridement,
Staphylococcus
Penicillin,
paravalvular
epidermidis
cloxacillin,
alive
leak
erythromycin
+
61
CAB X 2
4.5
A
Cephalothin Debridement
Streptococcus
viridans
rectus flap,
alive
56
Removal left
3
C
Klebsiella
Ampicillin,
Cloxacillin Debridement X 2,
atrial myxoma
pneumoniae
kanamycin,
alive
penicillin,
erythromycin
Staphylococcus
aureus
1 - penicillin,
Staphylococcus
epidermidis
erythromycin,
(2 strains)
gentamicin
2 — penicillin,
erythromycin,
gentamicin,
cloxacillin,
cephalothin,
kanamycin
35
Tetralogy
Staphylococcus
Cephalothin Drainage,
Penicillin
of Fallot
aureus
debridement,
repair
Staphylococcus
Penicillin
alive
epidermidis
64
CAB X 4
4.5
Proteus
Tetracycline,
Cephalothin Debridement X 2,
mirabilis
colistin
muscle flap, alive
Streptococcus
Cephalothin,
faecalis
gentamicin,
penicillin
65
CAB X 3
3.5
Staphylococcus
Cephalothin Debridement,
epidermidis
alive

Age,
yr
66
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22 serious infectious complications were
documented following 534 open-heart
surgical procedures, a rate of 4.1 %. These
complications occurred in 17 (3.3%) of
the 521 patients and were evenly dis
tributed among patients operated on by
the four cardiovascular surgeons.
The mean age of patients with serious
infections was 57.8 years compared with
55.9 years for those who did not
experience such complications. This
difference was not statistically significant,
nor was the mean duration of surgery in
patients with (5.4 hours) and without (4.6
hours) serious infectious complications.
In 15 (4%) of the 348 procedures that
w ere perform ed with cephalothin
prophylaxis there were infectious compli
cations compared with 7 (4%) in the 168
procedures performed with cloxacillin
prophylaxis. There was no significant
difference between cephalothin and clox
acillin prophylaxis and the risk of serious
postoperative infection as determined by
X2 analysis. This held true for all compli
cations combined (p > 0.6) and when
each com plication was exam ined
separately (bacteremia p > 0.8, carditis
p > 0.35 and sternal wound infection p
> 0.5).
In examining the relationship of proce
dure and risk of serious infection, we
noted that all six patients with carditis had
undergone valve replacements alone. This
complication was significantly (p <
0.001, x2 test) related to procedure.
There was also a significant (p < 0.01,
X2 test) relation between the development
of sternal wound infection and the patient
having undergone a procedure classified
as “ other” . There was no statistically sig
nificant relation between bacteremia and
any of the procedures performed. Table
IV presents the numbers and types of
infectious complications as a function of
each group of procedures. Although bac
teremia was not statistically related to
procedure as determined by x2 analysis,
three of seven episodes occurred in
patients who had undergone combined
coronary artery bypass and valve replace
ment, of which 23% were complicated by
a serious infectious complication.
Thirty-two of 521 patients died within
2 months of surgery — an early death rate
of 6.1% . Of these 32, only 2 (6%)

patients had a documented serious
postoperative infection. The death rate of
those with serious infectious complica
tions, however, was 11.8% (2 of 17),
almost double the overall death rate.
The organisms most frequently isolated
from patients with serious infectious com
plications were staphylococci, isolated in
14 of the 22 complications. There was an
almost equal frequency o f isolation of
Staphylococcus aureus (8 of 22 compli
cations) and S. epidermidis (9 of 22 com
plications). Two of the 13 strains of S.
epidermidis involved in these infections
were reported resistant to cloxacillin. The
sensitivity of another 1 of the 13 strains
was unavailable. None of the S. aureus
isolates were cloxacillin resistant. Gram
negative aerobic bacteria were isolated in
5 of the 22 complications. Of interest is
that Streptococccus faecalis was isolated
from two cases of early prosthetic valve
endocarditis and, in association with
another organism, from one case of ster
nal wound infection.
Figure 1 outlines the distribution of
serious infectious complications with
respect to the time of operation and spe
cifically to the 18 surgical procedures that
were associated with a serious infectious
complication. These infections occurred
randomly with no evidence of clustering.
It should be noted that in those months
when more than two infections occurred,
the surgeon and infecting organisms
differed for each infection.
Discussion
Our study demonstrates that despite
antibiotic prophylaxis, serious bacterial
infections can occur following open-heart
surgery. The reported rate of bacteremia
in this review was 1.3%, carditis 1.1%
and deep sternal wound infections 1.7%,
with a combined frequency of 4.1%.
Although these figures are relatively low,
and in keeping with the less than 5% rate
expected for clean surgical procedures,17
the associated mortality and morbidity
were substantial. Two of the seventeen
patients (11.7%) with such complications
died. Of the five patients with endocardi
tis, four underwent repeat surgery for
replacement of their infected valve. Five
of the nine patients with deep sternal

wound infections required myocutaneous
flaps in addition to debridement. Despite
the rather low rate of serious infectious
complications following open-heart sur
gery and the controversy regarding the
need for antibiotic prophylaxis in clean
surgery,17 the mortality and morbidity
associated with these complications
supports the practice of antibiotic
prophylaxis for patients who undergo
open-heart surgery.17’18’29
A change in the antibiotic used in our
centre occurred during the study and
allowed us to compare the efficacy of
cloxacillin and cephalothin in preventing
endocarditis and sternal wound infection.
The study showed no significant differ
ence in rates of serious infectious com
plications in patients receiving either of
these agents prophylactically. This was in
keeping with the findings of Myerowitz
and colleagues30 and Fong and asso
ciates19 who used methicillin or cephalo
thin with no significant difference. It is
interesting to note that in a number of
cases, the isolated pathogen was sensitive
to the prophylactic agent used. During the
study period, 1-g doses of cloxacillin and
cephalothin were used and one might
speculate that this dose was too low to
produce adequate blood levels in patients
placed on the bypass pump.
The cephalosporins have become the
preferred prophylactic agents for openheart surgery even though comparative
trials have failed to support their superi
ority.19,30 Theoretical advantages such as
their broadened gram-negative activity
and in-vitro sensitivity of methicillin and
oxacillin-resistant staphylococci may have
been considerations accounting for this

FIG. 1—Distribution of serious infectious
complications with respect to time of oper
ation.

Table IV-Serious Infectious Complications and Procedures
Procedure
CAB +
Valve
valve
replacement
replacement
CAB
17(3)
No. of patients (% of total)
97(18)
383 (72)
No. of infectious complications* (%)
8 (2)
7 (7)
4(23)
1
3
3
Bacteremia
6
0
0
Carditis
1
0
5
Sternal wound infection
'These 22 complications occurred in 17 patients, whose clinical features are detailed in Tables I, II and III.
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Other
37 (7)
3(8)
0
0
3

Totals
534
22
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practice. However, increasing reports
o f m ethicillin-resistant
stap h ylo
co cci,24-26’31 and reports o f cross
resistance to the cephalosporins22,24 leave
open to question the widely accepted use
o f the cephalosporins as prophylactic
agents for open-heart surgery. Although
our figures did not suggest methicillin
resistance was a major problem at our
centre, oxacillin and methacillin resistance
was documented in 2 o f the 13 strains of
S. epidermidis involved in the serious
infectious complications reviewed. Data
from other centres22,24,25,31 should alert
us to potential future problems with
methicillin-resistant staphylococci.
Although staphylococci were the most
frequently documented pathogens, our
study confirmed the importance of gram
negative aerobes as pathogens in this set
ting. Interestingly, three o f the five gram
negative pathogens isolated were resistant
to cephalothin, the agent administered
prophylactically during the procedure.
The isolation o f S. faecalis in 3 of 22
patients with infectious complications
suggests this organism may also be impor
tant in open-heart surgery. This would be
o f particular relevance since enterococci
are generally resistant to the
cephalosporins.
In examining factors that may have
been associated with the development of
a serious infectious complication, we
found a significant relation between cer
tain procedures performed and specific
infectious complications that developed.
All cases of carditis occurred in patients
who had undergone valve replacements.
There was also a statistically significant
relation (p < 0.01) between the risk of
suffering a sternal wound infection and
having undergone a procedure defined as
“ other” . Although one might expect such
procedures to be more complicated than
bypass procedures or valve replacement,
this is not reflected in an increased dura
tion o f surgery, and other factors need to
be considered. Of interest is that all
patients who had sternal wound infections
were men, raising the question of the
importance of preoperative shaving of the
chest and its relation to wound infection.
Cruse and Foord32 in their extensive
review, found that shaving the operative
site increased the infection rate o f clean
wounds. It is important to indicate that
at the time o f this review, preoperative
shaving of the chest was standard proce
dure at this institution. No statistically
significant correlation was demonstrated
between age o f the patient or duration of
surgery and the risk o f a serious postoper
ative infection.
One of the priorities in cardiovascular
surgery is to define factors predisposing
to serious infections and minimize them.
The relation between operative procedure
and specific complications needs to be

more closely examined since other factors
such as shaving may be important.
Staphylococci and gram-negative aerobes
were the most frequently isolated patho
gens and the prophylactic agent or agents
used should provide coverage for most o f
these organism s. By using broadspectrum antibiotics we may encourage
the development o f multiresistant organ
isms and possibly superinfections due to
enterococci or fungi. Narrower spectrum
drugs, on the other hand, directed at
staphylococci alone might promote gram
negative infections. Although this study
showed no significant differences between
cephalothin and cloxacillin, it would
appear that better controlled trials o f
prophylactic agents for open-heart sur
gery are appropriate.
We acknowledge the cooperation of the staff
o f the Division of Cardiovascular Surgery,
University of Alberta Hospital, and the statisti
cal expertise of Philip Ng, MD, Ph D, in the
preparation o f this paper.
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Pancreatic Islet-Cell Neoplasia, With Secretion of a
Parathormone-like Substance and Hypercalcemia
In a 47-year-old woman with a pan
creatic mass associated with hypercalce
mia and mental confusion, medical meas
ures failed to restore her serum calcium
level to normal. To do so, radical resec
tion of a locally invasive vascular
neoplasm arising from the body and tail
of the pancreas was necessary. The
neoplasm was a pancreatic islet-cell
tumour. Serum parathormone assays
demonstrated abnormally high secretion
of a parathormone-like substance.
Ectopic secretion of such substances
from islet-cell tumours should be consi
dered in association with refractory
metabolic disturbances. In view of the
often indolent clinical course of islet-cell
tumours and the potential for lifethreatening hormonal effects, biopsy
confirmation of adenocarcinoma should
be obtained before resorting to palliative
surgical management of pancreatic
neoplasms.
Les mesures medicales habituelles ont
echoue a retablir une calcemie normale
chez une femme de 47 ans presentant
une masse pancreatique associee a une
hypercalcdmie et a de la confusion mentale. Pour y parvenir, il fallut pratiquer
une resection radicale d'une neoplasie
vasculaire localement envahissante,
affectant le corps et la queue du pan
creas. II s'agissait d'une tumeur pancrea
tique des cellules des Hots de Langerhans. Les dosages de la parathormone
serique ont revele une sdcrdtion anormalement elevee d'une substance semblable
a la parathormone. Une secretion ectopique de telles substances a partir d'une
tumeur des cellules insulaires doit etre
envisagee en presence de troubles metaboliques refractaires. Devant revolution
souvent indolente des tumeurs des celiuFrom the •Department o f Surgery,
t Department o f Pathology and
\D epartment o f Medicine, The Halifax
Infirmary, Halifax, N S
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les insulaires et le risque d'effets hormonaux pouvant entratner la mort, une con
firmation par biopsie d'adenocarcinome
doit etre obtenue avant d'en venir au
traitement chirurgical palliatif des neoplasies pancreatiques.

The majority of pancreatic tumours are
adenocarcinomas, neoplasms with a poor
prognosis and a low rate of resectabil
ity.1 Physicians are understandably pes
simistic when faced with pancreatic
neoplasms and have adopted a conserva
tive approach to their surgical manage
ment. Occasionally, neoplasms arise from
the endocrine pancreas; they are easily
misdiagnosed as inoperable carcinoma,
but have a much slower rate of growth
and warrant a more aggressive attitude in
regard to resection.2 Moreover, these
tumours can secrete a variety of hor
mones,3-6 any of which may produce
bizarre systemic syndromes and have been
associated with elevation of the serum cal
cium level not related to bone metastases
or hyperparathyroidism.7-11

Case Report
A 47-year-old woman was admitted to the
Flalifax Infirmary with a 1-month history of
left upper quadrant abdominal pain associated
with fatigue and a weight loss of 14 kg. Apart
from hypertension, treated with diuretics, she
had been well. The liver edge was palpable just
below the costal margin and there was an illdefined mass in the left subcostal area. Physi
cal examination was otherwise unremarkable.
Complete blood count and urinalysis gave
normal results. The erythrocyte sedimentation
rate was 22 m m /h. The following were also
within normal limits: serum phosphate,
bilirubin, transaminase, creatinine, blood urea
nitrogen, albumin and globulin levels and pro
tein electrophoresis. Serum electrolyte levels
were normal apart from mild hypokalemia.
Urinary cyclic adenosine monophosphate levels
were not determined. The serum calcium level
was elevated to 4.14 mm ol/L (normal 2.13 to
2.63 mmol/L). The serum uric acid level was
elevated to 530 ^mol/L and alkaline phospha
tase to 161 U /L .
A chest x-ray film and electrocardiogram
obtained on admission appeared normal. A
technetium liver-spleen scan disclosed no

abnormalities. Abdominal ultrasonography
demonstrated an irregular mass, 9 cm in
diameter, in the left upper quadrant of the
abdomen, possibly arising from the left lobe
of the liver or tail of the pancreas.
Computerized tomography of the abdomen
confirmed a large retrogastic, soft-tissue mass
involving the body and tail of the pancreas,
possibly obstructing the splenic vein (Fig. 1).
Shortly after admission, the patient became
confused and lethargic with loss of orientation.
Neurologic examination revealed no focal
abnormalities; an electroencephalogram sug
gested a diffuse metabolic disorder. Her
elevated serum calcium level, repeatedly con
firmed, was aggressively treated with saline diu
resis and furosemide and gradually brought
under control, with return of normal mental
status.
In the absence of clinical and radiologic evi
dence of skeletal disease, the cause of the
patient’s hypercalcemia was unclear. The pos
sibility of primary hyperparathyroidism was
considered as was the potential for secretion
of a hypercalcemic stimulant by her abdomi
nal tumour. Serum parathormone assay was
carried out and reported as 291.0 pg/ml from
the C-terminal mid-region (normal, less than
500 pg/ml) which, in association with a total
calcium concentration of 4.1 mmol/L was
thought to be compatible with ectopic secre
tion of a parathormone-like substance.
Laparotomy, after her serum calcium level
had stabilized, disclosed a highly vascular mass
arising from the body of the pancreas, infiltrat
ing the greater curvature of the stomach and
the splenic hilum (Fig. 2). The mass appeared
fixed retroperitoneally but was not associated
with hepatic or lymph-node metastases. An
incisional biopsy of the lesion was attempted
but abandoned because of profuse bleeding.
In view of the apparent invasion of adjacent

FIG. 1—Abdominal computerized tomo
gram demonstrates mass arising from pancreas
(arrows) infiltrating splenic hilum with anterior
displacement o f stomach.
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organs, resection was judged to be unfeasible
and the abdomen was closed.
Postoperatively, despite continued saline
infusion with diuretics, high-dose prednisone
and treatment with calcitonin and mithramycin, her serum calcium level remained elevated
although her mental status was normal. Before
resorting to chemotherapy, we decided to
repeat the laparotomy in an attempt at radi-

cal resection of the tumour. Preoperative
mesenteric angiography confirmed a highly
vascular irregular mass in the region of the
lesser sac and splenic hilum, encasing the
splenic vessels and suggesting an islet-cell
tumour of the pancreas or retroperitoneal sar
coma (Fig. 3).
In an attempt to reduce tumour vascularity
before operation, the patient received a 3300
R course of external cobalt radiation. Because
o f continued nausea and inability to maintain
adequate caloric intake, total parenteral nutri
tion was begun. Two episodes of subclavian
catheter-induced sepsis occurred, necessitating
its removal and replacement. A cellulitis sur
rounding the catheter insertion site responded
to cloxacillin.
At the second operation a thoracoabdomi
nal approach was used to mobilize the pancreas
and spleen from surrounding retroperitoneal
structures. It was apparent that despite local
invasion of the fundus of the stomach and
spleen, the tumour was resectable. There was
FIG. 2—Tumour in body of pancreas with
no evidence of invasion of the left kidney or
extensive neovasculature.
of intra-abdominal metastases. An en bloc
resection of the body of the pancreas, spleen
and greater curvature of the stomach was car
ried out and a feeding jejunostomy tube placed
so that total parenteral nutrition could be with
drawn.
Histopathologically, the pancreatic tumour
was composed o f small regular uniform cells
displaying little or no mitotic activity (Fig. 4).
These cells occurred in small ribbons and nests
diagnostic of an islet-cell tumour of the pan
creas. The margins of excision were free of
tumour and regional lymph nodes were unin
volved. Im munoperoxidase staining for
parathormone was not carried out.
Postoperatively, there was a prompt and per
manent fall in her serum calcium level, and
during the early postoperative period she
required intravenous calcium supplementation
to maintain normocalcemia.
Her postoperative course was uncomplicated
until day 4 when there was evidence of systemic
sepsis. After appropriate culture specimens
were taken, she was started on broad-spectrum
antibiotics intravenously. Despite thorough
clinical and radiologic investigations no focus
FIG. 3—Mesenteric angiography demon
of sepsis could be determined.
strates vascular neoplasm (arrow) within body
One week later, despite a normal serum cal
of pancreas.
cium level, she became confused and dysarthric, as she was preoperatively. Blood and
urine cultures now became consistently posi
tive for Staphylococcus aureus. The investiga
tions for phlebitis were negative and despite
intravenous administration of cloxacillin, her
neurologic symptoms failed to improve. A pansystolic murmur developed and echocardiog
raphy confirmed subacute bacterial endocardi
tis with mitral regurgitation. Despite high-dose
cloxacillin and fusidic acid therapy, her cardiac
status deteriorated and placement of a porcine
mitral valve was necessary. Postoperatively, her
sepsis was controlled and her neurologic sta
tus improved with a return of orientation and
speech. Two years postoperatively her neuro
logic status and serum calcium and serum
parathormone levels were normal, with no clin
ical evidence of tumour recurrence.

Discussion
FIG. 4—Histologic section of tumour with
well-defined cells and minimal evidence of
cytologic atypia or pleomorphism (hematoxy
lin and eosin, original magnification x 63).

The association of hypercalcemia with
malignant disease is not uncommon and
usually suggests metastatic disease involv

ing bone or unrecognized hyper
parathyroidism. Recent reports have
drawn attention to the ability o f various
tumours to produce an elevated serum
calcium level independent o f bone
metastases or parathyroid dysfunction,
com patible with “ ectopic hyper
parathyroidism” .7_11
Considerable controversy exists as to
whether the hypercalcemia is indeed
linked to ectopic production of parathor
mone or to tumour synthesis of nonhormonal substances capable of inducing
hypercalcemia by separate mechanisms.
These include osteoclast-activating factor
and prostaglandins of tumour origin with
effects on bone mimicking the action of
parathormone. Recent work12 has sug
gested that certain tumours induce hyper
calcemia by stimulating adenylate cyclase
in bone through secretion of substances
immunologically distinct from parathor
mone. As suggested by Skrabanek and
colleagues13 criteria that suggest ectopic
parathormone secretion include: hyper
calcemia with normal parathyroid glands,
the absence of bone metastases, correc
tion of hypercalcemia following removal
of the tumour and elevation of parathor
mone in the tumour and the blood. A
thorough analysis of the literature failed
to reveal any case reports that unequivo
cally met these criteria and it was sug
gested that hypercalcemia in association
with neoplasia may have a variety of etiol
ogies independent of parathormone.
A number of recent case reports7' 11
have described the association of hyper
calcemia with islet-cell neoplasia of the
pancreas. As in our case, the rigid criteria
for ectopic hyperparathyroidism are
difficult to fulfil with certainty, and these
cases possibly represent secretion by the
tumour o f a stimulus of hypercalcemia
distinct from parathormone.
The ability of pancreatic endocrine cells
to secrete a variety of hormonally active
peptides, including parathormone, may
be linked to the APUD concept, the islet
cell being one of a number with a com
mon neural crest origin.14-15 This imma
ture stem cell likely becomes undifferen
tiated with the neoplastic process and
acquires the ability to secrete peptides
with varying endocrine effects.16
Although hypercalcemia in association
with a pancreatic mass is easily attributed
to skeletal metastases, isolated spread to
bone is uncommon in pancreatic
adenocarcinoma17 and should suggest
other causes. The diagnosis of hyper
parathyroidism is suggested by a series of
associated biochemical abnormalities
including decreased serum phosphate and
elevated serum chloride levels, both of
which are also compatible with pseudo
hyperparathyroidism. The differentiation
of these two disorders may be made by
the detection of an elevated serum
parathormone level in primary hyper-
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parathyroidism. However, the value o f
parathorm one
radioim m unoassay
remains controversial because o f difficul
ties in interpreting values as a result o f
immunologic heterogeneity and inter
laboratory variation.18 The finding o f a
normal serum parathormone level in our
patient suggests the presence o f other fac
tors related to the neoplasm that may
have induced hypercalcemia.
Although thiazide diuretics may induce
hypercalcemia, it persisted in our patient
for several weeks after they were discon
tinued. The multiple endocrine adenoma
tosis, type 1, syndrome is always a diag
nostic consideration in association with
endocrine tumours o f the pancreas. It
could reasonably be excluded in our
patient by the presence o f a normal skull
x-ray film and computerized tomogram
indicating the absence o f pituitary
neoplasia.
The symptoms o f hypercalcemia are
often nonspecific, with involvement o f
multiple organ systems that may easily be
attributed to the neoplasm itself rather
than the underlying metabolic distur
bance. Prompt recognition o f hypercalce
mia associated with neoplasm is impor
tant because o f its often fulminant course
and failure to respond to conservative
medical measures. Our case illustrates this
point with permanent control o f the
serum calcium level being achieved only
after the tumour had been surgically
resected.
Unlike adenocarcinom a, islet-cell
tumours o f the pancreas are often indo
lent, slow-growing neoplasms with the
potential for long-term patient survival
after recogn ition and appropriate
management. For this reason it is imper
ative that any mass arising from the pan
creas be confirmed as adenocarcinoma
before abandoning an aggressive surgical
approach. As in our case, this lesion may
be highly vascular with a risk o f profuse
bleeding at attempted biopsy.
Because o f the poor prognosis o f pan
creatic adenocarcinoma, with invasion
into contiguous organs, radical surgery is
contraindicated. In contrast, the lessaggressive nature o f islet-cell neoplasms
warrants an en bloc resection o f all
involved tumour if technically feasi
ble.2’9'19 Indeed, in view o f the possibil
ity o f life-threatening associated hor
monal effects, resection o f isolated
hepatic metastases has been advocated, as
this may provide effective palliation for
the slow-growing tumour. Unresectable
or metastatic tumours have been reported
to respond favourably to streptozotocin
chemotherapy with prompt regression o f
associated systemic effects.7,8
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Snowblower Injuries to the Hand
A single heavy snowstorm in Saskatoon
in late 1984 resulted in nine patients
sustaining snowblower injuries to 19
digits. Factors leading to injury included
rapid onset of colder temperatures, sud
den reuse of snowblowers after storage
for the summer, a heavy mid-week storm
that created a sense of urgency to clear
snow in dusky light conditions after a
day at work, frustration as exit chutes
became repeatedly clogged with heavy
wet snow and limited operator educa
tion. The injuries themselves resembled
low-velocity "missile" injuries. A practi
cal preventive measure would be to
encourage manufacturers to equip
machines with remotely located spring
opening clutches.
Au cours d'une seule tempete de neige
forte survenue a Saskatoon a la fin de
1984, neuf patients ont subi des blessures causee par des souffleuses a neige,
impliquant 19 doigts. Plusieurs facteurs
ont contribue aux blessures dont une
chute rapide de la temperature, la reutili
sation soudaine de la souffleuse a neige
aprbs remisage pour l'etd, une forte tem
pete en milieu de semaine qui a cree un
besoin urgent de nettoyer la neige dans
la semi-obscurity apres une journge de
travail, la frustration decoulant du biocage repute de la cheminee d'evacuation
par une neige lourde et mouillee et le
peu d'experience des utilisateurs. Les
blessures en soi ressemblaient a des
Idsions par des "projectiles" a faible
velocite. Une mesure pryventive pratique
consisterait a inciter les fabriquants a
equiper leurs machines d'embrayages a
ressort places y distance.

timetres of wet heavy snow fell on the city
— an unusual occurrence in an area that
usually receives a light fluffy powder.
Driving was nearly impossible and a sense
of urgency forced people to clear away
the rapid accumulations of snow. The wet
snow did not flow smoothly through
snowblowers and accidents happened.
Within 48 hours we saw and treated nine
patients with injuries to 19 digits caused
by snowblowers.
Mechanism of Injury

Snowblower design varies, but the typi
cal homeowner’s model is a two-stage
gasoline-powered machine (Figs. 1 and 2).
The first stage is a slowly rotating auger
mounted at the front. This passes snow
back to the second stage which is an
impeller blade that rotates rapidly to
throw snow out of an exit chute. Both
auger and impeller are driven from the
gasoline-powered engine. A system of
belts and pulleys reduces the high engine
revolutions to the correct rate for the
turning blades. A clutch allows for dis
engagement of the auger and impeller
from the engine.
Most hand injuries occur when the
patient’s fingers are struck by the impeller
blade whilst clearing snow out of a
clogged exit chute. The impeller blades
are close to the exit chute opening which
is frequently not guarded.
Patients and Method

The inpatient and outpatient charts of
the nine patients (eight men, one woman)

were analysed with respect to age, sex,
hand dominance, location of accident,
injuries sustained, management and out
come. Nine months after treatment, all
patients were called back for follow-up
examination and more-detailed question
ing about the circumstances of their
injury.
Findings

Nine patients sustained 21 injuries to
19 digits (Fig. 3). Six had multiple finger
involvement with segmental injuries to
two digits. The patients ranged in age
from 25 to 68 years. All patients were
right handed and in only one was the non
dominant hand involved. Only one acci
dent occurred in the work place, the
remainder happened at the patient’s
home.
Two patients sustained their hand
injuries unclogging jammed first-stage
augers. The other seven patients were
injured by second-stage impeller blades,
six of them attempting to clear clogged
exit chutes and one when using the exit
chute as a handle to lift the machine out
of a snow drift. None of the machines
were fitted with proper safety clutches.
Asked how their injuries had occurred,
seven of the nine said they put their hands
into the moving blades hastily without
thinking or because they thought there
was more distance between the exit-chute
opening and the rotating impeller blade
or because they thought that the firststage auger was the only blade on the
machine. Two patients, however, had
turned their snowblower off but reached

On Oct. 16, 1984, an unusually early
snowstorm hit Saskatoon. Forty cen
From the Division o f Orthopedic Surgery
and Division o f Plastic Surgery, University
o f Saskatchewan, Saskatoon, Sask.
Presented at the 54th annual meeting o f the
Royal College o f Physicians and Surgeons
o f Canada, Vancouver, BC, Sept. 12, 1985
Accepted for publication Dec. 2, 1986
Reprint requests to: Dr. Vaughan Bowen,
Department o f Orthopedics, University
FIG. 1—Typical homeowners’ two-stage
Hospital, Saskatoon, Sask. S7N 0X0
gasoline-powered snowblower.

FIG. 2—Diagrammatic representation of
working parts of two-stage gasoline-powered
snowblower.
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inside before the blades had stopped
spinning.
All injuries were distal to the metacar
pophalangeal joints and in each case the
blade hit the dorsum of the digit. Apart
from the complete amputations, there
were no flexor tendon injuries and only
one digital nerve laceration. This was on
the radial side of a ring finger and,
because it was only partial and very dis
tal, repair was not carried out. Injuries
ranged from skin lacerations through
open fractures to complete amputations.
All patients were treated with antibiotics,
tetanus prophylaxis when necessary,
wound excision, primary repair and
closure of tissues. Efforts were made to
conserve as much of the patients’ fingers
as possible.
Ten amputations occurred, 7 through
distal phalanges and 3 through middle
phalanges. Replantation was not possible
for any of the amputations, either because
injuries occurred distal to the digital
artery trifurcation or because of distal
segment damage. Three amputations were
distal with no exposed bone. These were
covered with a split-thickness skin graft.
The seven others were closed with phalan
geal shortening and using local skin flaps.
There were eight open fractures, two
in middle phalanges and six in distal
phalanges. In each case, the fracture was
explored and its wound excised and copi
ously irrigated. After reduction, Kirschner wires were used for internal fixation,
avoiding transfixion of the distal interphalangeal joint whenever possible. Apart
from carefully repairing the specialized
nailbed tissue, all other lacerated skin was
only very loosely approximated.
There was one open dislocation of a
distal interphalangeal joint. This was
cleaned like an open fracture and then

primarily fused with a single transarticular Kirschner wire. The remaining two
injuries were skin lacerations, which were
excised, irrigated and sutured.
All patients had sutures removed within
7 to 10 days and were followed up for 9
months.
There were no postoperative infections
or ischemic flaps or fingertips. No ampu
tations required revision and, in particu
lar, there were no problems with digital
nerve neuromas, paresthetic flaps or tight
or unsightly amputation stumps. None of
the patients who had undergone ampu
ta tio n experienced quadriga or
“ lumbrical-plus” syndrome. In patients
with proximal digital injuries, tendon
adhesion was not a problem and thus
tenolysis was never necessary. Intolerance
to cold was experienced by six patients but
was always mild. Other forms of cutane
ous hypersensitivity were not seen. The
patient with the digital nerve injury
achieved 8-mm two-point discrimination
by the end of follow-up and this pro
duced no functional disability.
Rehabilitation was started immediately
postoperatively as none of the injuries
needed cast immobilization. Patients were
seen weekly until rehabilitation was com
plete and the clinic therapist strongly
encouraged active motion. Only two
joints did not achieve a full active range
of motion within 6 weeks. One was the
fused distal interphalangeal joint, in
which there was complete bony union and
good function by 3 months. The other
was in a patient with an open fracture of
the distal phalanx who received 1 week
of formal hand therapy during the second
month and eventually achieved 0° to 40°
of active motion. All patients had
returned to work by 6 weeks.
Discussion

FIG. 3—Distribution of injuries sustained
by nine patients.
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Few publications have reported on
snowblower injuries to the hand. There
have been three epidemiologic studies,1-3
which demonstrated that most injuries
occurred when patients used their hands
to clear blocked exit chutes. Accidents
were most likely in heavy wet snow con
ditions and at a time when people were
relatively unprepared, not having used the
machines over the summer months. Other
etiologic factors were operator inex
perience and inadequately functioning
machines. In our study, factors leading
to injury were similar: rapid onset of
colder temperatures, sudden need for
snowblowers after storage for the sum
mer, a mid-week storm with an urgency
to clear snow in poor light after a day at
work, frustration as exit chutes became
repeatedly clogged with heavy wet snow
and limited operator education.
Only one previous paper4 has been
concerned with the injuries themselves. In
a biomechanical study, Barry and Linton

compared the speed of the blade tips and
kinetic energy between rotary lawnmowers and snowblowers. Results
showed that lawnmower injuries were
comparable to those from high-velocity
missiles whereas snowblower injuries were
more like those from low-velocity mis
siles. For this reason, patients in this series
were treated with thorough but minimal
wound excision and wounds were closed
primarily. The cosmetic and functional
results were good, patients returned to
work early, and the troublesome compli
cations that frequently occur after trauma
to the fingers were not seen. These results
were typical of those associated with lowvelocity missiles.
With respect to the exact mechanism of
injury, snowblower injuries, unlike many
other forms of accident are frequently
related to the machines themselves. Most
of the people stated that they were sur
prised how close the impeller was to the
exit chute opening and some did not even
know that there was a second-stage
impeller. Improved operator education
would theoretically be the ideal way to
prevent these injuries from occurring.
Unfortunately, because of the sporadic
use of snowblowers by the casual opera
tor, simple safety rules have either never
been learned or been long forgotten. Most
patients also admitted that, at the time of
injury, they were hurrying to keep up with
an overwhelming quantity of snow, were
frustrated because of the repeatedly
clogged exit chutes and acted hastily
without really thinking about what they
were doing.
Several newer snowblower models have
spring-loaded safety clutch bars mounted
on the handles and require two hands to
be gripping the handle bar in order to
have power engaged on the rotating
blades. With machines constructed in this
way, it should not be possible to reach
both clutch bars and rotating blades at the
same time. Theoretically, therefore, if all
machines were built in this manner, the
number of accidents could be considera
bly reduced, particularly if impeller blades
were made to stop turning abruptly when
the clutch bar was released.
It would seem that the most practical
preventable measure would be to improve
the safety of snowblowers, and manufac
turers should be encouraged to fit all
snowblowers with similar remotely
located spring-opening clutches.
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BILL 022
Rx FOR QUALITY HEALTH CARE
a s new
C
DRUG PATENT BILL C-22
-W HAT DOES IT M EAN
FOR YOU
A N D YOUR PATIENTS?

anad
he new drug patent bill
has sparked political
debates, advocacy cam
paigns, and a degree of public
concern. PMAC wishes all
practising health professionals
to u n d erstan d how these
changes will affect the quali
ty of health care and the cost
of drugs for Canadians. Here are the facts from which you
can judge the benefits of Bill C-22 for yourself and your
patients.

T

KEY FEATURES OF BILL C-22
Recognizes intellectual property o f health scientists
Bill C-22 restores partial recognition of the intellectual prop
erty of the inventors of new and improved drug products by
preventing a generic company from copying the product for
seven or ten years depending on whether or not the generic
company makes the fine chemical in Canada. These fixed
periods of protection are shorter than those provided by all
of our western industrialized trading partners. Nevertheless,
Bill C-22 does establish a fixed period o f protection where
none exists today.
Creates a Favorable Investment Climate
Fourteen individual PMAC members have already public
ly announced that they will spend more than $500 million
over the next five years on new research and development.
In total, PMAC has made a commitment to the government
to double the rate of research and development spending over
the next ten years. Total funding will be $3.0 billion, of which
$1.4 billion is due to changes in Bill C-22 and the favorable
investment climate it creates. This funding will directly create
3,000 high-tech jobs. The Bill also establishes a full govern
ment review o f the industry’s commitments after four and
ten years. Failure to honor these commitments will result in
a loss of protection.
Improves Quality o f Health Care
Quality biomedical research is at the heart of the best health
care systems. The more we have of biomedical research of
the highest calibre, the more our society gains from earlier
access to new medicines and medical procedures with an
overall improvement in quality of life. The $3.0 billion that
the industry will spend on Canadian research over the next
ten years is more than j ust money and high-tech jobs for our
university graduates. It is an investment in new, high quali
ty treatment for AIDS, cancer, Alzeheimer’s and other
diseases. It is an investment in the health care of the 21st
century.
Protects Patients from High Prices
Bill C-22 creates a Drug Price Review Board which will limit
the amount manufacturers can charge for a new product

and the am o u n t o f yearly
price increases. The Board will
determine if the prices o f new
products are excessive by com
paring them against the prices
o f existing products in the
same therapeutic class. The
Board will limit the rate o f an
nual price increases for all pro
tected products to no more than that of the Consumer Price
Index. Manufacturers that fail to abide by a directive o f the
Price Board will im mediately lose protection for their
products.

Maintains A vailability o f Generic Products
Under Bill C-22, all generic products on the market will re
main on the market. Forty (40) more high volume generic
products will reach the market over the next five years as pro
tection periods expire. This is three times the number of gen
eric products that reached the market in the past five years.

BILL C-22 A QUALITY Rx FOR CANADA
. ill C-22 is a positive reward to the inventor who has
.investigated 10,000 chemicals, spent ten years time,
' and invested $100 million to develop his one new pro
duct for better health. Bill C-22 stimulates biomedical
research in Canada to develop cures for the 21st century. Bill
C-22 protects patients by creating a new powerful Board to
regulate prices. Bill C-22 is a fair balance to all.

B!

You be the judge. If you think the benefits of Bill C-22 are
good for Canada, please write to the Prime Minister, or
sign and send him this
prescription for Canadian
health care.
PMAC thanks you for your
support.

For:
Address:

PHARMACEUTICAL MANUFACTURERS ASSOCIATION OF CANADA
Innovation ond Social Responsibility

The Honourable Brian Mulroney, Prime Minister of Canada
Langevin Building, Wellington Street
Ottawa, Ontario K1A 0A2

Date:
Rx

BILL C-22
A sound policy for consumer protection, expanded biomedical
research, and quality health care for all Canadians.
As a Canadian professional health practitioner, I support this
policy.

LE PROJET DE LOIC-22
Rx: SO IN S DE QUALITE
Le

n o u v e a u p r o je t
e nouveau projet de loi
Une garantie contre !a cherte des
sur Ies brevets pharm amedicaments
ceutiques a dedenche un
Le projet de loi C-22 prevoit la
debat politique, des campagnes
creation d ’un Conseil d ’examin
d ’opinion et une certaine controdes prix des medicaments qui
verse publique LACIM souhaite
limitera le prix de lancement des
que tous les praticiens du secteur
m edicam ents nouveaux et le
de la sante soient au courant de
m ontant des hausses periodila faqon dont les reformes pro
ques. Pour les nouveaux medi
posers influeront sur la qualite
caments, le Conseil procedera
des soins et sur le cout des medicaments. Voici done des faits qui
par comparaison avec les prix des produits existants dans chavous permettront de juger des avantages que presente le projet
que categorie therapeutique. Le prix d ’aucun produit exclusif ne
de loi C-22 pour vous-meme et pour vos patients.
pourra augmenter plus vite que la progression annuelle de l’indice des prix a la consommation. Tout laboratoire qui ne respecte
pas les directives du Conseil d ’examin sera immediatement prive
LES GRANDES LIGNES DE LA REFORME
de son exclusivite pour ses produits.

L

DE LOI CANADIENNE
SUR LES BREVETS (C -22):
REPERCUSSIONS POUR VOUS
ET VOS PATIENTS

A
i

v
A.

Reconnaissance de la propriete intellectuelle des scientifiques

Le projet de loi C-22 retablit en partie les droits de propriete in
tellectuelle de ceux qui decouvrent de nouveaux medicaments
ou qui perfectionnent des produits pharmaceutiques existants.
P o u r ce faire, la nouvelle loi in terd ira aux fabrican ts de
medicaments generiques de copier les produits brevetes pendant
une periode de sept ou dix ans selon q u ’ils se livrent ou non a la
production de chimie fine au Canada. La duree de cette protec
tion est certes plus courte que celle que garantissent tous nos
partenaires industrialises occidentaux, mais l’adoption d ’une
periode fixe est deja un grand progres pour le Canada.

Instauration d 'un climat favorable aux investissements
Quatorze laboratoires pharmaceutiques membres de l’ACIM ont
deja annonce q u ’ils ailoueront plus de 500 millions de dollars
leurs budgets de recherche-developpement au cours des cinq prochaines annees. Au total, l’ACIM s’est engagee envers le gouvemem e n t a d o u b le r le niveau des d e p e n se s de recherchedeveloppement dans un delai de dix ans. Le budget total de la
recherche s’elevera a 3 milliards de dollars, dont 1,4 milliard provenant directement des reformes introduites par le projet de loi
C-22 et du climat favorable q u ’il contribuera a creer en matiere
d ’investissement. Ce niveau de financement permettra de creer
directement 3 000 emplois dans un secteur de pointe. La nouvelle
loi prevoit egalement que les pouvoirs publics passeront integralem ent en revue le niveau de realisation des engagements pris par
l’industrie quatre ans et dix ans apres 1’adoption de la reforme.
Les entreprises qui ne tiendront pas promesse seront privees de
leur exclusivite.

M aintien des produits generiques sur le marche
Aux termes de la nouvelle loi, tous les produits generiques actuels pourront rester sur le m arche Une quarantaine de nouveaux
produits generiques a grand debit seront mis sur le marche d ’ici
cinq ans a mesure q u ’expireront les brevets qui les protegent en
core Ce chiffre est cinq fois plus eleve que le nombre de produits
generiques lances depuis cinq ans.

LE PROJET DE LOI C-22: Rx QUALITE POUR LE CANADA
e projet de loi C-22 recompense de facon tangible l’inventeur qui, en dix annees de travail, a etudie 10000 molecules
et investi 100 millions de dollars pour mettre au point un
medicament nouveau afin de proteger la sante. Le projet de loi
C-22 stimule la recherche biomedicale au Canada pour conquerir
les maladies du X X Ie siecle. Le projet de loi C-22 protege les
patients en creant une puissant Conseil d ’examin des prix. Le pro
jet de loi C-22 rend justice a tous.

L

Jugez-en vous-meme. Si vous pensez que le projet de loi C-22 est
bon pour notre pays, ecrivez
a u P rem ier m in istre du
C anada, ou signez cette ord o n n an ce d u m en t rem plie
pour assurer la sante future
des Canadiens.
L’A C IM vous rem ercie de
votre appui.
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Am elioration de la qualite des soins
La qualite de la recherche biomedicale est garante de la qualite
des soins. Plus le niveau de la recherche biomedicale canadienne
s’eleve, plus notre pays profite de la disponibilite immediate de
medicaments et traitements nouveaux, et plus notre qualite de
vie s’ameliore. Les 3 milliards de dollars que l’industrie consacrera
en dix ans a la recherche canadienne ne serviront pas seulement
a ameliorer les revenus de nos chercheurs et a creer des emplois
pour nos diplomes. C ’est un investissement dans la qualite future
des soins qui perm ettront de lutter contre le SIDA, le cancer, la
maladie d ’Alzheimer et les autres maladies encore invaincues ou
imparfaitement maitrisees. C ’est un investissement dans la sante
des Canadiens au XXL' siecle.
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Arthrodesis of the Wrist
In a retrospective study, the wrists of 18
patients who underwent arthrodesis by
the AO technique were assessed clini
cally, for hand strength and function.
Follow-up averaged 4 years (range from
1 to 7 years). Although wrist arthrodesis
improved grip strength, it was still only
50% to 60% of normal. Hand function
improved to within normal limits in 78%
of patients and bony union occurred in
94.4% . Thirteen patients were back at
work within 18 months. The AO tech
nique of wrist arthrodesis allows correc
tion of deformity, relief of pain,
increased grip strength and improved
hand function.

Arthrodesis is an excellent procedure for
improving function in a disabled wrist.
Although the literature shows that sur
geons agree on the desirability for a posi
tion of slight dorsiflexion, the technique
used to achieve fusion varies.1-6 In this
study the method of compression arthro
desis of the wrist was in accordance with
the principles for stable internal
osteosynthesis described by Muller and
colleagues.7
The current indications for wrist fusion
include irreversible destruction secondary
to rheumatoid arthritis or osteoarthritis,
causing prolonged pain and deformity,
and flaccid or spastic paresis causing
difficulty in using the hand.

Ce fut une etude retrospective de 18
patients ayant recu une arthrodfese du
poignet utilisant la techique AO. La
moyenne de post-observation fut de 4
ans avec une portde de 1 S 7 ans. Tous
les patients furent cliniquement evalues
ainsi que d'eprouver des assais formaux
pour I'intensite et fonction de la main.
Les r6sultats ont demontre que le taux
d'union fut 94.4% . Malgrds que I'arthrodese du poignet amdliore la force de serrage; ce n'est que 50% & 60% dans les
limites de la normal chez 78% des
patients. Treize patients retourn&rent au
travail en dedans de 18 mois. Alors la
technique AO d’arthrod&se du poignet
alloue une bonne amelioration de ddformite, soulage la douleur, augmente I'intensite de serrage et am£liore la fonction
de la main.

Materials and Methods
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anchored over the bone graft by at least
two screws in the second metacarpal, one
in the carpus and at least three in the
radius. Care should be taken to prevent
the extensor pollicis longus from cross
ing a screw head, as there have been
reports o f rupture secondary to attrition.
The tourniquet is released, hemostasis
obtained and the wound irrigated and
closed over a Hemovac drain. Operating
time is approximately 60 minutes.
Postoperative Care

All patients wore a protective gauntlet
for 2 to 4 weeks. Physiotherapy was
begun within 7 days. The hardware was
left in for an average of 2 years.
Results

The charts of 30 patients who under
went wrist arthrodesis at the Victoria
General Hospital in Halifax in the 7 years
between 1974 and 1981 were reviewed. Of
these, 18 patients were assessed clinically
and form the basis of this study. In 15
cases the fusion was required for trau
matic osteoarthritis, in 2 it was secondary
to inflammatory disease and in 1 to a
spastic monoplegia secondary to trauma.
The follow-up averaged 4 years (range
from 1 to 7 years).
Operative Method

Under general anesthesia, a tourniquet
is applied high on the upper arm and
inflated to 250 mm Hg. The wrist area is
prepared and draped. The joint is exposed
with a standard dorsal approach.. Artic
ular cartilage is removed with hand-held
curettes, rongeurs and a Hall drill. A
trough is then created from the radius to
the second and third metacarpals and a
bone graft from the iliac crest is fashioned
as a slab to fit the trough. Small cancel
lous bone grafts should be packed into the
intercarpal and radiocarpal joints. The
dynamic compression plate (six- to sevenholes narrow 4.5 mm) is then contoured
to 10° to 20° of dorsiflexion while its
position on the second metacarpal should
allow 5° of ulnar deviation. The plate is

The patients in this study were tested
for hand strength by the method outlined
by the Sister Kenny Institute,8 and for
hand function according to the method
of Jebsen and colleagues.9 These inves
tigators administered tests to more than
300 people with normal hands and drew
up tables, adjusting the results for age,
sex and dominant versus non-dominant
hand.
In order to assess hand strenght,
the 18 patients were first given four
tests: grip strength, palmar pinch, threepoint pinch and lateral pinch. The results
were compared with those for normal
hands (Table I). The wrist that required
arthrodesis for painful tenosynovitis, was
in the 90*70 to 100% group. The two
wrists in the 10% to 25% group were
fused in 5% to 10% ulnar deviation. One
o f the three in the under 10% group had
associated median and ulnar nerve pal-

Table 1--Hand Strength
Wrist arthrodesis
Percent of normal
1
90 - 100
75 - 90
0
10
50 - 75
2
25 - 50
10 - 25
2
< 10
3
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sies, one had a pseudarthrosis and the
third was the only patient in the study
with spastic monoplegia.
Hand function was then assessed by
giving each patient the following tests and
relating them to time: (a) writing, (b) abil
ity to pick up a small common object, (c)
simulated feeding using a spoon, (d) abil
ity to stack checkers, (e) ability to han
dle large light objects and (f) ability to
handle large heavy objects.
The results of these timed trials were
then related to the normal, as drawn up
by Jebson and colleagues9 (Table II).
The patient with pseudarthrosis was
within 1 standard deviation of normal but
three others scored greater than two stan
dard deviations. One had median and
ulnar nerve palsies, one had spastic
paraplegia and the third had chronic ulnar
osteomyelitis. Therefore, after fusion,
78% had acceptable hand function.
Patients were also asked to evaluate
their wrists subjectively with respect to
function and pain. The results were as fol
lows: excellent - no pain and unlimited
activity, good - no pain but some limited
activity, fair - minimal discomfort and
limited activity, poor - increased pain
with activity (Table III). Two patients in
the good group were unhappy with the
wrist position, complaining of too much
flexion. One in the fair group and one in
the poor group complained of pain over
the plate. All but one patient in the poor
group, who had the pseudarthrosis, felt
that the discomfort was much reduced
and functional level improved over the
preoperative state.
Complications
Only one pseudarthrosis developed,
giving a union rate of 94.4%. This nonun
ion was the direct result o f a split frac
ture of the second metacarpal which,
despite external im m obilization,
progressed to pseudarthrosis.
There were two infections. One was
superficial and cleared with antibiotic
treatment and wound care within 2 weeks.
The other was treated with antibiotics for
1 year and at follow-up after 5 years
showed good union, with the plate still
firmly in position.
Table 11-Hand Function
Wrist arthrodesis
Range
14
Normal
1 std deviation
1
> 2 std deviations
3
Table III- Subjective Evaluation of Function
Wrist arthrodesis
Evaluation
12
Excellent
3
Good
Fair
1
Poor
2
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Discussion
Previous techniques, using external fix
ation to immobilize the wrists, were com
plicated by pseudarthroses. With bone
grafts the frequency of this complication
is reported to range between 2% and
12%. However, cast fixation for as long
as 4 to 6 months, with further protection
in a splint, may be required to obtain ade
quate union. With the AO technique,
union was obtained in our study in all
wrists but one, and in that case nonun
ion was secondary to a split fracture of
the second metacarpal. If a split fracture
does occur it should be repaired opera
tively to achieve rigid internal fixation.
Arthrodesis of the wrist should result
in an increase in the power of grip but,
as this study shows, not much more than
50% to 60% of normal can be expected.
By using internal fixation the patient has
an early start in the use of the hand,
thereby minimizing the risk of adhesions
between the skin and the gliding exten
sor mechanism.
The plate should be placed on the
second metacarpal bone, radial to the ten
dons of the extensor digitorum communis
muscle. It does not seem to impair func
tion of the extensor pollicis longus
although rupture of that tendon has been
reported,7 probably caused by the ten
don crossing over one of the screw heads.
The use of a dynamic compression
plate is recommended, as opposed to the
narrow plate and compression instrument
described by Muller and colleagues.7 The
dynamic compression plate gives ade
quate compression and does not require
the extra exposure demanded by the com
pression instrument.
The plate should probably be removed
between 6 and 12 months postoperatively.
This is supported by U hthoff and
D ubuc10 who noted th at periosteal
resorption occurred after 6 months of
application of a plate. However, it is very
difficult to tell if the fusion is solid and
this accounted for our delay. Bone
remodelling and regression of the
osteopenia occur after the plate is
removed.10'11
Hand function was improved to within
acceptable limits in 78% of the wrists
operated on. The poor results were due
to pseudarthrosis, nerve palsy, spastic
monoplegia and chronic osteomyelitis.
Seventy-two percent of our patients were
back at work within 18 months of oper
ation.
Arthrodesis of the wrist using the AO
technique offers a stable internal fixation
that gives optimum conditions for rapid
bony union. It allows correction of defor
mity, relief of pain, and better hand grip
and function. The most important con
tribution of this technique is the high rate
of fusion despite major deformity
preoperatively.

We acknowledge the work o f Cathy
McAuley and Jill Tasker from the Dalhousie
University Physiotherapy Department.
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NOTICES
First In te rn atio n a l
S hock C ongress
The First International Shock Congress
and the Tenth Annual Conference on
Shock will be held in Montreal, June
7-11, 1987. The scientific program will
consist of workshops, symposia, submit
ted papers and poster presentations. As
well, the four finalists of the Young In
vestigator Awards Competition will
present their work. For information con
tact Dr. Sherwood M. Reichard, Medi
cal College of Georgia, Augusta, GA
30912.

C o ntinuing E ducation
— G astro en tero lo g y
The University of Rochester School of
Medicine is sponsoring a course entitled
“ Rochester Review in Gastroenterology”
in Toronto, Oct. 8-10, 1987. Dr. Jagdish
C. Mangla is the course director and Dr.
Sheila Sherlock from The Royal Free
Hospital in London the guest speaker. In
formation can be obtained from: Office
of Continuing Professional Education,
UR Medical Center, 601 Elmwood Ave.,
Box 677, Rochester, NY 14642 (tele
phone: [716] 275-4392).
continued on page 141
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Successful Treatment of a Traumatic Hepatic
Artery-Portal Vein Arteriovenous Fistula
by Interpositional Mesocaval Shunting
Hepatic artery-portal vein fistula is an
occasional sequel to invasive procedures
on the liver, such as biopsy and transhepatic cholangiography. When the
fistula is large it may result in portal
hypertension, gastrointestinal bleeding
and histologic and functional changes in
the liver. Treatment is usually directed at
the fistula, either embolizing, dividing or
resecting it. Portal decompression has
been discouraged in the past. The
authors describe a case in which recur
rent gastrointestinal bleeding, uncon
trolled by attempts at embolization, was
subsequently managed successfully by
portosystemic shunting. They suggest
that when the primary symptom related
to the fistula is variceal bleeding, portal
decompression is a reasonable therapeu
tic option.
Une fistule entre Tartfere hepatique et la
veine porte apparait en de rares occa
sions comme sequelle d'une intervention
avec penetration hepatique telle qu'une
biopsie ou une cholangiographie transhepatique. Dans les cas de fistules
importantes il peut s'ensuivre une hyper
tension porte, des saignements gastrointestinaux ainsi que des modifications
histologiques et fonctionnelles du foie.
On s'applique habituellement a corriger la
fistule, soit par embolisation, separation
ou resection. Dans le passe, la decom
pression du systeme porte a etd deconseillee. Les auteurs decrivent un cas ou
des saignements gastro-intestinaux recidivants, non corriges par une tentative
d'embolisation, ont pu etre reprimes par
la suite par une derivation du systeme
porte. Ms suggerent que quand le
symptome primaire de la fistule est
I'hemorragie variqueuse, la decompres
sion du systeme porte est une option
therapeutique acceptable.

From the *Department o f Surgery and
t Department o f Radiology, University o f
Toronto, Toronto, Ont. and the %Division
o f Gastroenterology, University o f Alberta,
Edmonton, Alta.
Accepted fo r publication Aug. 1, 1986
Reprint requests to: Dr. B. Langer, Eaton
Building, 9-236, Toronto General Hospital,
Toronto, Ont. MSG 1L7

Hepatic artery-portal vein arteriovenous
fistulas are very rare but potentially fatal.
A small number are congenital but most
are a result o f penetrating trauma,1
including surgical manipulation or inva
sive diagnostic procedures such as needle
biopsy or percutaneous transhepatic
cholangiography.1 In fact, with the
increased use o f diagnostic angiography,
asymptomatic arteriovenous fistulas
secondary to percutaneous needle punc
ture are often identified.2
Symptoms are proportional to the size
o f the fistula, with large fistulas leading
to portal hypertension and its complica
tions. After angiographic confirmation of
the diagnosis, treatment is usually surgi
cal and directed at the fistula. Concern
that treating the portal hypertension with
a portosystemic shunt will precipitate
cardiac failure appears to be more theo
retical than real. This paper reports a
patient with hepatic artery-portal vein
fistula whose serious portal hypertension
was treated successfully by mesocaval
shunting.

and endoscopy demonstrated a chronic duo
denal ulcer and esophageal varices which were
thought to be the source of the bleeding. A
superior mesenteric arteriogram revealed that
the hepatic arteriovenous fistula was patent,
so embolization was repeated using wire coils
(Fig. 3). A t follow-up endoscopy 1 week later,
the varices were flat with no evident bleeding.
A left nephrectomy was performed in
November 1983 for removal of a suspicious left
renal mass, which was found to be a benign
nephroma. The patient remained well for 8
months when she had massive hematemesis,
preceded by a 2-week history of melena, nausea
and malaise. No ulcer was present but

Case Report
A 67-year-old woman, who had no history
of alcoholism, was referred to the Toronto
General Hospital in July 1984 for treatment of
upper gastrointestinal bleeding. Her medical
history included long-standing peptic ulcer dis
ease, treated with cimetidine, and a gastric fundoplication performed in 1977 at which time
splenectomy was necessary due to intraopera
tive injury. In 1978 a percutaneous needle
biopsy of the right lobe of the liver was per
formed during investigation of jaundice and
d em onstrated steatosis histologically.
Endoscopy carried out for an upper gastroin
testinal hemorrhage in January 1982 revealed
esophagitis and gastritis. A second percutane
ous biopsy of the right lobe of the liver, done
in 1982, showed nonalcoholic steatonecrosis
and fibrosis. In May 1982, a second, major
upper gastrointestinal hemorrhage occurred.
Bleeding esophageal varices were seen on
endoscopy; these were managed conservatively.
Angiography demonstrated a large fistula
between a branch of the right hepatic artery
and the portal vein (Fig. 1). Gelfoam emboli
zation of the right hepatic artery was per
formed with successful closure of the fistula
(Fig. 2). Hematemesis recurred in October 1983,

FIG. 1— Initial angiogram demonstrating
fistula (arrow) between branch of right hepatic
artery and portal vein.

FIG. 2—Angiogram after Gelfoam emboli
zation of hepatic artery-portal vein fistula.
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esophageal varices were again seen. These were
sclerosed with 3% sodium tetradecyl sulfate
(Thrombovar) and an intravenous infusion of
Pitressin was started. Angiography demon
strated that the hepatic artery-portal vein
fistula in the right lobe of the liver was again
patent. She was transferred to the Toronto
General Hospital for further management.
On admission she was hemodynamically sta
ble, not icteric and had no peripheral stigmas
of chronic liver disease. Her liver was mildly
enlarged and nontender with no audible bruit
in the epigastrium or right upper quadrant.
Results of laboratory investigations, including
liver function tests, were all within normal
limits. Endoscopy revealed esophageal varices
which were sclerosed with 10 ml of ethanoleum
oleate.
In July 1984, after another variceal hemor
rhage, a portal systemic mesocaval shunt was
performed without difficulty using an interpositional Weavenit graft (Meadox Medical
Inc., Oakland, NJ). The liver appeared cir
rhotic. A wedge biopsy from the right hepatic
lobe demonstrated advanced macronodular cir
rhosis, compatible with a previous viral infec
tion. She made a smooth recovery and was dis
charged 9 days later. An angiogram obtained
before discharge revealed a patent mesocaval
shunt and filling of the arteriovenous fistula
through arterial collaterals with retrograde flow
in the portal vein.
Follow-up endoscopy 3 months later showed
flat esophageal varices, and 30 months
postoperatively she remained well, with no
recurrence of bleeding.

Discussion
Due to the close proximity of the
biliary, arterial and venous conduits in the
portal tract, there is a substantial risk of
injury to adjacent structures in trauma
and during invasive procedures aimed at
deliberate transhepatic cannulation of the
bile ducts. O kuda and colleagues2
demonstrated that the risk of arteri

ovenous fistula rises with increasing nee
dle calibre and length of penetration of
the instrument. None of the patients they
studied experienced
appreciable
symptoms and several who had follow
up arteriograms at 15 months and 5 years
after percutaneous transhepatic proce
dures failed to demonstrate a fistula. The
authors suggested that small intrahepatic
fistulas may be occluded by regenerating
hepatocytes and fibrosis.2 Nevertheless,
occasionally a hepatic artery-portal vein
communication may persist, secondary to
necrosis of sequestered hepatic paren
chyma, breakdown of a necrotic vesselwall hematoma or pseudoaneurysm for
mation. Fistulas occurring after major
liver trauma rarely close because of their
large size and the greater destruction of
surrounding hepatic parenchyma.3
Symptoms and signs vary, depending
on the size of the fistula and the timing
of presentation. When a hepatic arteryportal vein fistula occurs directly after
abdominal trauma, acute portal conges
tion and hyperemia of the intestinal
mucosa may present an enteritis-like pic
ture,4 with diarrhea, abdominal pain and,
occasionally, gastrointestinal bleeding.
Careful clinical examination may rev
eal a machinery type loud bruit over the
liver or epigastrium. Such patients may
deteriorate rapidly because of acute gas
trointestinal or intrahepatic bleeding.5 If
the fistula is small, collateral circulation
may provide adequate compensation for
the change in liver blood flow so that the
patient remains asymptomatic. Eventu
ally, usually after 4 or 5 years,3 the
patient may present with the sequelae of
portal hypertension — variceal bleeding
and, less commonly, ascites. The
hemodynamic alterations resulting from

FIG. 3—Angiogram demonstrating re-embolization of recurrent hepatic artery-portal
vein fistula.
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a portal systemic fistula are such that the
blood flow into the liver exceeds the
capacity of the outflow tract, and portal
hypertension ensues.6 However, unlike
large systemic arteriovenous malforma
tions, where tachycardia, elevated cardiac
output, cardiomegaly, widened pulse
pressure and heart failure are seen,
cardiac effects are unusual with hepatic
arterioportal fistulas.7 It appears that the
high venous flow rate is dampened by the
resistance of the hepatic sinusoids,
thereby sparing the heart.8
The definitive diagnosis is made by
angiography, although the history of
trauma or an invasive procedure, fol
lowed by symptoms of portal hyperten
sion and an epigastric bruit detected on
physical examination, are highly sugges
tive. The typical angiographic picture, as
seen in our patient, is one of early visuali
zation of the portal vein on aortic or
celiac artery injection, or filling of the
portal vein on a selective hepatic arterio
gram .4 Distal to the fistula arterial
calibre is diminished and the portal vein
may be tortuous and dilated.
Typically, liver function is normal,
consistent with the normal histologic
appearance o f the liver parenchyma.
Thickening of the muscularis of the por
tal vein with dilatation of the liver sinu
soids histologically is frequently described
and has been termed hepatoportal scle
rosis.6
Hepatic artery-portal vein fistulas, par
ticularly those located in the periphery,
are often small, have few collaterals and
usually close spontaneously. In contrast,
centrally located fistulas are often large
and more hemodynamically important.
Their large size and the collateral blood
flow makes treatment difficult. The dual
hepatic blood supply makes angiographic
embolization an attractive treatment
option,9"11 but fistula size and the large
number of collaterals may reduce the
likelihood or duration of success. Surgi
cal obliteration is generally regarded as
the treatment of choice.1,2'4,5'7 Proximal
ligation of the hepatic artery frequently
fails because there is a compensatory
increase in the collateral flow, and the
fistula persists. Division of the arterial
venous channel is desirable but often tech
nically impossible in deep-seated fistulas.
In this situation hepatic lobe resection has
been suggested.12 Attempts at reducing
the portal hypertension by means of a
portosystemic shunt have been con
demned by several authors,1,4 who argue
that this merely diverts the flow back to
the systemic circulation, thereby risking
the subsequent development of such
hemodynamic side effects of a systemic
fistula as cardiac failure.
In spite of this theoretical considera
tion, we did not find any reports of sys
temic complications resulting from a
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functioning portosystemic shunt for
hepatic artery-portal vein communica
tion. Ryan and Lorber13 reported the
case o f a 61-year-old man with a trau
matic fistula treated successfully with a
portacaval shunt. Ascites developed when
the shunt thrombosed, but the condition
was easily controlled medically. A woman
with a traumatic fistula was treated by
Donovan and colleagues6 with an end-toside portacaval shunt. The portal hyper
tension was relieved and she did not suffer
any deleterious cardiac effects.
Surgical treatment o f our patient was
directed at relief o f the portal hyperten
sion that led to life-threatening variceal
bleeding. A mesocaval shunt, function
ally a side-to-side portosystemic shunt,
was well tolerated and did not precipitate
high output cardiac failure or other seque
lae as has been suggested.1-4’14’15 Thirty
months after the shunt procedure, she
remains symptom-free. W e suggest, con
trary to long-standing beliefs, that por
tosystemic shunting is a safe, welltolerated means o f treating portal hyper
tension associated with large hepatic
artery-portal vein fistula, and it should
be considered a therapeutic alternative if
more conservative methods o f controll
ing the fistula fail.
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Prescribing Information
ZANTAC* INJECTION (ranitidine hydrochloride)
PH ARM ACOLO G ICAL CLASSIFICATION
Histamine H2-receptor antagonist
INDICATIONS AND CLIN IC A L USE
Zantac injection is indicated for the treatment of duodenal ulcer,
benign gastric ulcer, post-operative ulcer, reflux esophagitis,
Zollinger-Ellison syndrome and other conditions where reduc
tion of gastric secretion and acid output is desirable. These
include the prophylaxis of gastrointestinal haemorrhage from
stress ulceration in seriously ill patients, the prophylaxis of
recurrent haemorrhage in patients with bleeding peptic ulcers
and before general anaesthesia in patients considered to be at
risk of acid aspiration (Mendelson’s) syndrome, particularly
obstetric patients during labour.
For appropriate cases Zantac Tablets are also available.
CO NTRAINDICATIO NS
There are no known contraindications to the use of Zantac
(Ranitidine).
WARNINGS
Gastric u lcer-Treatm ent with a histamine H2-antagonist may
mask symptoms associated with carcinoma of the stomach and
therefore may delay diagnosis of the condition. Accordingly,
where gastric ulcer is suspected the possibility of malignancy
should be excluded before therapy with Zantac is instituted.
PRECAUTIONS
Use in pregnancy and nursing m o th ers-T h e safety of
Zantac in the treatment o f conditions where a controlled
reduction of gastric secretion is required during pregnancy has
not been established. Reproduction studies performed in rats
and rabbits have revealed no evidence o f impaired fertility or
harm to the fetus due to Zantac. If the administration o f Zantac
during pregnancy is considered to be necessary, its use requires
that the potential benefits be weighed against possible hazards
to the patient and to the fetus. However, therapeutic doses of
Zantac administered to obstetric patients in labour or undergo
ing caesarean section have been without adverse effect on
labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers
but the clinical significance of this has not been fully evaluated.
Use in im paired ren al fu nction-Ranitidine is excreted via
the kidney and in the presence o f severe renal impairment,
plasma levels of ranitidine are increased and prolonged.
Accordingly, in the presence of severe renal impairment, clini
cians may wish to reduce the oral dose to half of the usual dose
taken twice daily, similarly it is recommended that ranitidine
injection be administered in doses of 25 mg to patients with
renal dysfunction.
Children - Experience with Zantac in children is limited and
such use has not been fully evaluated in clinical studies. It has
however been used successfully in children aged 8-18 years in
doses up to 150 mg orally twice daily without adverse effect.
ADVERSE REACTIONS
No serious adverse effects have been reported to date in
patients treated with Zantac. There has been no clinically signi
ficant interference with endocrine, gonadal or liver function,
nor has the drug adversely affected the central nervous system
even in elderly patients.
The incidence of adverse events among Zantac-treated
patients (8.1 % ) was very little greater than that among
placebo-treated patients (7.7% ). Only five adverse events,
namely, tiredness (0.38% ), headache (0.90% ), dizziness
(0.32% ), diarrhea (0.52% ) and skin rashes (0.52% ) had a
greater incidence in the ranitidine treated group than in the
control group.
A small proportion (1.99% ) of patients treated with
ranitidine injection experienced itching or burning at the injec
tion site. This reaction was mild and usually subsided within
10-15 minutes.
Headache was experienced by 2.54% o f patients receiving
ranitidine injection. The majority of these cases were not
thought to be treatment-related. In some instances the headache
was thought to be due to over-rapid injection of ranitidine, and
did not recur on rechallenge with slow intravenous injection.
Similarly, some patients experienced nausea after rapid injec
tion of the drug, but on subsequent occasions with slow-intra
venous injection, experienced no ill-effects.

OVERDOSAGE
Zantac is very specific in action and accordingly no particular
problems are expected following overdose with the drug.
Symptomatic and supportive therapy should be given as
appropriate. If need be, the drug may be removed from the
plasma by haemodialysis.
DOSAGE A N D AD M IN ISTR A TIO N
Adults: Zantac injection may be given either as a slow (over
one minute) intravenous injection o f 50 mg, (*M any physicians
find it convenient to dilute a 2m L ampoule (50 m g) to 20 mL
with Normal Saline and administer over a period o f 5 to 10
minutes), which may be repeated every six to eight hours; or as
an intravenous infusion at a rate of 25 mg per hour for two hours;
the infusion may be repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration
in seriously ill patients or the prophylaxis o f recurrent haemor
rhage in patients bleeding from peptic ulceration, parenteral
administration may be continued until oral feeding commences.
Patients considered to be still at risk may then be treated with
Zantac tablets 150 mg twice daily.
In patients considered to be at risk of developing acid
aspiration syndrome Zantac injection 50 mg may be given
intramuscularly or by slow intravenous injection (s ee* above)
45-60 minutes before induction o f general anaesthesia.
Experience with Zantac in children is limited and it has
not been fully evaluated in clinical stu dies-see PRECAUTIONS.
A V A IL A B IL ITY
Zantac Injection is available as 2 mL ampoules each containing
50 mg ranitidine (as the hydrochloride) in 2m L solution for intra
venous or intramuscular administration. Packages of 10
ampoules.
Zantac Tablets are available as white film-coated tablets
engraved ZANTAC 150 on one face and GLAXO on the other
containing 150 mg ranitidine (as the hydrochloride), in packs of
28 & 56 tablets.
Zantac tablets are also available as white, capsule shaped,
film-coated tablets engraved ZANTAC 300 on one face and
GLAXO on the other, containing 300 mg ranitidine (as the
hydrochloride) packed in cartons containing 28 tablets.
Product Monograph available on request.
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Ticarcillin/Clavulanic Acid (Timentin) Compared to
Metronidazole/Netilmicin in Preventing Postoperative
Infection After Elective Colorectal Surgery
A randomized controlled trial was per
formed to compare the effectiveness of
ticarcillin/clavulanic acid to metronidazole/netilmicin in preventing postopera
tive infections after elective colorectal
surgery. Ninety-two patients were ran
domly allocated to receive three doses of
ticarcillin, 3 g, with clavulanic acid, 100
mg every 8 hours, or three doses of
metronidazole, 500 mg, and netilmicin,
80 mg intravenously every 8 hours. All
patients received a mechanical bowel
preparation with 3 L of Go-lytely
solution.
There were no operative deaths. Eight
patients had wound infections — three in
the ticarcillin/clavulanic acid group and
five in the metronidazole/netilmicin
group. One patient in the ticarcillin/clavu
lanic acid group had an intra-abdominal
abscess. There were two anastomotic
leaks, one in each group.
Ticarcillin/clavulanic acid and
metronidazole/netilmicin appear to be
equally effective in preventing postopera
tive infections after elective colorectal
surgery.
II s’agit d'un essai randomise et controle
ou I'on a compare I'efficacitg d'un traitement ticarcilline/acide clavulanique et
celle d'une association metronidazole/netilmicine dans la prevention des
infections postoperatoires consecutives a
la chirurgie colorectale non urgente.
Quatre-vingt-douze patients ont 6t6
affectes au hasard a I'un de deux groupes destings a recevoir trois doses de
3 g de ticarcilline et 100 mg d'acide cla
vulanique aux 8 heures, ou trois doses
de 500 mg de metronidazole et 80 mg
de netilmicine par voie intraveineuse aux
8 heures. Tous ont recu une preparation
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intestinale a I'aide de 3 L d'une solution
de Go-lytely.
II n'y a eu aucun deces operatoire.
Huit patients ont eu des infections de
plaies, trois dans le groupe ticarcilline/
acide clavulanique et cinq dans le groupe
metronidazole/netilmicine. Un patient du
groupe ticarcilline/acide clavulanique a
souffert d'un abcgs intra-abdominal. On
a enregistre deux bris d'anastomoses, un
dans chaque groupe.
Les associations ticarcilline/acide cla
vulanique et mgtronidazole/netilmicine
semblent etre d'egale efficacite dans la
prophylaxie des infections postopera
toires secondaires a la chirurgie colo
rectale non urgente.

It has long been recognized that surgical
transection of the colon or rectum is
associated with a relatively high rate (30%
to 77%1_3) of postoperative wound infec
tion in patients who undergo elective
colorectal surgery without antibiotic
prophylaxis. Although mechanical bowel
preparation may reduce the volume of
stool and thus, the volume of bacteria,
it is now accepted that the short-term
administration of antibiotics is necessary
perioperatively in order to reduce the risk
of postoperative wound infections.4
Studies5 have indicated that anaerobes
and gram-negative organisms are the
most important causative organisms in
this setting; therefore agents that are
effective against these organisms should
be used prophylactically. Timentin
(Beecham Laboratories, Inc., Pointe
Claire, PQ), a combination of a semisyn
thetic penicillin (ticarcillin) and clavulanic
acid, has been shown to be such an agent.
The object of this study was to compare
Timentin to a combination of metronida
zole and netilmicin with respect to their
effectiveness in preventing postoperative
infections in patients who undergo elec
tive colorectal surgery.
Patients and Method

All patients scheduled to undergo sur
gery of the small bowel, colon or rectum
at the Toronto General Hospital between
Apr. 1,1984 and Mar. 31, 1985 were eligi

ble for entry into the study provided that
they had not been on antibiotics within
7 days of operation. Excluded were
patients with liver or renal disease, a
bleeding disorder, a history of sensitivity
to any of the study medications, and preg
nant women. Informed consent was ob
tained from all patients. The study was
approved by the Research Ethics Com
mittee of the Toronto General Hospital.
Ninety-nine patients were randomly
grouped in blocks of 10. This was done
by the pharmacy department at the hospi
tal, according to a predetermined scheme.
The clinicians and investigators were una
ware of the treatment given to individual
patients.
All patients received metoclopramide,
10 mg intramuscularly, followed by
mechanical bowel preparation consisting
of clear liquids and 3 L of Go-lytely given
over 3 hours.
Fifty patients were randomized to the
ticarcillin/clavulanic acid group (group
1); they received ticarcillin disodium
equivalent to ticarcillin 3 g and potassium
clavulanate equivalent to clavulanic acid
100 mg in 100 ml of 0.9% sodium chlo
ride solution infused over 15 minutes. In
addition, 100 ml of normal saline was
given as a placebo and infused over 15
minutes. Forty-nine patients randomized
to the metronidazole/netilmicin group
(group 2) received metronidazole, 500 mg
in 100 ml of sterile water, buffered with
sodium phosphate, citric acid and sodium
chloride, and netilmicin, 80 mg in 100 ml
of 0.9% solution of sodium chloride,
each infused over 15 minutes. All patients
received three doses of the respective
medications. The first dose was infused
within 15 minutes of induction of
anesthesia, and the second and third doses
were given 8 hours and 16 hours later.
At surgery, the bowel preparation, the
presence of sepsis or contamination, the
amount of blood lost and the length of
the operation were assessed and recorded.
Postoperatively, wounds were examined
and body temperatures recorded daily for
1 week. Patients discharged from hospi
tal within 1 week of operation were reas
sessed at the clinic 2 weeks after the proce
dure. A wound infection was recorded
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when the surgical wound or peritoneal
cavity produced purulent discharge. Clin
ically infected wounds were cultured both
aerobically and anaerobically using stan
dard procedures.6,7 Urine, blood, spu
tum and wound tissue were cultured when
patients had body temperatures of greater
than 38.3°C on two occasions 4 hours
apart (excluding the first 24 hours after
surgery). Susceptibility of aerobes to
netilmicin was tested at 4 and 8 mg/L
by agar dilution according to standards
of the National Committee for Clinical
Laboratory Standards.8 Susceptibility of
aerobes to Timentin was performed using
the disk diffusion method.9 Susceptibil
ity of anaerobes was performed using the
disk elution method of Wilkins and
Thiel.10 Five (5 gg) discs of metronida
zole were added to 5 ml of anaerobic
brain heart infusion broth to give a final
concentration of 5 mg/L. Five Timentin
discs were placed in anaerobic broth for
final concentrations of 75 m g/L of ticarcillin and 10 m g/L of clavulanic acid.
Findings

Of the 99 patients, 7 (4 in group 1 and
3 in group 2) were excluded from the anal
ysis because they failed to meet the pro
tocol criteria. In three, the bowel was not
opened at surgery, two received other
antibiotics postoperatively and the wound
was left open in one patient. The last
patient was excluded because of excessive
intraoperative bleeding which the sur
geons believed may have been related to

the administration of ticarcillin/clavulanic acid. Later, it was recognized that
the patient had had an elevated partial
thromboplastin time preoperatively.
The remaining 92 patients (49 men, 43
women) had a mean age of 43 years
(range from 15 to 86 years). The groups
were well matched according to patient
characteristics, diagnosis and procedure
(Table I).
The mechanical bowel preparation was
modified in 45 patients — 21 in group 1
and 24 in group 2. The antibiotic
prophylaxis was modified in four
patients. Two patients in group 1 received
an average o f 17 extra doses of
metronidazole and netilmicin. In addi
tion, one of these received 18 doses of
cefazolin, 1 g intravenously, while the
other received 23 doses of ampicillin, 500
mg intravenously. Two patients in group
2 received an average of 16 extra doses
of the study medications. One of these
also received 32 doses of cefazolin, 1 g
intravenously, and the other 11 doses of
ampicillin, 500 mg intravenously.
Bowel preparation, assessed in 89
patients, was considered excellent in 62
(69.7%), fair in 18 (20.2%) and poor in
9 (10.1%). Fecal contamination occurred
in three patients but none had septic com
plications as a result.
The mean blood loss was 440 ml in
group 1 and 490 ml in group 2. The mean
operative times in the two groups were 2.9
hours and 2.8 hours respectively.
There were no operative deaths. Com
plications are listed in Table II. There

T a b le 1— P a t ie n t C h a r a c t e r is t ic s
G ro u p 1
C h a r a c te r is tic

(n -

46)

G ro u p 2
(n =

46)

A ge, yr
M ean

43

44
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1 6 -7 5

1 5 -8 6

2 5 :2 1

2 4 :2 2

16

18

M a le if e m a le
D ia g n o s is
U lc e r a tiv e c o litis
C ro h n 's d is e a s e
Cancer
O th e r

7

10

17

14

6

4

16

19

S u rg ic a l p ro c e d u re
C o le c to m y
P r o c to c o le c to m y

0

1

R e s to r a tiv e p r o c t o c o le c t o m y

7

3

A n te r io r r e s e c tio n

2

3

A b d o m in o p e r in e a l r e s e c t io n

1

2

S m a ll-b o w e l re s e c tio n
O s to m y c lo s u re
O th e r

4

2

12

16

4

0

T a b le I I — C o m p lic a t io n s
G ro u p 1 ,

G ro u p 2 ,

C o m p lic a tio n

n o . (% )

n o . (% )

W o u n d in fe c tio n

3 (6 .5 )

5 (1 0 .9 )

In tr a -a b d o m in a l a b s c e s s

1 (2 .2 )

0 (0 )

U r in a r y t r a c t in fe c tio n

1 (2 .2 )

5 (1 0 .9 )

Fever -

1 ( 2 .2 )

1 (2 .2 )

A n a s to m o tic d e h is c e n c e

1 1 2 .2 )

1 (2 .2 )

S m a ll-b o w e l o b s tr u c tio n

1 (2 .2 )

2 (4 .3 )

u n k n o w n e tio lo g y

were no significant differences in the
number o f postoperative infections
between the two groups. Escherichia coli
was isolated from the wounds of two
patients in group 1 and group D Strep
tococcus from one of them. Escherichia
coli was cultured from the peritoneal
cavity of a third patient, and coagulasenegative staphylococci and Corynebacterium sp. (most likely resident skin flora)
from the wound. In group 2, a mixed
growth of gram-negative organisms was
identified. Escherichia coli was isolated
from all patients and in addition, Proteus
vulgaris (one patient), Proteus mirabilis
(one), enterococci (one), group B Strep
tococcus (two), Enterobacter cloacae
(one) and Corynebacterium sp. (one) were
also cultured.
One patient in each group with urinary
tract infection had temperature spikes,
but no source was identified nor was there
microbiologic confirmation of sepsis.
Both patients were treated with antibi
otics. There were no complications
attributable to the antibiotics. In partic
ular, no bleeding complications or signifi
cant changes in the partial thromboplastin
time were detected in group 1 patients.
Discussion

The prophylactic use o f broadspectrum antibiotics is indicated for
patients who undergo surgical resection
of the colon or rectum. Ticarcillin is a
parenteral semisynthetic penicillin effec
tive against a wide range of bacterial
infections including those caused by Pseu
domonas aeruginosa. It is not, however,
effective against certain bacteria that
produce the /3-lactamase enzyme. In order
to protect it from the destructive effect
of these bacteria, ticarcillin has been com
bined with potassium clavulanate which
is a noncompetitive inhibitor of /3lactamase. Ticarcillin/clavulanic acid has
proven to be effective ag ain st
Staphylococcus aureus, Haemophilus
influenzae, Neisseria gonorrhoeae, E. coli,
Klebsiella sp., Enterobacter aerogenes,
Providencia, Proteus mirabilis, P. vul
garis and Bacteroides fragilis. Group D
streptococci are moderately resistant to
this combination.11
In this study, wound infection rates
were low: 6.5% in group 1 and 10.9% in
group 2. Previous trials2,12"17 have
docum ented the effectiveness o f
metronidazole as a prophylactic agent in
colorectal surgery, although the wound
infection rates have varied from 0% to
25% . Jagelm an and colleagues14
reported no wound or intra-abdominal
infections in 31 patients who received
metronidazole intravenously and neomy
cin orally. In a series o f 27 patients who
received only m etro n id azo le fo r
prophylaxis,16 no anaerobic infections
were reported but there were four infec-
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tions due to aerobic organisms. A wound
infection rate of 25% was observed in a
trial conducted by C unliffe and
colleagues,12 in which patients received
metronidazole alone. Thus, it would
appear that an agent which is effective
against gram-negative aerobic organisms
should be given in combination with the
metronidazole. Our standard regimen has
been metronidazole and an aminoglyco
side, netilmicin.
Ticarcillin/clavulanic acid appears to
be equally effective in preventing septic
complications after elective colorectal sur
gery. It has two potential benefits over the
metronidazole and netilmicin combina
tio n . F irst, although the risk of
nephrotoxicity associated with short-term
use of an aminoglycoside is low, this risk
is avoided by using ticarcillin/clavulanic
acid. Also, because of Timentin’s broad
spectrum, only one drug is administered,
thus reducing the time spent by nursing
and pharmacy staff and decreasing the
potential risk of drug error. This drug was
well tolerated by patients in our study. No
drug-related complications were detected.
The Birmingham group18 has advo
cated a 5-day perioperative course of
antibiotics for patients with inflammatory
bowel disease who undergo elective
colorectal surgery. In a randomized con
trolled trial (57 patients) comparing three
doses of metronidazole and gentamicin to
placebo, they reported abdominal wound
infection rates of 37% in the control
group and 23% in the treatment group,
not a significant difference. In a later
study, 30 patients were given metronida
zole and gentamicin for 5 days and results
were compared with those obtained in the
randomized controlled trial. The abdomi
nal wound infection rate in the patients
treated with the 5-day course was 13%,
significantly (p < 0.05) lower than that
of the placebo group but not significantly
different from that of the group treated
with only three doses of antibiotics. Simi
lar results were found when the total
infection rates (i.e., abdominal, perineal
and intra-abdominal abscess and septice
mia) were compared. In this study,
patients with inflammatory bowel disease
had more septic complications (eight in
51 patients with inflammatory bowel dis
ease versus one in 41 patients with other
indications for surgery [p < 0.05]). We
attribute this increased infection rate to
those patients with ulcerative colitis who
had a restorative proctocolectomy (ileal
reservoir and ileoanal anastomosis). Five
of 11 patients (2 of 7 in group 1 and 3 of
4 in group 2) who had this procedure sub
sequently had septic complications. At
our institution, the average time for these
operations is 6 hours, which may account
for the increase in wound infection rate.
If these 11 patients are excluded from the
study, then the overall septic complica
tion rate was 7.5% in patients with
122

inflammatory bowel disease and 2.4% in
patients with other conditions necessitat
ing colorectal surgery (p > 0.05). Fur
thermore, the wound infection rate in
patients with Crohn’s disease was only
5.9%. Thus, we do not routinely use
prolonged perioperative antibiotic cover
age for patients with inflammatory bowel
disease except those who undergo recon
structive procedures (i.e., continent
ileostom y
or restorative proc
tocolectomy).

(^Mefoxin
(sterile cefoxitin sodium, Frosst Std.)

ANTIBIOTIC
ACTIO N
In vitro studies demonstrate that the
bactericidal action of cefoxitin, a cephamycin
derived from cephamycin C, results from the
inhibition of bacterial cell wall synthesis.
Evidence suggests that the methoxy group in
the 7a position is responsible for the
resistance of cefoxitin to degradation by
bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
TREATMENT

Conclusion

This study demonstrates that ticarcil
lin/clavulanic acid (Timentin) and
metronidazole/netilmicin are equally
effective in preventing septic complica
tions after elective colorectal surgery.
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The treatment of the following infections when
due to susceptible organisms:
1 - Intra-abdom inal infections such as
peritonitis and intra-abdominal abscess
2 - G ynecological in fe ction s such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies
should be performed to determine the
susceptibility of the causative organism(s) to
MEFOXIN*. Therapy may be started while
awaiting the results of these tests, however,
modification of the treatment may be required
once these results become available.
Organisms particularly appropriate for
therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing
and non-producing strains)

E. coli
Kl e b s i e l l a s p e cie s (in c lu d in g
pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species

K.

Anaerobes

Bacteroides Iragilis
MEFOXIN* may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that
MEFOXIN* can be administered to patients
who are also receiving c a rb e n ic illin ,
gentamicin, tobramycin, or amikacin (see
PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for
p a tie n ts w ith bacterem ia, b a c te ria l
septicemia, or other severe or life-threatening
infections, or for patients who may be poor
risks because of lowered resistance resulting
from such d e b ilita tin g co n ditions as
malnutrition, trauma, surgery, diabetes, heart
failure, or malignancy, particularly if shock is
present or impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and
postoperatively) to patients undergoing
vaginal or abdominal hysterectomy and
abdominal surgery when there is a significant
risk of postoperative infection or where the
occurrence of postoperative infection is
considered to be especially serious.
In patients undergoing cesarean section,
intraoperative (after clamping the umbilical
cord) and postoperative use of MEFOXIN*
may reduce the incidence of surgery related
postoperative infections.
Effective prophylactic use depends on the
time of administration. MEFOXIN* usually
should be given one-half to one hour before
the operation. Prophylactic administration
should usually be stopped within 12 hours. It
has been generally reported that continuing
administration of any antibiotic beyond
*®Trademark

24 hours follow in g surgery increases the
possibility of adverse reactions but, in the
majority of surgical procedures, does not
reduce the incidence of subsequent infection.
If signs of postsurgical infection should
appear, specimens for culture should be
obtained for identification of the causative
organism(s) so that appropriate therapy may
be instituted.

CO NTRAINDICATIO NS
MEFOXIN* is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
s e n s it iv it y r e a c tio n s to M E F O X IN *,
cephalosporins, penicillins or other drugs.
MEFOXIN* should be given with caution to
penicillin-sensitive patients.
There is some clinical and laboratory evidence
o f p a rtia l c ro s s -a lle rg e n ic ity between
cepham ycins and the other beta-lactam
antibiotics, penicillins and cephalosporins.
Severe reactions (including anaphylaxis) have
been re p o rte d w ith m ost b e ta -la cta m
antibiotics.
Pseudomembranouscolitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed
with caution in individuals with a history of
gastrointestinal disease, particularly colitis. It
is im p o rta n t to consider a diagnosis of
pseudomembranous colitis in patients who
develop diarrhea in association with antibiotic
use. W hile studies indicate that a toxin
produced by Clostridium difficile is one
primary cause of antibiotic-associated colitis,
other causes should also be considered.
Any patient who has demonstrated some form
of allergy, particularly to drugs, should receive
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs,
a d m in is tra tio n o f the d ru g s h o u ld be
d is c o n tin u e d . S erious h y p e rs e n s itiv ity
re a c tio n s may re q u ire tre a tm e n t with
epinephrine and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced
when MEFOXIN* is administered to patients
with transient or persistent reduction of
urinary output due to renal insufficiency (see
DOSAGE AND ADMINISTRATION) because
h ig h and p ro lo n g e d serum a n tib io tic
concentrations can occur from usual doses
In patients treated with MEFOXIN* a false
positive reaction to glucose in the urine may
occur with Benedict's or Fehling's solutions
but not w ith the use of specific glucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine
va lu e s in serum m ay o c c u r if serum
concentrations of cefoxitin exceed 100 pg/mL.
Serum samples from patients treated with
M EFOXIN* should not be analyzed for
creatinine if withdrawn within two hours of
drug administration.
Increased nephrotoxicity has been reported
fo llo w in g concom itant adm in istratio n of
c e p h a lo s p o r in s and a m in o g ly c o s id e
antibiotics.
The safety of MEFOXIN* in the treatment of
infections during pregnancy has not been
e s ta b lis h e d . If th e a d m in is tr a tio n of
MEFOXIN* to pregnant patients is considered
necessary, its use requires that the anticipated
benefits be weighed against possible hazards
to the fetus. Reproductive and teratogenic
studies have been performed in mice and rats
and have revealed no evidence of impaired
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient's condition
is essential and if super-infection occurs
during therapy, appropriate measures should
be taken. Should an organism become
resistant during antibiotic therapy, another
antibiotic should be substituted.
In children 3 months of age or older, higher
doses o f MEFOXIN* (100 m g/kg/day and
above) have been a sso cia te d w ith an
increased incidence of e o sinophilia and
elevated SGOT.

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse
re a ctio n s ra re ly re q u ire d ce ssa tion o f
treatment and usually have been mild and
transient.
Local Reactions
T h r o m b o p h le b itis has o c c u rre d w ith
intravenous administration. Some degree of
pain and tenderness is usually experienced
after intramuscular injections using water.
Induration has occasionally been reported.
Allergic
M acu lo p a p u la r rash, urticaria, p ru ritu s ,
eosinophilia, fever and other allergic reactions
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported
rarely.
Blood
T r a n s ie n t e o s in o p h ilia , le u k o p e n ia ,
neutropenia, hemolytic anemia, and throm boc y to p e n ia have been re p o rte d . Som e
individuals, particularly those with azotemia,
may develop positive direct Coombs tests
during therapy with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum
LDFI, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure
has been re p o rte d ra re ly. The ro le o f
MEFOXIN* in changes in renal function tests
is d i f f i c u l t to a sse ss, sin ce f a c t o r s
predisposing to prerenal azotemia o r to
impaired renal fun ctio n have often been
present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN* can be
eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATIO N
M EFOXIN* may be adm inistered in tra 
venously or intramuscularly when required.
(See complete monograph for full details on
ADMINISTRATION and RECONSTITUTION.)
TREATMENT DOSAGE
Adults
The usual adult dosage is 1 g o r 2 g of
MEFOXIN* every 6 to 8 hours. Dosage and
route of administration should be determined
by severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
Usual Adult Dosage
Type of
of infection

Daily
Dosage

Frequency
and Route

U ncom plicated
form s* o f in
fe ctio n s such as
pneumonia,
urinary tract
infection, soft
tissue infection

3-4 g

1 g every 6-8 h
I.V. o r I.M.

M oderately
severe or severe
infections

6-8 g

1 g every 4 h
or
2 g every 6-8 h I.V.

Infections
com m only
needing a n ti
biotics in higher
dosage (e.g. gas
gangrene)

12 g

2 g every 4 h
or
3 g every 6 h I.V.

should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
A fte r a lo a d in g do se , th e f o llo w in g
recommendations for maintenance dosage
may be used as a guide:
RENAL
FU N C TIO N
Mild
im pairm ent
M oderate
im pairm ent
Severe
im pairm ent
Essentially
no fu n c tio n

CREATININE
CLEARANCE
mL/mln

DOSE

50-30

FREQ U ENCY

1-2 g

every 8-12 h

29-10

1-2 g

every 12-24 h

9-5

0.5-1 g

every 12-24 h

<5

0.5-1 g

every 24-48 h

In the patient undergoing hemodialysis, the
loading dose of 1 - 2g should be given after
each hemodialysis, and the maintenance dose
should be given as indicated in the Table
above.
Neonates (Including Prem ature Infants),
Infants and Children (See WARNINGS for
Neonates under ADMINISTRATION in the
complete monograph.)
Premature Infants
with Body Weights
Above 1500 g
20-40 mg/kg every 12 h I.V.
Neonates
01 week of 20-40
age mg/kg every 12 h I.V.
1-4 weeks of age
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years
of age

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

Children

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

In severe infections, the total daily dosage in
infants and children may be increased to
200 m g/kg, but not to exceed 12 g per day.
MEFOXIN* is not recommended for the ther
apy of meningitis. If meningitis is suspected,
an appropriate antibiotic should be used.
A t p re se n t there is in s u ffic ie n t data to
recommend a specific dosage for children
with impaired renal function."However, if the
administration of MEFOXIN* is deemed to be
essential the dosage should be m odified
consistent with the recom m endations for
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN is recommended as follows:
Vaginal o r abdom inal h yste re cto m y and
abdominal surgery
2 g a d m in is te re d in t r a m u s c u la r ly o r
in tr a v e n o u s ly ju s t p r io r to s u rg e r y
(approximately one-half to one hour before
initial incision).
The second and third 2g doses should be
administered at 2 -6 hour intervals after the
initial dose.
Cesarean Section
The first dose of 2 g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2 g doses should be given intravenously or
intramuscularly four hours and eight hours
after the first dose.

A VAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst
Std.) is supplied as sterile powder in boxes of
10 vials:
No. 3356 1 g cefoxitin as sodium salt
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored
below 30° C.

PRODUCT MONOGRAPH AVAILABLE
ON REQUEST

'Including patients in whom bacteremia is
absent or unlikely
Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infections should be maintained
for at least 10 days to guard against the risk of
rheumatic fever or glom erulonephritis. In
staphylococcal and other infections involving
a collection of pus, surgical drainage should
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients w ith
reduced renal function but a reduced dosage
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Two cases are described in which throm
bosis of both limbs of an aortobifemoral
bypass occurred after epidural anesthesia
for a nonvascular operation. This has not
previously been reported, and possible
reasons for its occurrence are discussed.
It seems likely that the hypotension
associated with epidural anesthesia, par
ticularly in patients already hypotensive
or volume depleted, may precipitate this
phenomenon. In addition, the sensory
loss produced by the anesthetic may
mask the signs and symptoms of acute
vascular occlusion. Epidural anesthesia is
not recommended in heparinized patients
because of the risk of an epidural
hematoma.

On fait ici la description de deux cas ou
une thrombose des deux branches d’un
pontage aortobifemoral est apparue consecutivement a une anesthesie epidurale
lors d'une chirurgie non vasculaire. Ceci
n'a pas ete signale jusqu'a maintenant.
On en commente les raisons possibles. II
apparait vraisemblable que I'hypotension
qui accompagne I'anesthesie epidurale
puisse precipiter ce phenomene, particulierement chez des patients deja hypotendus ou hypovoldmiques. De plus, la
perte sensorielle produite par I'anesthesique peut masquer les signes et symptdmes d'une occlusion vasculaire aigue.
L'anesthesie epidurale n'est pas recommandee chez les patients traitds b
I'heparine a cause du risque d'hematome
epidural.

From the Department o f Surgery, Division
o f Vascular Surgery, The Wellesley Hospi
tal, University o f Toronto, Toronto, Ont.
*Present address: Department o f Surgery,
St. Joseph’s Hospital, 268 Grosvenor St.,
London, Ont. N6A 4V2
A ccepted fo r publication Sept. 15, 1986
Reprint requests to: Dr. John L. Provan,
Ste. 217, E.K. Jones Building, The Welles
ley Hospital, 160 Wellesley St. E, Toronto,
Ont. M 4 Y 1J3
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Epidural anesthesia provides an effective
method of pain control. In addition to its
use in obstetrics it may benefit patients
with chronic obstructive pulmonary dis
ease or other problems that make general
anesthesia inadvisable because o f
postoperative respiratory depression.
Instead o f traditional narcotics it may be
used for postoperative pain control to
facilitate chest physiotherapy and ambu
lation.1 It is not recommended for
patients who require high abdominal inci
sions, and some2 believe it is contraindi
cated when heparin has been given
prophylactically before operation or in
patients w ho w ill be com p letely
heparinized intraoperatively, because
there is a risk o f producing an epidural
hematoma.
Despite occasional local neurologic
complications due to injection and inser
tion of the catheter, this form of anesthe
sia is generally considered safe if the
appropriate indications and contraindica
tions are observed.3 The purpose o f this
report is to describe two patients who
received epidural anesthesia intra- and
postoperatively and in whom thrombosis
o f both limbs of a previously placed aor
tobifemoral graft subsequently deve
loped. The usual signs were masked by
the epidural anesthesia, leading to a
marked delay in diagnosis in each case.
Case Reports

Case 1
In 1973, this 60-year-old man underwent
aortobifemoral bypass grafting. Subsequently
he was well until January 1984 when he
required resection of the sigmoid colon for car
cinoma. Postoperatively, an epidural catheter
was inserted to control pain. During chat night
his lotVer limbs became cool and mottled and
he complained of pain, which subsided with
further injections through the epidural
catheter. The following morning he had severe
ischemia of both feet and loss of pulsation in
the bypass graft. Bilateral thrombectomies and
right fasciotomy were attempted, but adequate
flow was established only to the left leg. A sub
sequent digital subtraction angiogram revealed

total occlusion of the right limb of his graft
and a stenosis of the aorta proximal to the take
off of the graft. Renal failure developed with
myoglobinuria. He was transferred to The
Wellesley Hospital for treatment.
U pon arrival he was dyspneic and
diaphoretic, with a pulse rate of 120 beats/min
and a blood pressure of 130/80 mm Hg. Find
ings on examination of his respiratory and
cardiac systems were otherwise within normal
limits. He had fresh scars on his abdomen and
both groins. No pulsation could be felt in the
right limb of the aortic graft, but it was ade
quate in the left limb. On the right lower limb
there was mottling of the skin with no sensa
tion or movement distal to the buttock. There
was diminished sensation in the toes on the left
with some limitation of movement. The mus
cles visible at the fasciotomy site were doubt
fully viable although the fat bled well. After
hemodialysis he was taken to the operating
room where a Fogarty catheter could be passed
from the right common femoral artery to the
foot with the return of a small amount of
liquefied thrombus. A right axillofemoral graft
was constructed. With re-establishment of
blood flow there was considerable swelling of
the leg requiring a full four-compartment fas
ciotomy of the lower leg. Postoperatively,
although the graft remained patent, the lower
limb was not revascularized and demarcated
at the level of the middle thigh. A high above
knee amputation was subsequently carried out
and many of the major muscle groups at this
level were found to be necrotic. Following
operation he did poorly. He had no return of
renal function and remained confused until his
death 3 weeks later.
Comment.— The actual cause of graft occlu
sion in this patient is debatable. Although there
was no major blood loss during the operation,
it is possible that hypotension associated with
the postoperative epidural block may have led
to thrombosis, particularly in the presence of
the aortic stenosis above the graft. With the
epidural anesthesia for pain control, the diag
nosis of acute lower limb ischemia was delayed
so the ischemic muscle was not revascularized.
If the graft occlusion had been diagnosed
earlier, corrective surgery might have preserved
the viability of the limbs and subsequently the
patient’s life.

Case 2
A 62-year-old woman was transferred from
another hospital for treatment of bowel
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obstruction. In 1978 she had undergone aortobifemoral bypass grafting for claudication.
The graft had since functioned well. In 1981,
a left modified radical mastectomy was per
formed for carcinoma of the breast. One of
three nodes in the specimen contained tumour.
Three years later she had bowel obstruction
that failed to improve with conservative
treatment.
On examination at The Wellesley Hospital,
the pulse rate was 80 beats/min and regular and
the blood pressure was 120/80 mm Hg. The
abdomen was grossly distended with ascites,
and a mobile central abdominal mass could be
felt. All peripheral pulses were present.
At operation for relief of her small-bowel
obstruction, multiple metastases were found in
the liver, spleen, omentum and ovary. Approx
imately 5 L of ascitic fluid were present in the
abdominal cavity. The anesthetic for the
laparotomy consisted of high epidural anesthe
sia with a general anesthetic. One additional
injection was given into the epidural catheter
in the recovery room. Throughout the opera
tion and in the recovery room she was hypoten
sive with a systolic pressure of 60 mm Hg,
probably due to a combination of hypovole
mia and the loss of vasomotor control secon
dary to the epidural block.
The next day she had profound weakness in
her lower limbs, which progressed over the next
24 hours, with decreased tone in the hips, knees
and ankles, worse on the left than the right.
She had a lax anal sphincter. The neurologic
defect was thought to be compatible with a
lesion at the level of L I-2. An emergency
myelogram appeared normal but computerized
tomography revealed a spinal cord infarct. It
was not until 48 hours later that the previously
felt femoral pulses were noted to be absent. On
examination of the lower limbs at this time
there was some movement in the right but not
the left foot. Her position sense was maintained
in both feet but the limbs were areflexic. Capil
lary refill was sluggish and no femoral or dis
tal pulses were palpable. After occlusion of the
aortobifemoral bypass graft and thrombosis of
the anterior spinal artery were diagnosed, we
attempted to restore blood flow to her lower
limbs. Multiple thrombectomies were required
on both sides due to repeated clotting of the
grafts. Over the next week both limbs of the
graft remained patent but there was no neu
rologic im provem ent. Subsequently she
suffered from an acute psychosis for which no
cause could be found. During this episode she
became hypotensive and her right foot again
became cold and mottled. As she was now a
formidable operative risk no attempt was made
to revascularize the leg. A high above-knee
amputation was carried out. Postoperatively
the stump healed, her confusion cleared and
she was discharged home. There was little neu
rologic recovery of the left leg.
Comment.—The only apparent etiologic fac
tor for the graft thrombosis was the hypoten
sion that was noted both intra- and postoper
atively. Although this could have been
secondary to fluid shifts associated with
drainage of the ascites it might have been made
worse by the loss of vasomotor control secon
dary to the epidural block. Although throm
bectomy of her graft would probably not have
altered the outcome neurologically, the diag
nosis of graft occlusion was delayed because
of the effects of the epidural anesthesia. Had
the diagnosis of graft occlusion been made in

the recovery room, an earlier thrombectomy
could have been carried out.

Discussion

Thrombosis of a previously placed aor
tobifemoral graft in conjunction with
epidural anesthesia has not been reported
previously. In both our patients the diag
nosis of graft occlusion was delayed due
to masking of the signs and symptoms of
ischemia by this particular form of
anesthesia. The unlikely event of throm
bosis of both limbs of both aortic grafts,
which was noted only once in 40 acute
occlusions of 364 aortic grafts surveyed
by Ameli and associates,4 suggests that
hypotension may have played a part, as
was noted in case 2. Since hypotension is
sometimes seen with epidural anesthesia
associated with high block or hypovole
mia, or both, there is a possible connec
tion between the use of epidural anesthe
sia and the graft thrombosis in both of
our patients. The cardiovascular effects
of extradural anesthesia have been
reviewed by Stanton-Hicks.5 He noted
that there was a linear relationship to the
height of the block and the degree of
hypotension but also commented that a
normovolemic man could compensate for
vasodilatation due to segmental blockade
of the sympathetic outflow up to the T5
level, by vasoconstriction in the upper
part of the body. Presumably, when the
patient is hypovolemic this compensatory
mechanism is impaired. Neurologic
deficits associated with epidural or spinal
anesthesia were reviewed by Kane3 in
1981, but of the 36 patients with severe
neurologic deficit after epidural block,
only 4 were noted to have hypotension as
a causative factor. In three cases an
epidural hematoma was blamed.
Late occlusion of vascular grafts is
usually due to neointimal hyperplasia or
progression of atherosclerotic arterial dis
ease. However, patients requiring an
operation for other reasons may be pre
disposed to occlusion of these grafts
because of altered coagulation secondary
to hypercoagulability caused by cancer,
dehydration or by hypotension and low
flow states. The cardinal signs and symp
toms of graft occlusion are the disappear
ance of a pulse in the graft and a cool,
painful, pale limb that becomes paralysed
and anesthetic as the limb becomes nonviable. Since epidural anesthesia alters
pain sensation and because paralysis will
be difficult to assess, vascular occlusion
and a nonviable extremity may not be
diagnosed. It is of paramount importance
that the diagnosis of vascular occlusion
be made early so that treatment can be
instituted. The tolerance of resting skele
tal muscle to ischemia has been reported6
to be as little as 6 to 8 hours depending
upon the degree and acuteness of the
episode.

When the warning signs of early graft
occlusion may be masked by epidural
anesthesia, it is essential to evaluate the
pulses in the limb frequently. This may
give early evidence of acute limb ische
mia and thus permit urgent revasculari
zation. Epidural anesthesia may not be
the technique of choice in patients with
previous vascular grafts as these grafts are
particularly vulnerable to thrombosis dur
ing the periods of hypotension that may
be associated with this form of analgesia
and anesthesia, and neither medical nor
nursing staff are likely to be attuned to
the possibility of acute graft occlusion
under the circumstances. Fuchs and
colleagues7 have recommended continu
ous epidural anesthesia for patients with
vascular disease, both for arteriography
and for aortobifemoral or femoral-distal
bypass grafting. They noted profound
pain relief with minimal depression of
pulmonary and myocardial performance
and no epidural complications in 193
patients. However, they suggested that
epidural anesthesia should not be used if
blood is obtained when the needle is
introduced into the epidural space,
because of the risk of epidural hematoma
in patients who require anticoagulation
during their operative procedure. They
also mentioned that hypotension can
occur with the use of this anesthetic. In
their series, hypotension usually respond
ed to fluid administration but in some
cases vasopressors were required.
The two cases we describe indicate that
epidural anesthesia may be hazardous
when used for intraoperative anesthesia
or postoperative analgesia in patients who
have had a previously placed vascular
bypass graft, unless the risks of associated
hypotension are recognized by the
anesthetists. The nursing staff and medi
cal attendants should also be aware of the
increased risks of thrombosis of the grafts
under these circumstances.
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Dalacin C

Phosphate S.S.

(clindamycin phosphate)

Rocommtnded Applications

Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when
the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contnlndlcitlons: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has
not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained. Dalacin C Phosphate is not indicated in the newborn
(infants below 30 days of age), or in pregnant women.
Mhrnings: Some cases of severe and persistent dianhea have been reported during or after therapy with
Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been
performed, some of these cases have shown pseudomembrane formation.
If significant dianhea occurs during therapy, this drug should be discontinued or, if necessary,
continued only with close observation. Significant diarrhea occurring up to several weeks post-therapy
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes may
respond to simple drug discontinuance. Moderate to severe cases, including those showing ulceration
or pseudomembrane formation, should be managed with fluid, electrolyte, and protein supplementa
tion as indicated. Corticoid retention enemas and systemic corticoids may be of help in persistent
cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes of colitis
should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day for 5 -1 0 or more days, there was a rapid observed
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea
Is should be noted that serious relapses have occuned up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as indicated by the
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
monitored during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in
patients with impaired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are not
effective means of removing the compound from the blood. Periodic serum levels should be determined
in patients with severe hepatic and renal insufficiency.
Advarsa Reactions: Local.
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin phos
phate) intramuscularly (with a solution containing 150 mg/mL). six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at the
injection site and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The majority of these cases
developed in conjunction with the use of indwelling I V. catheters and it is difficult to know how much
the drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as
follows:
Number of Patients
Rash........................................................................................................................................................ 7
U rticaria................................................................................................................................................. 1
Pruritus................................................................................................................................................... 1
Fever, Leucocytosis ............................................................................................................................ 1
Nausea, with or withoutvom iting....................................................................................................... 1
Diarrhea (See also under "W arnings")............................................................................................... 4
Hypotension .......................................................................................................................................... 1
Hypertension.......................................................................................................................................... 1
Shortness of Breath ............................................................................................................................ 1
Superinfection*..................................................................................................................................... 4
Cardiac arrest** ................................................................................................................................... 1
Bad and bitter taste inm outh.............................................................................................................. 5
* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true
side effect of clindamycin phosphate.
'* Due to underlying myocarditis in this patient.________________________________________

Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysis and liver and kidney function tests. Some of these tests were abnormal initially and returned
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment of Ovordosage: No cases of overdosage have been reported. No specific antidote
is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days have been
given without adverse effects.
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DOSAGE AND ADMINISTRATION

Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more than
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to I V.
administration to a dilution of 300 mg in 50 ml of diluent (6 mg/ml) or more, and infused in not less
than 10 minutes. Administration of more than 1200 mg in a single 1 hour infusion is not recommended.
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each
infused over 20 minutes or longer.
Severe infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip
or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and Infusion rates:
Diluent
Time
Dose
50 ml
10 min.
300 mg
20 min.
600 mg
100 ml
30 min.
150 ml
900 mg
45 min.
200 ml
1200 mg
Alternatively, drug may be administered in the form of a single rapid infusion of thefirst dose followed
by continuous I V. infusion as follows:
Maintenance
To maintain serum
Rapid
infusion rate
clindamycin levels
infusion rate
0.75 mg/min.
Above 4 mcg/ml
10 mg/min. for 30 min.
1.00 mg/min.
15 mg/min. for 30 min.
Above 5 mcg/ml
1.25 mg/min.
20 mg/min. for 30 min.
Above 6 mcg/ml
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2, 3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer. In severe infections, it is recommended that children be given no less
than 300 mg/day regardless of body weight. (Dilute Dalacin C Phosphate Sterile Solution in the same
manner as for adults.)
Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate when diluted with 1000 ml of the following commonly used in
fusion solutions was found to be physically compatible and demonstrated no significant change in pH
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection
Dextrose 5% in water
Dextrose 5% in saline
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride
Dextrose 2Vz% in Lactated Ringer's Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
Supplied:
Dalacin C Phosphate contains the following per ml of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml and 4 ml ampoules.
NOTE: Do not store below 15°C.
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Implantable Device for Venous Access
This paper reports the experience a t the
Royal V ic to ria Hospital in M on tre a l w ith
the firs t 5 0 P ort-A -C ath devices
im planted fo r venous access in patients
requiring lo n g -te rm c h e m o th e ra p y. There
were 2 5 w om en and 2 2 men. ranging in
age from 18 to 8 5 years. T w e n ty -tw o
devices w ere im planted fo r hem atologic
m alignant disease, 2 6 fo r solid tum ours
and 2 fo r benign disease. The mean
operative tim e w as 4 6 .3 m in u te s, using
a percutaneous subclavian s tic k te c h 
nique in 9 4 % o f in se rtio n s. Blood sam
pling and in fu sio n s w ere easy in 8 8 %
and 9 2 % respectively. S e ve n ty-e ig h t per
ce n t o f th e p a tie nts accepted th e device
w ell. Nine devices w ere rem oved, four at
th e end o f th e ra p y (m edian fu n ctio n in g
tim e o f 2 0 8 .5 days) and fiv e because o f
sepsis (median tim e 18 days). The
m edian tim e o f the s till-fu n c tio n in g
devices in live p a tie nts is 1 4 1 .5 days.
Septic co m p licatio n s w e re seen in 12% ,
blockage in 6 % and skin necrosis in 2% .
One death occurred fro m sepsis in a
poor-perform ance p a tie n t w ith stage IV
breast cancer and hypercalcem ia. We
believe th a t the P ort-A -C ath is e fficie n t,
safe and easily accessible fo r pa tie nts on
long-term chem otherapy.

Cet article fa it le bilan des 50 premieres
im p la nta tio n s d 'in s tru m e n ts Port-A-Cath
a etre pratiquees ii I'h o p ita l Royal V icto 
ria de M ontreal pour e ta b lir un acces veineux chez des pa tie nts aya n t besoin
d'un e ch im iotherapie a long te rm e . On
c o m p ta it 2 5 fem m es e t 2 2 hom m es dont
I'age va ria it de 18 d 8 5 ans. V ingt-deux
in stru m e n ts o n t etd im p la n t s pour des
a ffe c tio n s hem atologiques m alignes, 26
pour des tu m e u rs solides et 2 pour des
m aladies non cancdreuses. Le tem ps
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operatoire m oyen a ete de 4 6 .3 m inutes;
une technique d 'in s e rtio n sous-claviere a
ete utilisee dans 9 4 % des cas. Les preleve m e n ts sanguins e t les perfusions o n t
dtd fa cilite s dans re sp e ctive m e n t 8 8 % et
9 2 % des cas. S o ixa n te -d ix-h u it p o u rce n t
des pa tie nts o n t bien acce p te ('in stru 
m en t. N euf appareils o n t dte retires, quatre a la fin du tra ite m e n t (apres un te m p s
m edian de fo n c tio n n e m e n t de 2 0 8 .5
jo u rs) et cinq pour cause d 'in fe c tio n
(tem ps m edian de 18 jo u rs). Chez les
p a tie n ts qui s u rv iv e n t, la m ddiane du
te m p s de fo n c tio n n e m e n t e st de 1 4 1 .5
jo u rs . Des co m p lica tio n s in fe ctie use s o n t
etd observees dans 1 2 % des cas, un
blocage dans 6 % , e t une necrose cutanee dans 2 % . Un d£c6s e st attribuable a
I'in fe c tio n ; il s 'a g it d 'u n e pa tie nte souffra n t d 'u n cancer du sein au stade IV e t
d 'h yp e rca lce m ie , e t qui a m al evolue.
Selon les auteurs, le P ort-A -C ath est e fficace, sur et h la portee des patients
d e va n t recevoir une ch im io th e ra p ie au
long cours.

macia [Canada] Inc., Dorval, PQ). It
consists o f a stainless steel portal with a
silicone catheter that self-seals by means
o f a stainless steel lock. The reservoir is
entered through a self-sealing silicone
rubber septum that will accept without
leakage at least 1000 punctures with an
atraumatic 22-gauge Huber-point needle
or a 22-gauge Yale hypodermic needle
(see this issue page 75). The external
diameter o f the catheter is 2.79 mm, the
internal diameter 1.02 mm and the inter
nal volume o f the reservoir 0.4 ml.
Surgical Procedure
Under sterile conditions in the operat
ing room and with local anesthesia in
most cases, the catheter is introduced by
puncturing the subclavian vein percutaneously, using a modified Seldinger tech
nique and a special peel-away introducer
used for pacemaker introductions. With
the patient in the Trendelenburg position
the subclavian vein is entered with a

Suitable venous access in cancer patients
receiving chemotherapy is often a major
problem. Peripheral veins may be inade
quate from the outset or progressively
occlude. The frequently used central
venous catheters require a certain amount
o f care from the patient. Recently, a com
pletely implantable device has been
introduced, and we report on the first 50
cases of implantation o f these devices for
venous access.

Patients and Methods
From March 1984 to January 1986, 47
patients had 50 insertions of implantable
devices for venous access (3 patients had
a second device inserted after removal o f
the first). There were 22 men and 25
women; the median age was 48.5 years
(range from 18 to 85 years) (Fig. 1). The
types of tumours encountered are shown
in Table I. Two patients with benign dis
ease had the device inserted because o f
poor venous access and the necessity for
frequent blood transfusion.
The drug delivery system used was the
totally implantable Port-A-Cath (Phar

FIG. 1—Age and sex distribution. White
bars = men, black bars = women.

Table 1—Types of Tumour
Type
Hematologic
Lymphoma
Leukemia
Solid tumours
Gastrointestinal
Breast
Lung
Gynecologic
Genitourinary
Mediastinal paraganglioma
Benign
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No.
22
16
6
26
2
9
5
5
4
1
2
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16-gauge needle. A steel J guide wire is
introduced and its position checked by
fluoroscopy with the C arm. An oblique
incision 5 cm long is made parallel to the
deltopectoral groove, incorporating the
puncture site at its upper end. A pocket
is fashioned medially over the pectoralis
major fascia. In obese patients, the sub
cutaneous fat is thinned to a thickness of
5 to 7 mm. The vessel dilator and sheath
introducer are positioned using the guide
wire. The dilator is removed and the
catheter slipped into the peel-away sheath
which in turn is removed leaving only the
catheter in place. The catheter position is
checked by fluoroscopy; its length is
adjusted and it is connected to the reser
voir. The reservoir is then sutured to the
fascia and the incision closed. The system
is flushed with 5 ml of heparinized saline
at a concentration of 100 units/ml. We
do not tunnel a catheter.
M ethod o f Use
After the skin has been disinfected with
iodine solution and alcohol, the septum
is punctured percutaneously with an Lshaped 90° bent Huber-point needle con
nected to an extension tube that has been
flushed with saline. If blood return is
good the system is connected to an
intravenous solution and the infusion is
carried out. Blood sampling follows the
same procedure, after initial flushing of
the reservoir. First, 10 ml of blood is aspi
rated, discarded and the sample is then
taken. After infusion or blood sampling,
the system is flushed with 5 ml of heparinsaline solution containing 100 units/ml of
heparin. Heparinization is initially carried
out in the operating room, and then every
4 weeks, or less in patients who have
chemotherapy more frequently. No dress
ing is applied over the injection site.
Results

The mean operating time was 46.3
minutes (range from 15 to 180 minutes).
Forty-seven (94%) implantations were
done using a percutaneous subclavian
stick technique. Three (6%) were done by
cephalic cut-down, one after failure of the
percutaneous technique. Thirty-eight
(76%) were placed in the left side; 12
(24%) in the right side.
O f the 50 implanted devices only 9 were
removed — 4 at the end o f therapy and
5 because of sepsis. Fourteen patients died
with the device in place. The median time

of function was 67.5 days (range from 17
to 353 days). The respective median times
of the functioning devices were 115.5 days
(range from 12 to 400 days) for the 41 left
implanted, 208.5 days (range from 89 to
553 days) for the ones removed at the end
of therapy and 18 days (range from 14 to
63 days) for the ones removed because of
sepsis.
Infusion was easy in 46 cases and
difficult, requiring a change in the
patient’s position, in 4. Blood sampling
was easy in 44, difficult in 3 and impos
sible in another 3 cases. Of 42 patients
assessed, tolerance and acceptance of the
device were good to excellent in 33 (79%)
and acceptable in 9.

Sepsis occurred in six (12%) cases,
blockage in three (6%) and skin necrosis
one (2%). Pneumothorax or hematuria
were not encountered (Table II). There
was one death, thought to be caused by
sepsis in a poor-performance patient with
breast cancer who had widespread
metastases, hypercalcemia, and in whom
the insertion was done under general
anesthesia.
Five of the six patients had their
catheters removed. Blood cultures from
the Port-A -Cath were positive for
Staphylococcus aureus in two,
Staphylococcus epidermidis in three and
Escherichia coli in one (Table III). After
intensive chemotherapy, 50% of the
patients were neutropenic at the time of
sepsis, which developed twice in one
patient, and the device had to be removed
each time. In the other three, the leuko
cyte count ranged from 3.0 x 109/L to
12.1 x 109/L . Three catheters blocked,
two at 21 and 31 days respectively after
implantation. Patency was restored in
these two by streptokinase infusion but
the third had to be repositioned.

was well accepted by 78% of the patients;
blood sampling was easy in 88% and
infusion in 92% of the cases, thus reduc
ing patient anxiety and improving their
general well-being. The failure of blood
sampling in three patients is difficult to
explain especially since infusion was ade
quate. We placed the catheters laterally
in order to avoid compression between
the clavicle and first rib, as described by
Aitken and M inton.1
Catheter-related sepsis has been a
major problem in other angioaccess
methods. Sepsis with the Hickman
catheter is reported to be from 3% to
13%.2-4 Slater and colleagues5 reported a
13% sepsis rate in 140 patients receiving
chemotherapy, using a silicone elastomer
catheter placed percutaneously without
tunnelling. We encountered sepsis in 12%
of our cases. We did not routinely use
prophylactic antibiotics perioperatively.
In only three instances was the leukocyte
count lower than 1.0 x 109/L when sep
sis developed and two of these occurred
in the same patient with acute leukemia.
In five of the six septic patients, the
catheter was removed after persistent
fever, with positive blood cultures and
adequate adm inistration of broadspectrum antibiotics. The median time at
removal was 18 days. Early sepsis might
suggest that contamination occurred in
the peri-implantation period rather than
after prolonged use so perioperative
administration of antibiotics might be
helpful in decreasing the incidence of
infection. Our results are not in keeping
with those reported by Brincker and
Saeter,6 who reported no cases of sep
ticemia in 78 implantations.
The duration of function compares
favourably with that of the Hickman
catheter, where the median duration of
function was 91 days,7 compared to
115.5 days overall when the device was
in place and functioning.

Discussion

Conclusions

Complications

The implantable Port-A-Cath system

The Port-A-Cath venous access system
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offers important advantages over previ
ous methods of venous access: operating
time is relatively short, the implantation
technique is easy and patient acceptance
has been good. It provides easy and relia
ble venous access and the complication
rate is low. We believe that the Port-ACath is a good implantable device for
patients on chemotherapy with poor
venous access.
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Innovative Palliative Surgical Procedure for Hypoplastic
Left-Heart Syndrome
A novel surgical procedure was per
formed on a 2-day-old infant with
hypoplastic left-heart syndrome. It con
sisted of partitioning the pulmonary trunk
thereby creating two channels, one lead
ing to the pulmonary arterial system and
the other to the aorta, and atrial septec
tomy to relieve left atrial pressure and
facilitate mixing of blood. The technique
avoids the use of conduits.

Une nouvelle operation chirurgicale fut
tentee chez un nourisson de 2 jours de
vie qui presentait un hypoplasie du coeur
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gauche. Cette intervention comprend: a)
la diviser de I'art&re pulmonaire, creant
deux canals, I'un vers le systeme arteriel
pulmonaire et I'autre vers I'aorte et b)
une septectomie auriculaire visant a
diminuer la pression dans I'oreillette
gauche et faciliter la melange du sang.
Cette technique n'utilise pas les conduits
artificielles.

The generic term hypoplastic left-heart
syndrom e1 or, as earlier described,
hypoplasia o f aortic tract complex2'3
includes aortic atresia or severe aortic ste
nosis with mitral stenosis and coexistent
aortic and mitral atresia.4 Neonates with
hypoplastic left-heart syndrome usually
die during the first week o f life. The
problem is especially important because
most of these infants are born at term and
are otherwise normal.
So far the methods o f treatment have
been futile, highly controversial or
promising but risky. We describe and
illustrate a first-stage palliative surgical
procedure that was performed with satis
factory early results in one case.

Case Report
A male infant weighed 2.8 kg when born at
term. Cyanosis, tachypnea and metabolic aci
dosis were noted soon after birth. Two dimen
sional echocardiography demonstrated the fea
tures of hypoplastic left-heart syndrome.
Preoperative management included continuous
infusion of prostaglandin Ej and administra
tion of sodium bicarbonate as required. Two
days after birth, the following procedure was
performed.

The anterior mediastinum was exposed
through a median sternotomy. The thymus was
partially excised and the innominate vein
ligated and divided. The major branches of the
aorta and the right and left pulmonary arter
ies were encircled with silk ligatures. Deep
hypothermic (13°C) extracorporeal circulation
was instituted after cannulating the pulmonary
trunk with a no. 10 cannula for arterial inflow
and the right atrium with a no. 18 cannula for
venous return. The right and left pulmonary
arteries were occluded. Subsequently, the atrial
septum was excised through a right atriotomy,
taking care to avoid damage to conductive tis
sue. Total circulatory arrest was initiated with
occlusion of major branches of the aorta.
Additional cephalic surface cooling was
provided by ice bags. The coronary circulation
was perfused intermittently with slightly cooled
blood (34°C) injected through a no. 8 French
catheter inserted in the proximal aortic arch.
The ductus arteriosus was excised. The orifice
created in the aorta was enlarged in the form
of a tear drop with the tapered end pointing
toward the descending aorta. The pulmonary
trunk was opened longitudinally by parallel
incisions along its lateral borders. The roof of
the pulmonary trunk was tipped forward to
expose the floor of the artery and orifices of
the two main branches. A calibrated Hegar
dilator (4 mm) was used as a guide to construct
a narrowed pulmonary trunk from this
posterior portion of artery. A 3 x 1-cm lanceolated patch, fashioned from autologous
pericardium, formed the floor of the anterior
portion of the artery, thus creating a second
augmented channel originating at the bifur
cated pulmonary trunk. The distal end of the
augmented tube was connected to the descend
ing aorta at the site of the transected ductus
arteriosus. The right atriotomy was closed.
Coronary artery perfusion was discontinued.
Cardiopulmonary bypass was resumed with
gradual rewarming and when it was discon-
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tinued there was good contraction and ejection
with normal sinus rhythm and a systolic pres
sure of 80 mm Hg. Bypass time was 3 hours,
systemic circulatory arrest was 80 minutes and
intermittent coronary perfusion was main
tained for 50 of the 80 minutes of total arrest.
Postoperatively, the infant spent 6 days in
the pediatric intensive care unit. His condition
was monitored with a radial artery line, cen
tral venous pressure catheter, cerebral function
monitor and a pulse oximeter. He was mechan
ically ventilated using a Servo 900C ventilator
(Siemens Corp., Iselin, NJ) and paralysed with
pancuronium bromide. Cardiogenic shock
required dopamine, dobutamine and dextrosecalcium-insulin infusions. A 20-second episode
of asystole following suctioning occurred on
postoperative day 2. This responded to a 1-ml
bolus of epinephrine and 5 ml sodium bicar
bonate and was attributed to a vagal or hypoxic
response to suctioning. Periods of ectopic atrial
tachycardia not requiring therapy were noted.
Hemodynamic and ventilator support were
withdrawn 5 days after operation. Oral feed
ing and digitalis were begun on day 6, and the
infant was transferred to the neonatal unit.
Cardiopulmonary function was excellent — an
oxygen saturation of 85% to 90% on 30% oxy
gen by face mask, normal serum creatinine
level, no neurologic deficit and a normal elec-
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FIG. 2—Postoperative angiogram. Oblique view after injection of contrast in right ventri
cle showing retrograde flow into ascending aorta (common coronary), adequate passage into
thoracic aorta and branches, and symmetric filling of pulmonary arteries.
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FIG. 1—Surgical approach to hypoplastic left-heart syndrome. (A) Operative findings. Huge pulmonary trunk (12 mm diameter) and
markedly narrowed ascending aorta (4 mm diameter); diameter of left main pulmonary artery was 5 mm and that of right main pulmonary
artery 6 mm. Left atrium was small and tense. (B) Cardiopulmonary bypass was conducted at deep hypothermia (13°C). Ice bags were used
for surface cooling of head. Dashed lines indicate sites of incisions. (C) Atrial septum was cut away with scissors. Ductus arteriosus was dis
sected and transected at its aortic and pulmonary ends. Pulmonary trunk was divided longitudinally along lateral borders. Parallel incisions
were extended proximal^ to orifices of two main branches. Direct closure of posterior portion of artery created narrowed (4 mm diameter) pul
monary trunk. Pericardial patch was inserted to form floor of anterior channel, with special caution to increase calibre at its origin from pulmo
nary artery. (D) Anterior channel was connected to descending aorta. (E) After surgery, mixed blood was ejected through only ventricular outlet
into short common artery where it must detour preferentially towards aorta through channel of almost same calibre as descending aorta and
to main pulmonary arteries through calibrated trunk.
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troencephalogram. Premature atrial beats and
episodes of moderately rapid supraventricular
tachycardia were controlled with digoxin and
Inderal. Cardiac catheterization was carried out
1 month postoperatively. The mean pressure
in each atrium was 3 mm Hg. The right ven
tricular pressure was 104 mm Hg systolic with
an end-diastolic pressure of 4 mm Hg. Left
atrial saturation was 91%. Right ventricular
saturation was 73%. It was not possible to
guide a catheter into the reconstructed main
pulmonary artery. Contrast medium injected
into the right ventricle demonstrated unob
structed, balanced flow through both systems.
A pulmonary perfusion study done 1 month
after surgery gave normal results. Seven weeks
after the operation the baby weighed 3.7 kg.
Blood pressure was 78/45 mm Hg. At 53 days
of age the infant was discharged and treatment
with digoxin and Inderal was continued. At
3 months of age his weight was 4.6 kg.

tions and Miss V. Jennings for typing the
manuscript.
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Discussion
Although relatively infrequent among
congenital heart defects, hypoplastic leftheart syndrome accounts for almost one
in four cardiac deaths occurring in infants
during the first week of life.5
Because of the generally good condi
tion of these infants at birth and their
rapid deterioration once the ductus arteri
osus starts to close, surgeons have become
interested in finding an operative proce
dure that offers some hope for long-term
survival.6' 12 Prompt clinical recognition,
echocardiographic confirmation and
adjunctive pharmacologic intervention to
arrest the closure of the ductus13 and to
maintain acid-base balance are crucial in
preparation for surgery.
The initial stage in the surgical pallia
tion described here (Fig. 1) establishes
unobstructed pulmonary venous return
and assures mixing of blood. A morpho
logic right ventricle supports both the pul
monary and the systemic circulations. The
former is restricted by partitioning the
pulmonary trunk and the latter is restored
by anastomosing a diverted segment of
the pulmonary trunk to the descending
aorta (Fig. 2). The procedure bridges the
frequently encountered obstruction of
coarctation of the aorta.14-16 Eventually,
one anticipates that separation of the two
circulations can be accomplished by
applying the Fontan concept.17
The procedure described here was con
ceived about 2 years ago. We tried it on
cadavers and attempted it clinically once,
unsuccessfully. The result of the opera
tion in our second case led us to present
this preliminary report with the confi
dence that it can be done successfully by
others.
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SESAP V Critique
ITEM 3
For small pulp defects without exposed bone, simple occlusive dressings
minimize the loss of time from work, preserve length, avoid immobilization
of the digit, and provide both satisfactory appearance and good two-point dis
crimination. Skin grafting is not necessary for such defects. While useful for
more severe defects, cross-finger flap procedures require immobilization, and
may result in ankylosis of the donor finger and excessive scarring or diminished
sensation in the recipient digit. Removal of the distal portion of the distal
phalanx shortens the finger and is not necessary for this type o f injury.
D
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COUMADIN
(Warfarin sodium) A N TIC O A G U LA N T
INDICATIONS COUMADIN®. Prophylaxis and treatment of venous throm bosis and its extension, treat
ment o f atrial fibrillation with embolization, prophylaxis and treatm ent of pulmonary em bolism , and
as an adjunct in the treatment of coronary occlusion.
The following are some of the more com m on clinical disorders which may be associated w ith or
predispose patients to the above indications: 1. Thrombophlebitis 2. Congestive heart failure 3, Surgical
procedure or trauma associated with a high risk of thromboembolism 4. Myocardial infarction 5. Cerebral
em bolism . It may also be useful as an adjunct in the treatment of transient cerebral ischem ic attacks
due to intravascular clotting.
CONTRAINDICATIONS Any localized o r general physical condition o r personal circumstance in which
the hazard o f hemorrhage m ight be greater than its potential clinical benefits, such as:
Pregnancy: COUMADIN® is contraindicated in pregnancy because the drug passes through the
placental barrier and may cause fatal hemorrhage to the fetus in utero. Furthermore, there have been
reports o f birth malformations in children born to mothers who have been treated with warfarin during
pregnancy. Women of childbearing potential who are candidates fo r anticoagulant therapy should be
carefully evaluated and the indications critically reviewed w ith the patient. If the patient becomes preg
nant w hile taking this drug, she should be apprised of the potential risks to the fetus, and the possibility
of term ination of the pregnancy should be discussed in light of those risks. Hemorrhagic tendencies
or blood dyscrasias. Recent or contemplated surgery of: 1. central nervous system 2. eye a tra um a tic
surgery resulting in large open surfaces. Bleeding tendencies associated with active ulceration or overt
bleeding of: 1. gastrointestinal, genitourinary or respiratory tracts 2. cerebrovascular hemorrhage 3.
aneurysms - cerebral, dissecting aorta 4. pericarditis and pericardial effusions 5. subacute bacterial
endocarditis. Threatened abortion, eclampsia and preeclampsia. Inadequate laboratory facilities or un
supervised senility, alcoholism, psychosis, or lack of patient cooperation. Spinal puncture and other
diagnostic o r therapeutic procedures with potential for uncontrollable bleeding. Miscellaneous: major
regional, lum bar block anesthesia and m alignant hypertension.
WARNINGS The m ost serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis
and/or gangrene of skin and other tissues. The risk of hemorrhage is related to the level o f intensity
and the duration of anticoagulanttherapy. Hemorrhage and necrosis have in some cases been reported
to result in death or permanent disability. Necrosis appears to be associated w ith local throm bosis and
usually appears within a few days of the start of anticoagulant therapy. In severe cases of necrosis, treat
ment through debridement or amputation of the affected tissue, limb, breast or penis has been reported.
Careful diagnosis is required to determine whether necrosis is caused by an underlying disease. War
farin therapy should be discontinued when warfarin is suspected to be the cause of developing necrosis
and heparin therapy may be considered for anticoagulation. Although various treatments have been
attempted, no treatm ent for necrosis has been considered uniform ly effective. See below fo r inform a
tion on predisposing conditions. These and other risks associated w ith anticoagulant therapy m ust be
weighed against the risk of throm bosis or embolization in untreated cases.
Warfarin sodium is a potent drug with a half-life of 2.5 days: therefore, its effects may become more
pronounced as daily maintenance doses overlap. It cannot be emphasized too strongly that treatm ent
of each patient is a highly individualized matter. Dosage should be controlled by periodic determina
tions of prothrom bin time or other suitable coagulation tests. Determinations o f whole blood clotting
and bleeding tim es are not effective measures for control of therapy. Heparin prolongs the one-stage
prothrom bin time. Therefore, to obtain a valid prothrombin tim e when heparin and COUMADIN® are
given together, a period of at least 5 hours should elapse after the last intravenous dose and 24 hours
after the last subcutaneous dose of heparin, before blood is drawn. Caution should be observed when
administered in any situation or in the presence of any predisposing condition where added risk of hemor
rhage o r necrosis is present. Administration of anticoagulants in the following conditions w ill be based
upon clinical judgement in which the risks of anticoagulant therapy are weighed against the risk of throm 
bosis o r embolization in untreated cases. The following may be associated w ith these increased risks:
• Lactation - Coumarins may pass into the m ilk of mothers and cause a prothrombinopenic state in
the nursing infant. • Severe to moderate hepatic o r renal insufficiency. • Infectious diseases or distur
bances o f intestinal flora - sprue, antibiotic therapy. • Trauma which may result in internal bleeding.
• Surgery or trauma resulting in large exposed raw surfaces. • Indwelling catheters. • Severe to moderate

hypertension.
Known or suspected heredity, familial or clinical deficiency in protein C: This condition, which should
be suspected if there is a history of recurrent episodes of throm boem bolic disorders in the patient or
in the fam ily, has been associated with an increased risk o f developing necrosis following warfarin ad
m inistration. Skin necrosis may occur in the absence of protein C deficiency. It has been reported that
initiation of anticoagulation therapy w ith heparin for 4 to 5 days before initiation of therapy with
COUMADIN® may minimize the incidence of this reaction. Warfarin therapy should be discontinued when
warfarin is suspected to be cause of developing necrosis and heparin therapy may be considered for
anticoagulation.
Miscellaneous: polycythemia vera, vasculitis, severe diabetes, severe allergic and anaphylactic
disorders. Patients w ith congestive heart failure may become more sensitive to COUMADIN,® thereby
requiring m ore frequent laboratory m onitoring, and reduced doses o f COUMADIN.® Concurrent use
of anticoagulants with streptokinase or urokinase is not recommended and may be hazardous. (Please
note recom m endations accompanying these preparations.) Abrupt cessation of anticoagulant therapy
is not generally recommended; taper dose gradually over three to four weeks.
PRECAUTIONS Periodic determination o f prothrombin time or other suitable coagulation testis essential.

Numerous factors, alone or in combination, including travel, changes in diet, environment, physical
state and medication may influence response o f the patient to anticoagulants. It is generally good prac
tice to m onitor the patient's response with additional prothrombin time determinations in the period
immediately after discharge from the hospital, and whenever other medications are initiated, discon
tinued or taken haphazardly. The following factors are listed for your reference: however, other factors
may also affect the prothrombin response.
The following factors, alone in or combination, may be responsible for increased prothrombin time
response: ENDOGENOUS FACTORS: Carcinoma; collagen disease; congestive heart failure; diarrhea;
elevated tem perature; hepatic disorders - infectious hepatitis; hypothyroidism; jaundice; poor nutri
tional state; vitam in K deficiency - steatorrhea. EXOGENOUS FACTORS: A lcoholf; allopurinol;
am inosalicylic acid; amiodarone; anabolic steroids; antibiotics; bromelains; chloral hydratet; chlor
propamide; chym otrypsin; cimetidine; cinchophen; clofibrate; COUMADIN® overdosage; dextran;
dextrothyroxine; diazoxide; dietary deficiencies; diflunisal; diuretics); disulfiram; drugs affecting blood
elements; ethacrynic acid; fenoprofen; glucagon; hepatotoxic drugs; ibuprofen; indomethacin; influenza
virus vaccine; inhalation anesthetics; mefenamic acid; methyldopa; methylphenidate; metronidazole;
miconazole; monoamine oxidase inhibitors; nalidixic acid; naproxen; oxolinicacid; oxyphenbutazone;
pentoxifylline; phenylbutazone; phenyramidol; phenytoin; prolonged hot weather; prolonged narcotics;

pyrazolones; quinidine; quinine; ranitidine); salicylates; sulfinpyrazone; long-acting sulfonamides; sulindac; thyroid drugs; tolbutamide; triclofos sodium; trimethoprim/sulfamethoxazole; unreliable prothrombin
time determinations.

The following factors, alone or in combination, may be responsible for decreased prothrombin time
response: ENDOGENOUS FACTORS: Edema, hereditary resistance to coumarin therapy, hyperlipemia,
hypothyroidism. EXOGENOUS FACTORS: Adrenocortical steroids; alcohol); antacids; antihistamines;
barbiturates; carbamazepine; chloral hydrate); chlordiazepoxide; cholestyramine; COUMADIN® under
dosage; diet high in vitam in K; diuretics); ethchlorvynol; glutethimide; griseofulvin; haloperidol:
meprobamate; oral contraceptives; paraldehyde; primidone; ranitidine); rifampin; unreliable prothrombin
time determinations; vitamin C. A patient may be exposed to a combination of the above factors, some
of which may increase and some decrease the patient's sensitivity to COUMADIN.' Because the net
effect on prothrombin time response may be unpredictable under these circumstances, more frequent
laboratory monitoring is advisable. Drugs not yet shown to interact or not to interact with coum arins
are best regarded w ith suspicion, and when their adm inistration is started or stopped, the prothrombin
time should be determined more often than usual. Coumarins also affect the action of other drugs.
Hypoglycemic agents (chlorpropamide, tolbutamide and glyburide) and anticonvulsants (phenytoin and
phenobarbital) may accumulate as a result o f interference w ith their metabolism or excretion.
ADVERSE REACTIONS Potential side effects may include: • Hemorrhage from any tissue or organ. This
is a consequence of the anticoagulant effect. Signs and sym ptom s will vary according to location and
degree or extent of bleeding. Therefore, the possibility of hemorrhage should be considered in evaluating
the condition of any anticoagulated patient with complaints which do not indicate an obvious diagnosis.
Bleeding during anticoagulant therapy does not always correlate w ith prothrombin activity. (See TREAT
MENT FOR OVERDOSAGE.) Bleeding which occurs when the prothrombin time is within the therapeutic
range warrants diagnostic investigation, since it may unmask a previously unsuspected lesion, e.g. tumor,
ulcer, etc. • Necrosis of skin and other tissues. (SEE WARNINGS). • Other adverse reactions are infrequent
and consist of alopecia, urticaria, dermatitis, fever, nausea, diarrhea, abdominal cramping, a syndrome
called "purple toes," and hypersensitivity reactions. • Priapism has been associated w ith anticoagulant
administration, however, a causal relationship has not been established.
DOSAGE: Should be gauged according to prothrombin time determinations by a suitable method. Blood
prothrom bin time should be determined daily after the adm inistration of the initial dose until prothrom 
bin time results stabilize in the therapeutic range. Intervals between subsequent prothrombin time deter
minations should be based upon judgement of the patient’s reliability and response to warfarin in order
to maintain the individual within the therapeutic range. Acceptable intervals for prothrombin time deter
minations have usually fallen within the range of one to fo u r weeks. Satisfactory levels for maintenance
of therapeutic anticoagulation are 1.5 to 2.5 tim es the norm al prothrom bin tim e (e.g. 18 to 30 seconds,
w ith a control of 12 seconds).
Induction - Induction may be initiated w ith 10 to 15mg daily and thereafter (usually 2 or 3 days)
adjusted according to prothrombin time response. The basis fo r the no-loading dose regimen is that
the depression of Factors II, IX, and X is not accelerated by the administration of a loading dose. Avoidance
of a large priming dose may minimize the possibility of excessive increases in prothrombin time.
Maintenance - M ost patients are satisfactorily m aintained at a dose of 2 to 10mg daily. Flexibility
is provided by breaking scored tablets in half. The individual dose and interval should be gauged by the
patient’s prothrombin response. Alternatively, 40 to 60m g for average adult or 20 to 30mg for elderly
and/or debilitated patients for one dose only.
Duration o f therapy - The duration of therapy in each patient should be individualized. In general,
anticoagulant therapy should be continued until the danger of throm bosis and embolism has passed.
Treatment during dentistry and surgery- Management of patients requires close liaison between
attending physicians, surgeons and dentists. Interruption of anticoagulant therapy may precipitate
thromboembolism, conversely, at full doses, some patients may hemorrhage excessively. If it is elected
to adm inister anticoagulants prior to, during, or im m ediately following dental or surgical procedures,
it is recommended the dosage be adjusted to maintain the prothrom bin time at approximately 1.5 to
2.5 tim es the control level. The operative site should be lim ited to perm itthe effective use of local pro
cedures for hemostasis including absorbable hemostatic agents, sutures, and pressure dressings if
necessary. Under these conditions dental and surgical procedures may be performed without undue
risk of hemorrhage.
COUMADIN^with heparin - Since a delay intervenes between the administration of the initial dose
and therapeutic prolongation of prothrombin time, it may be advisable in emergency situations to ad
m inister sodium heparin initially along with COUMADIN.® Heparin may affect the prothrombin time,
and therefore, when patients are receiving both heparin and COUMADIN,® the blood sample for pro
throm bin tim e determination should be drawn just prior to the next heparin dosage, at least 5 hours
after the last intravenous injection or 24 hours after the last subcutaneous injection.
SYMPTOMS AND TREATMENT OF OVERDOSAGE Excessive prothrombinopenia, with or w ithout
bleeding, is readily controlled by discontinuing COUMADIN,® and if necessary, by the oral or parenteral
administration of vitamin K ,. The appearance of m icroscopic hematuria, excessive menstrual bleeding,
melena, petechiae or oozing from nicks made while shaving are early manifestations of hypoprothrombinemia beyond a safe and satisfactory level. In excessive prothrombinopenia w ith mild or no bleeding,
om ission of one or more doses of COUMADIN® may suffice, and if necessary, small doses of vitamin
K, orally, 2.5 to 10mg will usually correct the problem. If m inor bleeding persists, or progresses to frank
bleeding, vitamin K, in doses of 5 to 25mg may be given parenterally (please note recommendations
accompanying vitamin Kt preparations prior to use.) Fresh whole blood transfusions should be con
sidered in cases of severe bleeding or prothrombinopenic states unresponsive to vitam in K ,. Resump
tion of COUMADIN® administration reverses the effect of vitam in K, and a therapeutic hypoprothrombinemia can again be obtained.
DOSAGE FORMS COUMADIN® TABLETS are single-scored, and are imprinted as follows:
SIZE:
2mg
2.5mg
5mg
10mg
CODE:
0101
0201
0301
0401
COLOR:
lavender
orange
peach
white
IMPRINT:
COUMADIN
Side 1:
COUMADIN
COUMADIN
COUMADIN
bisected 2
bisected 2 1/2
bisected 5
bisected 10
Side 2:
Du Pont
Du Pont
Du Pont
Du Pont
Supplied in bottles of 100.
Tlncreased and decreased prothrombin time responses have been reported
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New Options in the Surgical Management
of Crohn’s Disease
Conventional surgical treatment of
Crohn's disease involves multiple or
extensive resections or bypass proce
dures. These contribute to the morbidity
and mortality of the disease. Minimal
resection with appropriate “ stric
tureplasty" is proposed as an alternative
approach. Strictureplasty is analogous to
pyloroplasty. The authors performed 15
strictureplasties in three patients, all of
whom had previously undergone smallbowel resection for Crohn's disease.
They presented with symptoms of
chronic bowel obstruction resistant to
medical therapy. There were two minor
postoperative complications. Two
patients were asymptomatic 20 months
postoperatively; the third required
reoperation for recurrent enterovesicai
fistula. The technique is safe. Its efficacy
will be determined by long-term
follow-up.

Le traitement chirurgical traditionnel de
la maladie de Crohn comprend des resec
tions larges ou multiples ou des opera
tions de derivation. Ces interventions
contribuent a la morbidity et a la morta
lity rattachees a la maladie. On propose
comme choix d'approche une resection
minimale avec "stenoplastie" appropriee.
La stenoplastie est analogue a la pyloroplastie. Les auteurs ont effectue 15 stenoplasties chez trois patients qui avaient
tous subi prealablement une resection du
grele pour maladie de Crohn. Ils presentaient des symptomes d'obstruction
intestinale chronique resistant au traite
ment medical. Ils ont enregistre deux
complications postopgratoires mineures.

Deux patients demeuraient asymptomatiques 20 mois apres ('intervention; le troisieme a du etre rdopere pour recidive
d'une fistule enterovesicale. Cette tech
nique est sure. Son efficacite sera ytablie
par une surveillance h long terme.

The surgical treatment of Crohn’s disease
has passed through several distinct stages
since it was first considered in the
1930s.1 Initially, bypass was favoured.
Two methods were used. Bypass in con
tinuity was popularized in the 1950s in the
United States because it was so effective
in the late President Eisenhower;
however, the outcome was poor in the
majority of patients. Not only did the dis
ease fail to settle down, but the postoper
ative course was often stormy and com
plicated by fistulas and abscesses. It was
recognized that diversion of the fecal
stream away from the site of inflamma
tion was critical to the success of such sur
gery. Thus, bypass with exclusion became
the procedure of choice. Later, as surgi
cal technique and perioperative care
improved, resection was preferred, except
in patients with complicated inflamma
tory masses. Physicians and surgeons then
became preoccupied with the resection
margins, some2 advocating wide resec
tion, others3 dwelling on disease-free
frozen sections. Such considerations
proved to be irrelevant,4 giving early
support to the concept of Crohn’s disease
as a panenteric problem. Meanwhile,
reports of the development of carcinoma
in bypassed segments made it clear that
exclusion surgery should not be consi
dered further.5
The Present

From the *Division o f Gastroenterology
and fDivision o f General Surgery, Sunnybrook Medical Centre and University of
Toronto, Toronto, Ont.
Accepted fo r publication Aug. 12, 1986
Reprint requests to: Dr. F.G. Saibil, Divi
sion o f Gastroenterology, Sunnybrook
Medical Centre, H Wing, Rm. 962, 2075
Bayview Ave., Toronto, Ont. M4N 3M5

The natural history of Crohn’s disease
does not conform to a set pattern, but the
majority of patients will eventually
require laparotomy.6 Surgery should be
undertaken only for complications resis
tant to medical management, such as
recurrent obstruction or extraintestinal
fistulization. There are two groups of

patients with Crohn’s disease in whom
surgical therapy may create at least as
many problems as it solves: patients with
at least one previous small-bowel resec
tion, who require another and patients
with extensive (more than 100 cm) smallbowel disease, having resection for the
first time.
It is established that most patients who
lose 100 cm or more of ileum will have
steatorrhea,7 which is often difficult to
manage. The resulting malnutrition adds
to that inherent in the primary disease
when it recurs clinically. The morbidity
in this group is high.
It is because of these patients that the
concept of minimal surgery has evolved.8
Minimal surgery takes one of two forms
— “ strictureplasty” and minimal resec
tion. The former is analogous to
pyloroplasty, from which the technique
and nomenclature have been adapted.
Strictureplasty was introduced in India,9
in order to avoid extensive resection and
relieve obstruction in patients with
burned-out tuberculosis, which mimics
Crohn’s disease of the small bowel. In
fact, patients with Crohn’s disease were
included and seemed to fare as well as the
patients with tuberculosis. Within a short
time the technique was introduced to the
Western world by two British surgeons
working independently.10’11
A lexander-W illiam s11 has dem on
strated this technique in many parts of the
world and did so at our hospital in March
1985 (case 1). We have since performed
the procedure on two patients* and report
our experience.
Patients and Methods

All three patients had previously under
gone resection for Crohn’s disease of the
small bowel. The total duration of symp
toms from the time of original diagnosis
was 8, 16 and 23 years, and the intervals
between the resection and strictureplasty
*Since submission of the manuscript, six addi
tional patients have undergone a total of 53
strictureplasties.
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were 2, 4 and 21 years respectively, with
recurrent symptoms having been present
for 6 months, 3 years and 2 years. All
were evaluated preoperatively by two of
us (F.G.S. and A.W .H.). One patient
(case 1) had been followed up for 7 years,
and the other two were referred specifi
cally for strictureplasty. All three had
sym ptom s o f chronic small-bowel
obstruction, and multiple strictures were
demonstrated on barium studies of the
small bowel. An enterovesical fistula was
present in case 1. Pancolonoscopy
demonstrated a macroscopically normal
large bowel in each case.
Because of a right paramedian scar in
each case, our approach was through a
midline incision. After exploration, the
entire small bowel was mobilized. Each
patient had more strictures than were
identified radiologically. A longitudinal

FIG. 1— Strictureplasty for short strictures.
Strictu re is opened lon gitu d in ally on
antimesenteric border (A). Running simple
sutures are begun laterally at midpoint of
enterotomy. Alignment for closure is demon
strated by tension on these knots (B,C).
Enterotomy is closed by tying sutures across
apex (D).
134

enterotomy was performed through one
of the strictures and others were identi
fied by anterograde and retrograde pas
sage of a Foley catheter, after the method
of Alexander-Williams.12 As he re
ported, this is necessary because areas of
stenosis are not always evident on inspec
tion of the serosal aspect of the gut. Stric
tureplasties were then performed sequen
tially, starting with the site of the initial
enterotomy. Strictures were opened lon
gitudinally on the antimesenteric border.
Single strictures separated by more than
3 cm, or two closely spaced strictures,
were repaired after the method of
Heineke-Mikulicz with a single layer of
continuous 3-0 Maxon suture (Fig. 1).
Areas of multiple (three or more), closely
spaced strictures were repaired after the
method of Finney, again using a continu
ous suture (Fig. 2).
In case 1, an area of stricture was found
just distal to a small abscess and fistulous
tract into bladder. The induration around
the fistula was broken down by blunt dis
section. The opening into the bladder was
closed with absorbable Lembert sutures.
The opening into the small bowel was
extended longitudinally through the stric
ture and closed by the Finney technique.
No drains were left in the abdomen.

Nasogastric suction was maintained until
the patients passed gas, and progress to
a full diet was intentionally slow.

Case Reports
Case 1
This man first experienced symptoms of
Crohn’s disease, with abdominal pain and
fever, in 1969, at the age of 17 years. After 4
years of intermittent therapy with steroids and
sulfasalazine, he was hospitalized with a midsmall-bowel obstruction that failed to respond
to medical management. Laparotomy was said
to have revealed extensive segmental Crohn’s
disease of the entire small bowel. An exclusion
bypass was performed at the site of obstruc
tion in the jejunum. He did well for several
years, being maintained on sulfasalazine. In
March 1981, an episode of partial small-bowel
obstruction was treated by giving clear fluids
only. In May 1981, barium studies of the small
and large bowel gave normal findings; the
excluded intestine was, of course, not
visualized.
Because of intermittent left-sided abdomi
nal pain, recurrent iron-deficiency anemia and
concern about the possibility of carcinoma in
the excluded loop, laparotomy was performed
in April 1983. This revealed active disease
within the bypassed segment and obstruction
at the previous anastomosis. The bowel other-

FIG. 2—Strictureplasty for multiple or long strictures. Area is opened longitudinally and
about 2 cm past strictures on each end (A). Bowel is folded at midline of enterotomy (B). Run
ning simple suture is begun at angle of inner or posterior wall. First knot is inside lumen. This
suture is brought outside lumen at apex (C). Running simple suture is begun at anterior angle
and continued to meet first suture which has been continued onto anterior wall of strictureplasty
to avoid tying at apex (D,E). Enterotomy is closed by tying these sutures across anterior wall (F).
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wise appeared normal, except for a short seg
ment of “ burnt-out” terminal ileitis. He was
well for 3 months and then complained of a
variety of nonspecific symptoms suggestive of
reactivation of his Crohn’s disease. In 1984,
he had a severe exacerbation of the disease and
an enterovesical fistula developed. He com
plained of abdominal bloating, crampy pain
after eating solid food and diarrhea. He
required a course of total parenteral nutrition,
and steroid therapy was begun. He responded
to treatment but could not tolerate a reduction
of prednisone below 20 mg/d. His obstructive
and urinary tract symptoms progressed and
anemia developed. The symptoms were totally
controlled only when he was on a zero-residue
liquid diet, consisting of Ensure and clear
fluids.
In March 1985, he underwent laparotomy,
having been maintained on the liquid diet for
4 weeks. Three discrete strictures were identi
fied in the last 20 cm of ileum. The distal stric
ture was tightest and 1 cm proximal to this a
fistula entered the bladder. Three HeinekeMikulicz strictureplasties were performed. On
postoperative day 5 the patient had symptoms
and signs suggestive of a small intestinal leak;
they settled with conservative management. He
was discharged home 3 Vi weeks postoperatively. He was weaned off prednisone and
gained 3 kg eating a full diet. Two months after
the operation he complained of marked
fatigue, and very mild, occasional, right lower
abdominal discomfort. One month later he was
clearly having a flare-up of his ileitis, with right
lower quadrant pain and anorexia. After
another month, he was readmitted with a recur
rent abscess between the ileum and the blad
der. Excellent control of symptoms was
achieved with total parenteral nutrition,
steroids and antibiotics, and he was discharged.
Five months after strictureplasty, he ex
perienced an episode of gastrointestinal bleed
ing, apparently due to Crohn’s disease.
During the next 5 months, he did reasona
bly well on a gradually reduced dosage of pred
nisone, in combination with 5-aminosalicylate
(Salofalk tablets; Interfalk Canada, Inc., Mon
treal, PQ). However, 10 months after his last
surgery, the enterovesical fistula recurred and

FIG. 3—Case 3. Appearance of small bowel.
At laparotomy, 17 discrete strictures were
found.

12 months postoperatively he underwent
laparotomy and ileocecal resection. The oper
ative and pathological findings will be the sub
ject of a separate report.

Case 2
A 49-year-old woman was well until, at the
age of 26 years, she had her first symptoms of
ileitis while pregnant. Eighteen months later,
she suffered small-bowel obstruction which
necessitated ileocecal resection, with removal
o f approximately 100 cm of terminal ileum.
She was then well for 19 years, until 1983, when
she experienced symptoms of recurrent disease
in her small bowel. After 2 years of medical
management, she was hospitalized again with
small-bowel obstruction. An upper gastroin
testinal and small-bowel series demonstrated
at least four small-bowel strictures with dilated
bowel proximally. One month later, she
became intolerant of solid food, but was other
wise well. This intolerance was not relieved by
a period of bowel rest combined with total
parenteral nutrition, so she was referred to us
for strictureplasty.
Laparotomy in May 1985 revealed 120 cm
of normal proximal small bowel. Distal to this
was an inflammatory mass of diseased smallbowel loops. Within this segment, approxi
mately 75 cm long, were five strictures. Distally, an additional 120 cm of grossly normal
small bowel was identified.
The inflamed segment contained dilated jeju
num, two closely spaced short strictures,
another area o f dilatation, two more closely
spaced strictures and one hard stricture about
20 cm long which was opened with a Finney
strictureplasty. The two pairs of short strictures
were opened by the Heineke-Mikulicz tech
nique. Apart from a slightly prolonged ileus,
the postoperative course was uncomplicated
and she was discharged on a full diet 14 days
postoperatively. Currently, 21 months after
operation, she has gained 6 kg and is on no
medication or dietary restriction.

Case 3
This 25-year-old man was well until the age
o f 17 years when he presented with diarrhea,
abdominal pain and an anal fissure. A short
segment of ileitis was demonstrated radiologically. He was managed medically until 1981,
when laparotomy was performed because of
intractable symptoms and an extensive
jejunoileitis was found. Thirty centimetres of
ileum and a small segment of right colon were
resected. A stenotic lesion 200 cm from the liga
ment of Treitz was bypassed by enteroenterostomy and the remaining diseased portion
left in situ. He was well for 1 year but then ane
mia, pain and diarrhea not responsive to
steroids developed. A small-bowel enema rev
ealed numerous strictures (Fig. 3). Because o f
progressive symptoms of partial small-bowel
obstruction, he was referred for strictureplasty.
A t laparotomy there were 17 discrete stric
tures, the most proximal being 100 cm from
the ligament of Treitz. Seven Heineke-Mikulicz
and two Finney strictureplasties were per
formed. One of the latter included several stric
tures in a 40-cm segment of bowel and the other
included the previous bypass.
Postoperatively he had a prolonged ileus, but
was discharged on a low-residue diet 3 weeks
after operation. He was readmitted 1 week later

with what appeared to be a small-bowel
obstruction. This resolved quickly with naso
gastric suction, and he was discharged 6 days
later. A t the time of writing, 19 months after
operation, he is on a full diet, has gained 15
kg and is on no medication. In August 1986,
he underwent an elective cholecystectomy after
several attacks of biliary colic. His only medi
cation is iron.
D isc u ssio n

Strictureplasty is used to decrease the
incidence o f short-bowel syndrome secon
dary to multiple resections for Crohn’s
disease. It may not, however, reduce the
frequency of clinical recurrence.13 One
must remember that the technique was
developed not to reduce recurrence, but
to reduce the frequency o f resection. In
our patients, resection was delayed and
may have been prevented. Long-term
follow-up is required.
The technique contravenes conven
tional surgical teaching. Areas o f inflam
mation are left in situ, opened and
sutured. Contrary to popular belief, the
inflamed bowel wall holds sutures well
and complications are no more common
than after any other procedure involving
enterotom y.13 This durability o f the
inflamed bowel may be due to the fibro
sis o f the bowel wall seen with long
standing Crohn’s disease. It may be,
therefore, that obstruction from early
Crohn’s disease would be less amenable
to strictureplasty, but some surgeons are
now using this as a primary procedure.14
The patient in our first case has
required reoperation for recurrent entero
vesical fistula and obstructive symptoms.
This may be the earliest reported recur
rence o f obstruction in an area o f previ
ous strictureplasty (Alexander-Williams J:
Personal communication, 1985). At
present, we cannot tell what factors would
have allowed us to predict this unfor
tunate course. The patient did seem to
have more active disease at operation, and
was steroid-dependent preoperatively, but
these factors have not been contraindica
tions to strictureplasty in other series. The
patient also had a suspected postopera
tive intestinal leak, but thus far this has
not been considered a prognostic factor.
Most patients who undergo this proce
dure have had chronic obstruction
without other complications o f Crohn’s
disease. It may be that abscess and fistula
represent relative contraindications to the
operation. In keeping with the concept o f
minimal surgery, it would be reasonable
to combine segmental resection with stric
tureplasty in selected cases, as has been
suggested.10
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Transient Focal Cerebral Ischemia Resulting From Digital
Palpation of the Carotid Artery in the Neck
Complications of digital palpation of the
carotid artery in the neck are uncommon.
They include cardiac arrhythmias and
cerebral ischemic events. A 65-year-old
woman experienced transient paralysis of
the left arm immediately after palpation
of the right carotid artery; at surgery, a
friable, atherosclerotic plaque was
removed from the bifurcation of the
artery. The most likely cause of a tran
sient neurologic deficit after digital
manipulation of the carotid artery in the
neck is an embolus from an
atherosclerotic carotid plaque. The
authors review the literature on the fre
quency and pathogenetic mechanism of
this complication.

Les complications de la palpation digitale
de I'artere carotidienne au niveau du cou
sont frequentes. L'arythmie cardiaque et
I'ischdmie cerebrale en font partie. Une
femme de 65 ans a souffert d'une
paralysie transitoire du bras gauche
immediatement apres la palpation de la
carotide droite; a la chirurgie, une plaque
d'atherome friable a ete retiree de la
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bifurcation carotidienne. La cause la plus
probable du deficit neurologique transi
toire aprds manipulation de la carotide
avec les doigts est une embolie originant
de la plaque d'atherome. Les auteurs
passent en revue des publications sur la
frequence et le mecanisme pathogenetique de cette complication.

Although digital palpation o f the carotid
artery in the neck is commonly used for
both diagnostic and therapeutic reasons,
complications attributable to carotid
manipulation are rare. They consist
mainly of cerebral ischemic events and
cardiac arrhythmias. This report describes
a case of transient cerebral ischemia that
followed digital palpation o f the carotid
artery. We review the appropriate litera
ture regarding the frequency and possi
ble pathogenesis o f this iatrogenic event.

tal examination of the region by a number of
physicians, the patient experienced a dense
monoparesis of the left arm that resolved com
pletely in 2 hours. Cardiac examination rev
ealed normal heart rate and rhythm and no
murmurs; an electrocardiogram was normal.
Computerized tomography of the head rev
ealed no abnormality. Transfemoral carotid
arteriography demonstrated a 40% stenosis of
the right internal carotid artery near its origin
(Fig. 1). The left internal carotid artery
appeared normal.
The patient underwent right carotid endar
terectomy as prophylaxis against cerebral
infarction. The carotid bifurcation was found
to be quite bulbous and firm to palpation.
Arteriotomy exposed a large, extremely fria
ble plaque which was removed. Pathologically,
the specimen consisted of an atheromatous
plaque with no evidence of dissection (Fig. 2).
The patient’s postoperative course was uncom
plicated and she remains symptom-free 3 years
later.

Discussion

Case Report
A 65-year-old right-handed woman was
referred to an otolaryngologist because of dys
phagia associated with a painful mass in the
right side of the neck, present for 1 year. The
patient was a cigarette smoker with no history
of diabetes, hypertension, angina or leg clau
dication. There was a family history of hyper
tension and stroke. There were no episodes of
amaurosis fugax or symptoms of transient
cerebral ischemia. Oropharyngeal examination
gave negative findings. A 2 x 2-cm firm,
mobile, pulsatile mass was palpable in the right
submandibular area, but no accompanying
bruit was heard. Minutes after repeated digi

The first neurologic complication
attributable to carotid manipulation was
reported in 1941 by Marmor and Sapirstein.1 The patient, a 53-year-old man
with generalized arteriosclerosis,
experienced bilateral thrombosis of the
anterior cerebral arteries shortly after
serial compression of both carotid bifur
cations. Total right hemiparesis occurred
within minutes o f the procedure, preceded
by a syncopal episode, bradycardia and
a generalized seizure. The largest series of
hemiplegia following carotid manipula
tion was reported by Askey2 in 1946,
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who described eight cases. Six patients
suffered cerebral infarction, one had a
deficit resolving within 24 hours and one

patient experienced two transient ischemic
attacks, both occurring shortly after
carotid sinus stimulation. Generalized
vascular disease was clinically evident in
six of these patients. In seven instances
the hemiplegia followed routine diagnos
tic testing for carotid hypersensitivity, and
in one it followed compression of the
neck during a chiropractic maneuver. The
authors attributed the six cases of cerebral
infarction to either thrombosis or small
hemorrhage, and the transient events to
reflex vasoconstriction of the ipsilateral
cerebral circulation, a theory no longer
in favour.3 No mention was made of the
possibility of embolism. In a series of 188
elderly patients tested for carotid sinus
hypersensitivity, Zeman and Siegal4
described an 83-year-old man who
experienced fixed right-arm paralysis after
serial bilateral carotid compressions.
Webster and G urdjian5 examined a
group of patients with pre-existing
hemiparesis or hemiplegia from a variety
of causes. Of 100 patients exposed to
carotid artery compression, worsening of
an existing hemiparesis was observed in
1. Others3-6'7 have reported hemiplegia
related to carotid palpation.
In their series of four patients, Calverley and Millikan8 reported on a
35-year-old man, the youngest such
patient in the literature, who had con
tralateral hemiplegia during neck massage
to relieve muscle tension. The authors
speculated that a hemodynamic cerebral
infarction was caused by decreased flow
to the ipsilateral cerebral circulation
secondary to manual occlusion of the
artery. Conversely, it was proposed that

Fig. lb
FIG. 1—Right carotid angiogram — (a)
lateral and (b) anteroposterior views — demon
strating atherosclerotic plaque of internal
carotid artery without hemodynamically sig
nificant stenosis.

FIG. 2—Photomicrograph of surgical speci
men showing atherosclerotic plaque with subintimal lipid-laden m acrophages (to p ),
cholesterol clefts, and media (bottom )
(hematoxylin and eosin, bar = 200 jtm).

another patient who suffered cerebral
infarction after intraoperative manipula
tion of the carotid artery suffered either
an in-situ thrombosis or an embolism of
atherosclerotic debris. More recent
reports have implicated carotid compres
sion ocular tonography9 and carotid
massage for the termination of supraven
tricular tachycardia10 in causing cerebral
infarction. Several2-11 have described a
delayed onset of hemiparesis, approxi
mately 24 hours after initial carotid
manipulation. This time lapse is compat
ible with local arterial trauma producing
delayed embolism, as opposed to immedi
ate embolism or thrombosis, or cardiac
dysfunction.
Pathological verification of cerebral
ischemia precipitated by digital carotid
artery compression has been reported
infrequently. Marmor and Sapirstein’s
original paper clearly described anterior
cerebral artery thrombosis at autopsy. In
one of Calverley and Millikan’s patients,
exam ined post m ortem , m ark ed
atherosclerotic changes were found in
both carotid arteries associated with
thrombosis of the previously palpated
vessel. Nelson and M ahru12 confirmed a
case of massive hemispheric infarction
secondary to internal carotid artery
thrombosis after digital occlusion o f the
carotid artery in the neck. Pathological
evidence of an artery-to-artery embolism
after carotid artery compression is
documented by Beal and colleagues.13 A
79-year-old man suffered right hemiple
gia 1 minute after left carotid sinus pres
sure was applied; autopsy disclosed an
intraluminal mass of atherosclerotic
material at the bifurcation of the left mid
dle cerebral artery and an ulcerated
atherosclerotic plaque in the left internal
carotid artery in the neck. Further sup
port for an embolic cause of transient
cerebral ischemia after carotid artery
compression is inferred by the report of
Cohen and Jacobson.14 They described a
50-year-old physician who experienced a
transient ischemic attack while demon
strating carotid massage to a patient with
paroxysmal atrial tachycardia; at carotid
endarterectomy an ulcerated plaque con
taining loose fibrinous material was
removed.
Despite the reported adverse conse
quences, carotid artery palpation appears
to carry a low morbidity. In an attempt
to ascertain the relative frequency of neu
rologic complications, it is worthwhile
examining the cardiology and neurology
literature pertaining to routine carotid
massage or compression. Sigler15 evalu
ated 1193 patients with carotid sinus mas
sage and encountered no complications
attributable to focal cerebral ischemia.
Lown and Levine16 reported just one
brief episode of transient facial weakness
in several thousand such tests. Smiddy
and colleagues17 confined their study to
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feilthy men over 65 years of age without
e Jence of cardiac arrhythmia or
raocardial infarction; in 58 instances of
cs»tid sinus massage no neurologic
evnts were observed. Deaths have been
afcibuted to induced cardiac arrhythmias
Wowing carotid sinus massage;18-19
however, this occurrence is also rare. In
the neurologic examination of patients,
carotid compression to assess cerebrovasculr insufficiency used to be routine;20
Toole and Bevilacqua21 performed over
250) carotid compressions and reported
no oeurologic events. In another study,
2 of 479 patients so tested suffered
cerebral infarction.22 Janeway23 used
carotid compression as a screening test to
evaluate cerebral collateral reserve; of
2800 compressions in 336 patients there
w as one cerebral infarction. Fieschi and
colleagues24 performed carotid sinus
massage in 274 patients who had previ
ously experienced one or more transient
ischemic attacks. No cerebral ischemic
events were attributed to these maneuvers
even though 148 of these patients had
stenotic or complicated carotid plaques
demonstrated on angiography. Precipita
tio n of hemiplegia ipsilateral to the
carotid artery compressed has also been
recorded25 and explained on the basis of
hemodynamic ischemia of the con
tralateral hemisphere due to impaired col
lateral flow to the hemisphere above a
totally blocked carotid artery.
Possible mechanisms to explain the
occurrence of cerebral ischemia follow
ing carotid artery palpation include the
follow ing: (a) embolism from an
atheromatous plaque of the internal
carotid artery, (b) local trauma to the
arterial wall with resultant thrombosis or
intimal dissection, (c) manual compres
sive occlusion of the internal carotid
artery with resultant decreased flow to the
hemisphere, (d) decreased cardiac output
from an arrhythmia, causing thrombosis
o f the internal carotid artery or
hemodynamic focal cerebral ischemia and
(e) mural thrombus in the heart with dis
tal embolization precipitated by cardiac
arrhythmia. The likely cause of our
patient’s transient ischemic attack was an
atheromatous embolus dislodged from
her friable internal carotid artery plaque
by firm digital palpation. This theory is
supported by the observation that bright
retinal plaques indicative of cholesterol
emboli have been seen immediately after
carotid palpation and surgical manipulation.23-26-27 It is puzzling, however, that
cerebral ischemic symptoms are infre
quently reported after palpation of the
carotid artery, a maneuver that is often
done in older individuals. The friable
nature of carotid artery atherosclerotic
plaques seen at surgery or autopsy sug
gest that traumatic dislodgement of
emboli from firm digital manipulation
should be more common. Perhaps this
138

does happen but the emboli are too small
to cause clinically recognizable neurologic
deficits. Alternatively, such deficits may
be common but are infrequently reported.
Regarding the relative safety of digital
manipulation of the carotid artery in the
neck, most authors1-2’4-9-10-13 recommend
caution when performing carotid sinus
massage on elderly, atherosclerotic,
hypertensive patients. However, the liter
ature offers no firm predictors of the
occurrence of cerebral ischemia as a result
of carotid palpation.
In patients already experiencing tran
sient ischemic symptoms (i.e., amaurosis
fugax or a transient ischemic attack), dig
ital palpation of the artery in the neck is
contraindicated; it provides little clinically
useful inform ation that cannot be
provided m ore anatom ically and
accurately by carotid angiography or dig
ital intravenous subtraction angiography.
In asymptomatic older patients, routine
digital palpation of the artery in the neck
is also unlikely to give much information
regarding the cerebrovascular status and
therefore is not indicated. In younger
patients with supraventricular tachyar
rhythmias, carotid sinus massage remains
an important therapeutic and diagnostic
modality and the risk of precipitating
artery-to-artery embolism in this popula
tion is low. Carotid massage for
supraventricular tachyarrhythmias in
elderly patients would carry a higher risk,
but the relative benefits of this procedure
would outweigh the apparently small risk
of precipitating neurologic problems.
Perhaps auscultation of the neck for
bruits would be a prudent screening test
in these patients, although the relation of
cervical bruits to the risk of embolic
cerebral infarction is uncertain.28
When a transient ischemic attack is
apparently precipitated by digital palpa
tion of the neck for whatever reason, the
clinician must investigate the patient
thoroughly, and that includes a search for
a surgically significant atherosclerotic
lesion in the internal carotid artery in the
neck.
We thank Dr. L. Resch for supplying the
photomicrograph, Lynn Kovacs for preparing
the manuscript and Dr. D. Borts for his cardi
ologic critique.
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Harvey's discovery of the circulation had
its roots far back in his early studies in
medicine at the University of Padua
where he was a pupil of the famed
anatomist Fabricius, who was very
interested in the valves of the veins. The
difference between his teacher and Har
vey was Harvey's dedication to the
modern concept "scientific method".
Other influences on his findings included
the earlier work of Erasistratus and
Galen. Harvey, after a long period of
experimentation, published his findings
on the circulation of the blood in his
famous treatise De Motu Cordis in 1628.
It is noteworthy that Harvey as a clinical
practitioner failed thereafter to apply his
discoveries to his work as a physician.
The first of two articles on Harvey, this is
concerned with his work as a scientist
and discoverer. The second article is
devoted to his work as a medical doctor.

La d£couverte de Harvey sur la circula
tion prit naissance loin, dans ses premie
res etudes medicales & I'Universite de
Padoue oil il fut I'eleve du celebre anatomiste Fabricius, lequel s'interessait de
pres aux valvules et aux veines. Contrairement a son maitre, Harvey s'en remettait au concept moderne de la "methode
scientifique ". Parmi les autres influences
sur ses recherches, on note les travaux
anterieurs d'Erasistrate et de Galien.
Apres une longue p£riode d'experimentation, Harvey publia ses resultats sur la
circulation du sang dans le traite bien
connu De Motu Cordis en 1628. II faut
remarquer que, tout praticien Clinique
qu'il fut, Harvey negligea par la suite
d'appliquer ses decouvertes a son travail
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The title of this article was suggested by a
quote from Henry Power, a student of Glisson’s at Cambridge and an interesting
example of Harvey’s influence exerted at
a distance. In the late 1640s, Power fol
lowed his friend Thomas Browne’s advice
to learn anatomy by autopsia, and most
especially, to make himself master of H ar
vey’s De Motu Cordis. The tract he pub
lished in 1652, Circulatio Sanguinis,
brought to light over 50 experiments, both
dissectional and vivisectional, to support
“ our Reverend and Worthy Dr. Harvey”
and “ that Incomparable Invention of his,
the Circulation of the Blood” . (In the 17th
century, the word “ invention” was used
synonymously with our term “ discovery” .)

comme medecin. Le premier de deux
articles sur Harvey est consacre a ses
travaux en tant que scientifique et chercheur. Le second se penche sur son tra
vail de medecin.

Through his discovery of the circula
tion of the blood, William Harvey
(1578-1657) laid the foundation of
modern physiology and made possible the
development of medicine as an applied
science. In the 14th chapter of his famous
treatise, De M otu Cordis (1628), Harvey
gave a brief restatement or summary of
the new doctrine, concluding that “ in
animals the blood is driven round in a cir
cuit with an unceasing, circular sort of
movement, that this is an activity or func
tion of the heart which it carries out by
virtue of its pulsation, and that in sum it
constitutes the sole reason for that heart’s
pulsative movement” .
Nothing could be clearer and no scien
tific treatise contains a more conclusive
demonstration of the truth of the doctrine
propounded in it. Yet Harvey’s great con
tribution to our knowledge of anatomy
and physiology does not represent the
totality of his achievement. That is to be
found in his sound empiricism, his mov
ing from an idea, a premise, through dis
section and experimentation, to establish
“ scientific” proof of his hypothesis. In
employing this approach, he not only

founded a branch of modern science and
made possible its application to other
sciences, in particular medicine, but he is
now recognized as the true pioneer in the
modern conception — the “ scientific
m ethod” . Argument from known facts,
supported by experiments on living
animals and autopsies on humans, had
shown once and for all the validity of a
fundamental physiological truth that had
escaped every previous anatomist. “ Clear
reasoning and perfect scientific method
with quantitative measurements had set
a pattern initiating advances in the bio
logical sciences and was destined to
influence all scientific investigation for
the rest of time.” 1
Origins of the Circulation Doctrine
From Plato to Galen
The doctrine of the circulation of the
blood, it has been claimed, had been
known to antiquity. Knowledge of it has
been credited to ancient Chinese and
Hindu civilizations. However, if there
were any real foundation to these claims,
it seems likely that Plato and Aristotle
would have had a more accurate concep
tion of the heart and its functions than
can be found in their writings.2
Plato, writing in the fourth century,
described the heart as protected by the
lungs and as being the origin of the blood
vessels. He made no distinction between
arteries and veins. This distinction was
first made by Praxagoras o f Cos (circa
320 BC), although he thought the func
tion of the arteries was to carry air.
P lato’s pupil Aristotle subscribed to this
delusion and was responsible for perpetu
ating it.
Erasistratus of Alexandria, a little later
than Praxagoras, shared the belief that
the arteries were designed to carry air,
explaining the issue of blood from a
severed artery as due to blood “ passing
through free anastomoses from the veins”
to fill the vacancy caused by the arterial
lesion.
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Some 400 years after Erasistratus, in
the second century AD, Galen, the last
of the great Greeks, set about making a
comprehensive synthesis of body struc
ture and functions. Although Galen may
not have anticipated the central truth of
the movements of the blood, he believed
implicitly in the value of experimentation
in elucidating anatomical and physiolog
ical problems. By dissections and experi
ments on animals, he defined their
organs, watched them work and thus
arrived at a synthesis, combining his find
ings with those of authorities of his day.
These findings are summarized in a book
on the uses of the parts (De Usu Partium).
His conception of the movements of the
blood is contained in scattered passages
of his writings. His syncretic blend of ana
tomical structure and function was so
closely knit and authoritative that it
remained unchallenged for the next 1400
years. After Galen’s time, his teaching
acquired an almost divine authority, so
that things stood as he left them until
Harvey’s remarkable discovery published
in 1628. Galen is considered to be H ar
vey’s “ true father in science” , not so
much for what he achieved, but for how
he achieved it.3
Harvey at Padua and the Influence
of Fabricius

Harvey was born in Kent, educated at
Canterbury School and went on to hold
the Parker scholarship at Gonville and
Caius College, Cambridge. This college,
originally known as Gonville Hall, was
refounded by Dr. John Caius, sometimes
regarded as the father of the study of
anatomy in England, as a seat of learn
ing for young men with a particular scien
tific bent. Its reputation as a place where
medical studies were encouraged was
widely known. This college must have had
a special attraction for Harvey, a youth
with identifiable scientific and medical
leanings. Probably he received a better
medical education there than is generally
conceded, for as we shall see, he spent lit
tle more than 2 years at Padua before
graduating with an MD degree, although
there were no formal medical lectures
during this time.
Following in the footsteps of Caius and
Linacre, Harvey chose to complete his
medical education at Padua, a medical
school famous for its anatomical and clin
ical training. A statute of 1558 at Gon
ville and Caius College, proposed by
Caius, recognized that the medical
instruction then available at Cambridge
was not adequate for full training as a
doctor. Bachelors of arts wishing to pur
sue a medical career were allowed to leave
Cambridge and go to Padua, Bologna,
Montpellier or Paris. It is thought that
Harvey was attracted to Padua in the first
140

place by the celebrity of the medical
school and the excellence of the teaching
provided there. In anatomy the sequence
of Vesalius, Columbus, Fallopius and
Fabricius in the professorial chair had
indeed given the school a quite dazzling
distinction.4'5 Beginning with the
influence of the physician Montanus
(under whom John Caius had studied),
the Clinical School of Padua for more
than half a century had provided a unique
form of teaching. In this milieu Harvey
had the opportunity to study anatomy
with the best teachers, and here he was
also able to acquire clinical knowledge
and bedside experience in the hospitals.
Harvey was profoundly influenced,
through his teachers at Padua, by Aristo
tle. Many reasons can be listed to explain
Harvey’s loyalty to Aristotle. Paduan
Aristotelianism must have made a deep
impression on him in his formative years,
personified as it was in his teacher,
Fabricius. Harvey calls him his guide next
to Aristotle himself.6’7 His real teacher
Fabricius of Aquapendente was at this
time completing the work for his treatise
on the valves of the veins (De Venarum
Ostiolis). Although it has often been
assumed that a fast friendship sprang up
between master and pupil, this has never
been firmly established, nor did Harvey
ever serve as a special assistant to
Fabricius. We can be sure, however, that
the venal structures were demonstrated by
the famous master to students in Padua’s
anatomy theatre during Harvey’s first
year of residence there. Fabricius was
him self saturated in A ristotelian
philosophy and scientific concepts. His
example, in the wide range of his investi
gations into the cardiovascular system
and into the entire field of animal biol
ogy and generation, had a profound
effect on Harvey’s thinking and methods
of work, more than any other teacher he
is likely to have met at Padua or else
where.
At the beginning of chapter 13 in De
M otu Cordis, Harvey makes reference
to “ the discovery of the valves” by
Fabricius. This chapter and the two previ
ous ones are of particular interest for they
show how Harvey had come to appreci
ate the true purpose of valves in veins.
These chapters include observations
describing Harvey’s dissections of the
veins in the limbs and his attempt to pass
a probe downwards. Invariably the valves
provided a complete obstacle, though the
probe passed easily in the other direc
tion toward the heart. Then comes the
celebrated demonstration of the valves in
the veins of the forearm, for which Har
vey used figures copied from the draw
ings published by Fabricius in 1603 in his
book De Venarum Ostiolis. These were
the only illustrations Harvey included in
the first edition of De Motu Cordis, and
they appeared in virtually every subse

quent edition of the book except the
English version of 1653.
A glance back at Fabricius’s discovery
in its relation to Harvey’s later findings
is revealing. Hitherto, Fabricius claimed,
the valves of the veins had escaped the
notice of anatomists of his own and
earlier generations. Never had they been
mentioned. No one had even set eyes on
them until 1574 when he first noticed
them in the course of his dissection. In
point of fact, they were known to
Vesalius at Ferrara in 1545, and earlier
still to Giambattista Canano (circa 1536).
Neither of these two men, however, had
ever published his observations. Both
understood the function of the valves no
better than Fabricius did.
The Latin word ostiolum, correctly
translated, means little door. Translating
it to mean valve is questionable. Whether
or not Fabricius correctly named the
valves, it is plain that he completely mis
understood their function. He was aware
that they opened upward and accepted the
established idea that the function of the
veins was to afford a passage of blood to
the extremities, but he had no notion that
the blood might be moving in the oppo
sition direction, toward the heart. To his
way of thinking, the ostiola were placed
where he found them to delay the passage
of blood downward in the lower limbs
and not to act as valves preventing it. Lit
tle doors they were, partly opened to per
form their function, in his construct.8
In his dedication of De Motu Cordis,
Harvey takes pains to profess his pro
found faith in the philosophic love of
truth and wisdom, from whomsoever it
might come. At the same time he depre
cates making attacks on the errors of his
predecessors and teachers; he was loathe
to provoke his contemporaries, anticipat
ing how controversial his discoveries
would be. And yet, he found it impossi
ble entirely to avoid making these attacks.
More than once he is found naming his
old teacher, Fabricius, as the propagator
of erroneous doctrines. It is pertinent to
note that in chapter 13 he designated the
valves by the Latin word valvula, not
ostiola. He proceeded to point out that
“ the discoverer of the valves did not
rightly understand their real function, and
others went no further” .
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Evidence in the Lumleian Lectures

Evidence in Harvey’s early anatomy
lecture notes suggests that even he did
not, as early as 1616, fully understand the
implications of the venous valves, or the
fact that they gave free passage to the
blood toward the heart, but opposed its
passage the other way. The notes Harvey
prepared for his lectures, now in the Brit
ish Museum, were written on folded fool-
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scap paper. In the opinion of Keynes and
other experts, folio 80, including the terse
passage which at last clearly comprehends
and explains the circulation of the blood,
was inserted much later than 1616, the
date at which it is arranged in chronologic
order with the other folios. The rest of
the lecture notes do not appear to have
taken the discovery of the circulation into
account. He certainly did not realize the
point when he witnessed the demonstra
tion by Fabricius, and a long interval,
perhaps until 1627, elapsed before he
dared to question his teacher’s interpre
tation, at least in public discussions. Har
vey waited to demonstrate the truth in his
book published 25 years after the appear
ance of the treatise by Fabricius.
In the seventh chapter of De Motu
Cordis, Harvey argues closely, with the
supporting passages from Galen, how the
blood finds its way from the right ventri
cle through the parenchyma of the lungs
into the pulmonary vein and left ventri
cle. He never did see the capillary vessels
giving passage to the blood; lack of
refined optical apparatus prevented him
from seeing and demonstrating them.
Galen’s errors are corrected, but Harvey
credits him with having provided conclu
sive evidence for a pulmonary circulation
by his description of the valves of the
heart and the passage of blood through
the lungs. Nowhere in his writings did
Galen provide a clear statement of it.
Harvey provides his own arguments,
using Galen, as far as he went, to support
them. His interest was in demonstrating
a general systemic circulation, not in
proving the existence of the lesser circu
lation.
Geoffrey Keynes, in his life of Harvey,
has subjected De Motu Cordis, chapter
by chapter, to a thorough textual analy
sis. There is far too much of interest in
his biography to discuss within the space
of a short article.9 Strangely, however,
his study does not mention Harvey’s
failure to apply his discoveries to his clin
ical practice. Harvey eventually came to
realize many of the consequences that
would follow from the illuminating truth
he had revealed with his discovery of the
circulation, affecting every part of medi
cine — physiology, pathology, therapeu
tics. It is surprising, therefore, that Har
vey never made any direct application of
his findings on the circulation to his clin
ical practice of medicine, although he had
examined closely and in full detail the
structure of the heart and disclosed many
new findings on its mechanical efficiency.
Harvey’s mind did not work like
Francis Bacon’s. He was more like
Galileo or Gilbert, engrossed in his par
ticular problem, and sometimes unaware
of the possible repercussions of what he
was discovering. In spite of his advanced
views on the circulation of the blood,
Harvey was still Artistotelian in his prac

tice of medicine. And yet his work had
an influence on the development of the
scientific method wide and universal
enough to have satisfied even a mind like
Bacon’s.
Conclusions

The continuing fascination with H ar
vey derives mainly from his work and
influence as the discoverer of the circu
lation of the blood. As a scientist he was
sui generis. It is often overlooked,
however, that he chiefly made his way in
life by filling a more conventional role,
that of the practising physician. It is not
unnatural to think of Harvey as having
devoted the bulk of his attention to anat
omy, dissection and scientific experiment,
but this view of him loses a sense of
proportion. While still a student at
Padua, he was studying medicine in its
widest possible meaning. In 1662 Sir
Charles Scarburgh characterized him as
“ one not to be bound by the laws of a
single discipline” . He had gathered
professional knowledge from experience
in hospital wards and autopsy chambers
as well as in lecture theatres that would
later be applied to a wide range of patients
in private as well as public practice, and
that would include two kings of the
realm, James I and Charles I. Harvey in
fact was to distinguish himself by busily
developing an uncanny capacity for
observation of everything that concerned
him as a doctor.

It is with that role as fellow of the Col
lege of Physicians in London and as a
medical practitioner during the years he
worked at St. Bartholomew’s Hospital
that a second article will be concerned.
From 1609 onwards, Harvey’s time was
divided between his hospital duties, his
private practice, his anatomical and phys
iological research, and his various duties
at the College of Physicians, in which he
held every office available to a fellow
between 1607 and 1628 except that of
president. In September 1654 the College
of Physicians elected Harvey president,
an honour he declined for reasons of old
age and failing health. He was intensely
loyal to its status and dignity for the
remaining years of his life.
References
1. KEYNES G: The Life o f William Harvey, Clarendon,
Oxford, 1966: 185
2. BAYON HP: William Harvey, physician and biologist: his
precursors, opponents and successors. A n n Sci 1938; 3:
436-456
3. WHITTER1DGE G: Harvey’s Galen. Barts H osp J 1957;
61: 175
4. DALLA Vo lta A: Harvey at Padua. In McMlCHAEL J
(ed): Circulation: Proceedings o f the Harvey Tercentenary
Congress H eld on June 3rd-June 8th, 1957 at the Royal
College o f Surgeons o f England, London, Blackwell,
Oxford, 1958
5. UNDERWOOD EA: The early teaching o f anatomy at
Padua. A nn Sci 1963; 19: 1-26
6. PAGEL W: New Light on Harvey, Karger, Basel, 1976: 13
7. Randall JH : The development of scientific method in
the school of Padua. J Hist Ideas 1940; 1: 177-206
8. KEYNES G: The Life o f William Harvey, Clarendon,
Oxford, 1966: 29
9. Idem: Ibid: 175-187

NOTICES
continued from page 116

Progress in Vascular Surgery

American Back Society

“ Progress in Vascular Surgery” is the ti
tle of a course being sponsored by the
University of Minnesota Medical School.
The course will be held June 17-19, 1987
in Minneapolis. Write to Office of CME,
University of M innesota, Box 202
UMHC, 420 Delaware St. SE, Minneapo
lis MN 55455 for information or call (612)
626-5525.

A Symposium on Back Pain will be held
in Anaheim, Calif., Apr. 29-May 2, 1987,
sponsored by the American Back Socie
ty and St. Rose Hospital. The program
is approved for 18 hours Category I con
tinuing medical education credit. Contact
Dr. Rene Cailliet or Dr. Aubrey A.
Swartz, American Back Society, 2647
East 14th St., Ste. 401, Oakland, CA
94601; (415) 536-9929 for information.

Institutional Program
Guidelines

Applied Basic Science Course

Health and Welfare Canada’s publication
“ Cardiovascular Services in Hospitals”
has been approved by the Federal/Provincial Advisory Committee on
Institutional and Medical Services and is
available for distribution. A copy of these
guidelines may be obtained by writing to:
Mr. D.F. Moffatt, Chairman, SubCommittee on Institutional Program
Guidelines, Health Services Directorate,
Health Services and Promotion Branch,
Department of National Health and Wel
fare, Ottawa, Ont. K1A 1B4.

“ Behaviour of the Growth P late” is the
title of the title of the 14th annual applied
basic science course sponsored by the Di
vision of Orthopaedic Surgery of the
University of Ottawa, together with the
Pediatric Orthopaedic Society o f North
America. The course will be held May
13-15, 1987 at the Health Sciences Com
plex; more information can be obtained
by contacting Dr. Hans K. U hthoff, Di
vision of Orthopaedics, Ottawa General
Hospital, 501 Smyth Rd., Ottawa, Ont.
K1H 8L6; (613) 737-8377.
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BOOK REVIEWS
GREENHILL’S SURGICAL GYNECOL
OGY. 5th ed. Edited by Stephen L. Cor
son, Thomas V. Sediacek and Jerome J.
H offm an. 376 pp. Illust. Year Book Med
ical Publishers, Inc., Chicago, 1986. Price
not stated. ISBN 0-8151-1863-5.

This edition of Greenhill's Surgical Gynecol
ogy has been revised considerably from the last
version which appeared 17 years ago. As with
its predecessors, it is an atlas of monochro
matic drawings and photographs with a mini
mum of text. It attempts to describe and illus
trate the majority of surgical gynecologic
procedures.
Brief initial chapters are presented on the
handling of surgical instruments, basic fluid
and electrolyte metabolism, abdominal inci
sions and wound healing and pre- versus
postoperative care. The information contained
in these chapters might be of use to a surgeonto-be in the first days of training but is in no
way comprehensive.
The following chapters are divided by topic
into vulvar operations, urinary stress inconti
nence, vaginal, abdominal and obstetric oper
ations, sterilization and hysteroscopy. The
illustrations are clear and easy to follow, but
are necessarily limited by simplification of
detail, two dimensional character and lack of
colour. Normal anatomy is presumed and por
trayed for the most part, and the accompany
ing descriptive text is sparse.
The majority of the text is devoted to depict
ing gynecologic procedures. This might be of
use to a student, surgeon in training or “ old
hand” who needs a quick reference illustration
for teaching or personal review. Although the
chapters on obstetrics and sterilization might
interest a student, they are too brief and sim
plified to benefit an experienced surgeon.
In summary, this reference text in its latest
edition might be suitable for a university hospi
tal or operating-room library. Whether or not
it would be of value in one’s personal library
is best left to individual preference.

P hillip F. H all , md , frcsc
Assistant professor,
Obstetrics and Gynecology,
University of Ottawa,
Ottawa General Hospital,
501 Smyth Rd„
Ottawa, Ont.
K1H 8L6

INFECTION IN THE FEMALE. 2nd ed. Wil
liam J. Ledger. 293 pp. Illust. Lea &
Febiger, Philadelphia, 1986. $51.25. ISBN
0-8121-0992-9.

Few aspects of obstetrics and gynecology have
undergone more recent change than those con
cerned with infections. Examples of such
changes are the appreciation of the significance
of organisms (papillomavirus, Chlamydia), the
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improved technology that now allows routine
culture of potentially virulent organisms
(anaerobic bacteria), the necessity of using
combinations o f antibiotics (clindamycin and
aminoglycosides) when treating postoperative
soft-tissue infection and the augmentation of
antibiotic choice (second and third generation
cephalosporins, ureidopenicillins). There is a
need to bring the whole subject together and
to put the new information into perspective.
This book’s 12 chapters are arranged in a
logical format. The first seven discuss such
basic topics as microorganisms, their labora
tory handling, the host response and antibiotic
therapy; the clinical portion consists of four
chapters that separately discuss obstetrical and
gynecologic infections as acquired in either
community or hospital; there is also a section
on adverse fetal outcomes.
The first chapter is a brief historical outline,
the second a perhaps too sketchy bacteriologic
overview. The third chapter pertains to the col
lection of specimens for microbiologic culture,
and it was disappointing. Whereas I had hoped
to find clear guidelines for the investigation of
patients with postoperative fever, I found the
advice to be confusing. For example, one page
advocated culdocentesis, the next page sug
gested that the procedure was of little value.
The chapter on the laboratory testing of antibi
otics is especially involved with measuring
serum levels of aminoglycosides. Toxic levels
of this drug are rarely reached in obstetrical
and gynecologic patients because renal func
tion of our more youthful patients is generally
good. Ledger points out that the levels may not
be therapeutic.
The chapter on the host response to infec
tion was excellent. For a brief moment I under
stood helper, suppressor and cytolytic T cells
and the role o f T cells in the secretion of lymphokines (lymphokines stimulate monocyte
phagocytosis). In acquired immune deficiency
syndrome (AIDS) the T cell’s lymphokine
secretion is suppressed; patients thus become
subject to diseases that are controlled by mono
cyte phagocytosis (i.e., fungi, viruses).
The chief interest in the chapter on a “ clin
ical overview” was the evaluation of journal
articles; although it was interesting, I am not
certain why it was included. The prophylactic
use of antibiotics is an important subject, but
I thought the discussion was outdated. For
instance, I examined all references cited in
chapters 7 to 10 and found that 48% of them
dated to 1977 or before.
There is a fine discussion on the animal
model of mixed bacterial infection, which is
the basis of our present understanding of softtissue infections and peritonitis. It was personal
and the author’s long experience and familiar
ity with the subject allowed a critical review.
The chapter on community acquired gyneco
logic infections was not up to expectations.
There seemed to be undue emphasis on herpes
infections. Clinical experience would suggest
that more information on recurrent yeast infec
tions is needed. Biopsy for condyloma of the
vulva, culture of the vagina for ureaplasma

urealyticum or draining the peritoneal cavity
through the vagina should rarely be required
as opposed to the frequency recommended in
this chapter. Further, the indifferent results
that apparently follow subcuticular sutures
with appendectomy are not reasons to discon
tinue their use with abdominal hysterectomy,
and the advocation of colpotomy was not con
vincing. Much of the chapter on hospitalacquired gynecologic infections concerns
postoperative fever but since no information
was given of the relative importance of each
etiologic factor, the chapter was not very help
ful clinically.
Maternal infections with adverse fetal out
comes would have been better served by includ
ing AIDS and reducing the information related
to syphilis; the whole chapter seemed strangely
dated. The last two chapters were unsatisfac
tory, much was unrelated to obstetrics and
gynecology or was repetitive, with the excep
tion perhaps of the sections on soft-tissue infec
tions and endometritis.
There is certainly a need for a book of this
sort. Should this be your first choice? I think
not.

M.E. Boyd , md , frcsc
Vice-chairman,
Department of Obstetrics and Gynecology,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1AI
PROGRESS IN PEDIATRIC SURGERY.
Volume 19. Long-gap Esophageal Atresia.
Prenatal Diagnosis of Congenital Malfor
mations. Edited by P. Wurnig. 205 pp.
Illust. Springer-Verlag New York, Inc.,
New York, 1986. $55.50 (US). ISBN
0-387-15881-2.

This volume of Progress in Pediatric Surgery
covers primarily the treatment of long-gap
esophageal atresia and to a secondary degree
the prenatal diagnosis of congenital malforma
tions and their possible treatment.
The problems of long-gap esophageal atre
sia for which primary anastomosis is difficult
or impossible are dealt with in 12 papers that
review the world literature fully. In most cases
they also report the individual author’s per
sonal experience. Earlier methods of bridging
the gap between the two ends of the esopha
gus are discussed, including colonic or jejunal
grafts on a vascular pedicle. More recently, a
reversed gastric tube has been used. The dic
tum of Nathan Myers that the patient’s own
esophagus is the best is generally held and there
have been many attempts to find a method of
repair that avoids the use of transplanted intes
tine or stomach. Various stretching procedures
that have been used in attempts to elongate
both the upper and lower pouches are covered.
The circular or spiral myotomy of Livadites,
which has been used extensively, particularly
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in the upper pouch, is also described. These
myotomies are generally considered to be of
value in elongating the esophagus. Various ten
sion methods of drawing the two ends of the
esophagus together using variants on Rehbein’s
Olive technique are described. So also are
attempts to create a fistula between the two
pouches using suture material to pass across
the gap between them after high-tension
approximation. There is still considerable dis
cussion as to the efficacy of these methods.
Although reconstruction of the thoracic
esophagus using autotransplantation of small
intestine has been carried out in an experimen
tal model in piglets, it has not been used in
humans. Moreover, it is unlikely to be used in
the neonate because of problems in vascular
anastomosis. Interesting experimental work in
animals has been done using jejunal mucosa
and submucosa alone. But, in general, exten
sive dissection of the upper pouch combined
with Livadites myotomy appears likely to offer
the best chance of a primary anastomosis.
Although gastric tube replacements have their
own problems they are probably superior to
colonic replacements. Interest in this section
will be limited mainly to pediatric surgeons,
although it may be of interest to thoracic sur
geons working with caustic burns of the
esophagus.
The second part of the volume concerns
antenatal ultrasonographic diagnosis of con
genital malformations. All the papers in this
section originate from Europe. The advantages
to the child include biochemical and genetic
screening. If the diagnosis is accurate — and
the accuracy rate for many abnormalities is
really very high — the information may allow
choices as to the best time for delivery, the best
type of delivery, the possibility of intrauterine
surgery and considerations as to whether the
pregnancy should be terminated. The possibil
ities for intrauterine surgery are extremely
limited, and these articles clearly indicate that
unreasonable expectations of success have been
raised. The knowledge of an antenatal diag
nosis can, however, be valuable. For example,
gastroschisis, an abnormality of the abdomi
nal wall, is commonly the only abnormality
present, so the outlook for such children, if
treated promptly at birth, is good. Primary
closure of the abdomen in an otherwise healthy
child can be successfully carried out in more
than 80% of cases. On the other hand, a diag
nosis of omphalocele suggests the likelihood
o f multiple congenital abnormalities, so the
prognosis would be much more guarded. Chro
mosomal examination of the amniotic fluid
may give more information, allowing a more
informed decision as to the treatment of the
infant.
This second part is particularly valuable in
that it raises in a most logical way the problems
and advantages of being able to make an
antenatal diagnosis of the congenital lesions.
However, it often does not and cannot offer
a life-saving solution for the individual child.
This book should be in the libraries of all
major hospitals and medical schools.
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Professor and chief of surgery,
Children’s Hospital of Eastern Ontario,
401 Smyth Rd.,
Ottawa, Ont.
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Surgeon
Required
An excellent opportunity exists for an
experienced Fellow ship General Sur
geon to practice in a new 150-bed facility
with expansion potential to 300 beds.
Our facility boasts state-of-the-art tech
nology with 4 O.R. theatres currently in
use.
We are a young, affluent community of
35,000 with outstanding recreational
and cultural facilities.
For further information write in con
fidence to: Mr. Grant Lemon, President,
Fort McMurray Regional Hospital, #7
Hospital Street, Fort McMurray, Alberta
T9H 1P2 Phone (403) 791-6161
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1 month before issue
date. Regular classified rates (for each insertion): $40.00 for the first 40 words or less, additional words 50C each (additional $16.00 for frame). Special Display
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HEAD, MULTI-ORGAN TRANSPLANTATION
PROGRAM — The University of Toronto, Depart
m ent o f Surgery is seeking Head of its Multi-Organ
Transplantation Program. The incumbent w ill be
expected to integrate the existing renal, liver, lung
and heart transplant program and to develop a
pancreas transplant program. He/she would be ex
pected to develop a training program in transplan
ta tio n and facilitate the development of research
in parallel w ith the clinical program. Applicants will
be expected to have an established reputation in
organ transplantation as well as in teaching and
research. Applications and curriculum vitae should
be sent to : Dr. B. Langer, Chairman, Department
of Surgery, University of Toronto, 100 College St.,
Toronto, ON M5G 1L5. Closing date for receipt
o f applications is May 30, 1987. Effective date
o f appointm ent as early as September 1, 1987.
In accordance with Canadian immigration require
m ents th is advertisement is directed to Canadian
citizens and permanent residents o f Canada.
-S 8 7 -4 4
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GENERAL SURGEON: BC — locum required for the
m onth of July in the Cariboo, for a full accredited
80-bed active surgical hospital w ith tw o ORs and
one endoscopy, drawing from a catchm ent area
o f approximately 40 000. Current medical staff
includes one other general surgeon to share call
w ith three other specialists and more than 14
general practitioners. The summer can be very
busy. Apply to : Dr. P.A. Cullum, 203 — 143
Fourth Ave. South, Williams Lake, BC V2G 1J8.
—S87-42

CLINICAL DAYS IN CRITICAL CARE
PRESENTED BY THE INTENSIVE CARE UNITS
OF TORONTO GENERAL HOSPITAL
APR IL 2 & 3, 1987
D A Y 1 - A P R IL 2nd.
INTENSIVE WORKSHOP IN CRITICAL CARE.
Intensive re v ie w of current topics w ith hands on skill
stations.
REGISTRATION IS RESTRICTED TO 16 PHYSICIANS.
FEE FOR DA Y 1: $ 15 0.00 (edn funds).
DAY 2 - A p ril 3rd.
CLINICAL DAY.
Clinical presentation of current topics of in terest to
internists, anaesthetists, surgeons and nurses manag
ing patients in intensive care units.
NON-RESTRICTED REGISTATION.
FEE FOR D A Y 2: PHYSICIANS $50 .00
NURSES
$ 25 .00
For more information regarding registration, please con
tact: Deborah J. Wilson; 416-595-4623. —S 87-43

Auto Suture Company Canada
Inside Front Cover
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Davis & Geek
Outside Back Cover

Available J uly 1, 1987 for a one year period
in a Medical — Surgical Unit. Duties comprise
clinical research in a strong academic and
teaching unit. Present research includes the
clinical epidemiology of ICU care, nutrition,
and respiratory muscle physiology.

Du Pont Pharmaceutical
90, 132

Frosst
Mefoxin

8 4 ,8 5 ,1 2 2 ,1 2 3

Reply to: Dr. I.M. Fraser, Director, EAICU
Ste. 246, E.K. Jones Bldg
160 Wellesley St.E
Toronto, ON M4Y 1J3.
Tel. (416) 92 6 -7 7 4 7
-S 8 6 -3 5

Glaxo Laboratories
Zantac

86,119

Johnson & Johnson
Nu-Gauze

76

Pharmaceutical Manufacturers
Association of Canada
113, 114

Rhone-Poulenc Pharma Inc.
Stemetil

78

Royal College of Physicians
and Surgeons of Canada, The
89

Searle Pharmaceuticals
Metamucil/Anucaine

102, 110

Upjohn Company of Canada, The
Dalacin C
144

MICROSURGICAL COURSE: — The Department
o f Surgery, McMaster University is now offering
one week, on-going courses in microsurgery, us
ing animal facilities and videotapes. These courses
are for anyone interested in small vessel anasto
mosis, nerve repairs, vas and fallopian tube recon
structions. The laboratory is organized to guide
you through the basic microsurgical techniques to
more advanced tasks w ith the help of an assis
tant on a one-to-one basis. Please call: Dr. A. Thoma at (416) 523-0019 for further information.
-S 8 6 -2 3

CLINICAL FELLOWSHIPS
Ewart Angus Intensive Care Unit
Wellesley Hospital
Toronto

Bard Canada Inc.

Coumadin

ACADEMIC APPOINTMENT: ON - Queen s
University, Department of Surgery geographic full
tim e position in general surgery. Applicants should
be licensed to practise in Ontario and be Fellows
o f The Royal College of Physicians and Surgeons
o f Canada. The successful candidate will be ex
pected to teach at undergraduate and postgradu
ate levels and engage in research. He/She w ill be
expected to have specialized training and interest
in critical care/trauma. The closing date for appli
cation is March 31, 1987. In accordance w ith
Canadian immigration requirements, this adver
tisem ent is directed to Canadian citizens and per
manent residents. Candidates o f both sexes w ill
be given equal consideration. Applications w ith a
curriculum vitae and the names o f three referees
should be sent to: Dr. Charles Sorbie, Head,
Department of Surgery, Queen's University, King
ston, ON K7L 3N6.
-S 8 7 -3 9

100, 101, 126

HEAD, DIVISION OF ORTHOPEDIC SURGERY The Hospital for Sick Children (University of
Toronto) a 587-bed teaching hospital is seeking
a Head for the Division of Orthopedic Surgery. The
division consists of six members who have been
extremely productive in clinical and research ac
tivities. The characteristics w hich w ill be consi
dered in applicants include excellence in patient
care, leadership in teaching, adm inistrative capa
bilities and demonstrated achievements which
would foster research w ithin the division. The ap
plicant m ust be certified or eligible for certifica
tion by The Royal College o f Physicians and
Surgeons o f Canada. In accordance w ith the im
migration requirements, priority will be given to
Canadian citizens and permanent residents of
Canada. Please reply w ith curriculum vitae to:
Robert M. Filler, MD, Surgeon In Chief, Depart
ment of Surgery, University of Toronto, 555
University Ave., Toronto, ON M5G 1X8. -S 8 7 -4 1

How do you spell
truth in
advertising?

PAAB
CCPP
This logo appearing on pharmaceutical advertisements In
professional journals means that the advertisements have
been reviewed—and cleared for publishing— by the Phar
maceutical Advertising Advisory Board/Conseil Consuttatif
de Publicity Pharmaceutique.
This unique screening system for pharmaceutical advertis
ing is the first of its kind in North America. The Board of
Directors is composed of individuals representing the fol
lowing organizations: • Association des fabricants du
Quebec de Produits Pharmaceutiques • Association des
medecins de langue frangalse du Canada • Association of
Medical Media • Canadian Advertising Advisory Board •
Canadian Drug Manufacturers • Canadian Medical Associa
tion • Canadian Pharmaceutical Association • Consumers'
Association of Canada • Pharmaceutical Manufacturers
Association of Canada.
The Health Protection Branch of Health and Welfare Canada
acts as advisor and resource body to the board.
The program ensures the accuracy of pharmaceutical ad
vertising to the health professions, so that It may continue
to serve the ultimate best interest of the patient.
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Bard introduces the Harvard PCA
Patient'Controlled Analgesia System.

Now, there’s a much better way to
control pain. Because now there’s
the Harvard PCA* System.
It’s far more effective than intra
muscular injections. It infuses in
travenous analgesics on patient
demand.. .but only under physicianprescribed dosages and intervals.
By just pushing a button, patients
can self-administer small doses of
medication more frequently. Relief
is immediate. Patient anxiety is
reduced.
And because there’s optimal serum
concentration, the cycles of pain
and sedation are minimized.
Plus, research+ indicates that
patients using a PCA pump may
require less medication, experience
faster recovery time and prefer PCA
to I.M. injections.

NOW,
PAIN CONTROL
IS RIGHT
AT H AN D...

Accuracy, to ±1%, special
security, detailed recall.
The Harvard PCA* System is accu
rate to ±1% to prevent overmedica
tion. It’s safe, with a broad range of
status alarms, and a locked narcotics
compartment and access code.
For flexibility (and cost savings),
the system can be used in a PCA
mode, a PCA/Basil mode and a
Continuous Infusion mode. All three
modes use a 60 cc syringe that’s not
prefilled. So you can choose your
own medication and concentration.
And a detailed history recall
provides hour-by-hour review of
patient cumulative dose attempts,

m/s\mro

Bard Canada Inc.
2345 Stanfield Road
Mississauga, Ontario L4Y 3Y3
1-800-268-2862

injections, and prescribed dose and
interval.
To evaluate the Harvard P C A *
System in your hospital, call Bard
Canada Inc. 1-800-268-2862.
Or just clip and return the coupon
below.
Now, physician-prescribed, patientcontrolled pain relief is right at
hand.

Clip and mail to:
Bard Canada Inc.
2345 Stanfield Road
Mississauga, Ontario
L4Y 3Y3

Please send details on the Bard
Harvard PC A * Patient-Controlled
Analgesia System.
N am e_
Address
City_____________ Prov.______ Postal Code
Hospital Affiliation______________________
P hone(

"“Trademark
+ Bennett, R.L., Griffen, W.O.,: Patient Controlled Analgesia.
Contemporary Surgery. 23:75-89; 1983.

)__________________________

Meet som e members
of our family
Mow a monofilament suture
that is easy to handle and tie

now comes the
Even Greater Stapler

■

• Soft, supple, flexible
• Resists kinking
• Yields secure knots
•Strong
the manageable monofilament.

ULC
Ultra Light Compact
disposable skin stapler

gfe,;.-

Automatically released staples
Improved staple visibility
Proven reliability
Allows for excellent accuracy
Quality stapler supplied inexpensively

FO R A DIFFfIRENCE
YOU CAN] FEEL.
n e w p r e [■CYDE*
j (Ctdorlwxidine Gluconate)

TV Tew Pre-Cyde is the only

IN germicidal antiseptic hand
wash that combines all the
effectiveness of chlorhexidine
with a gentle emollient to
sooth the skin.

M
DEXON PLUS
Excellent knot security plus superior handling
and smoother tissue passage.

quality

Pre-Cyde's broad antibacterial
spectrum makes it an excellent
bactericidal and fungicidal
antiseptic!2

Pre-Cyde is safe, virtually
non-irritating,'and has a
pleasant emollient...for a
difference you can feeL

products from

DAVIS+GECK
Cyanamid Canada Inc.

i

A TRADITION OF INNOVATION

Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5

•Registered Trademark of Cyanamid Canada Inc.

